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ABSTRACT 
Introduction and Background 
Measles, mumps and rubella (MMR) are infectious diseases, primarily of childhood, which 
cause significant mortality and morbidity globally. These infections are, however, vaccine 
preventable and there is potential for them to be eradicated worldwide through the strategic 
use of organised population immunisation programmes.  
 
Following the introduction of the MMR vaccination in the UK in 1988, uptake was initially 
good and a high level of population vaccination coverage was achieved. This was sustained 
until 1998 when a study by Dr Wakefield and colleagues was published in the Lancet 
suggesting the theoretical possibility of an association between MMR and Autism /bowel 
disease. Intense media coverage followed, uptake of MMR vaccine fell to less than 80% in 
Somerset, and community outbreaks of measles, which had almost been eliminated in the 
UK, began to reappear. The Wakefield study was subsequently discredited and was 
eventually retracted by the Lancet in 2010. 
 
In August 2008 the Chief Medical Officer announced a national MMR catch-up campaign, 
targeting all children between the age of 13 months and 18 years who had either not been 
vaccinated against measles, mumps and rubella, or had only partial immunisation. These 
children were invited again for vaccination and the campaign was completed in January 
2009.  
 
This study was undertaken to explore, in depth, the quantitative data available in respect of 
the uptake of MMR at the time of the 2009 campaign, and also to provide new qualitative 
data in relation to the attitudes, beliefs and experience of MMR and immunisation services of 
parents who continued to decline MMR for their children after the 2009 campaign, in order to 
identify factors which affected parental decision-making, add to the wider knowledge base, 
and to use this knowledge to improve the future development of immunisation services in 
Somerset. 
 
Methods 
The overall objective of the study was to investigate a number of social, demographic and 
geographic characteristics of parents and children associated with MMR uptake, to compare 
these characteristics within and between defined sub-sets of the Somerset population, and 
to explore the basis on which parents in Somerset make decisions in relation to MMR 
immunisation.  
 
The study design adopted was a ‘mixed methods’ approach comprising of a cross-sectional 
design with three sequential phases -  an exploration of baseline epidemiological data; a 
survey conducted with parents of children who remained unimmunised after 2009; and 
finally, semi-structured interviews with a sub-set of these parents.  
 
Results 
The key findings from the study are: 
Parents who decline MMR for their children are not a homogenous group, but consist of a 
number of sub-groups each of which have different motives, decision pathways and 
predicted outcomes in relation to potential to change their mind and accept MMR 
There are differences in geographic distribution between the two age groups investigated  
 
Whilst the ‘Wakefield’ study did, and still does have, an impact, it is not the only or most 
important factor in their continuing decision-making. 
 
There is evidence that health professionals have a key role in addressing parental concerns 
in respect of immunisation. GP practice was the most significant factor associated with 
uptake in the Phase 1 study, and this was further confirmed in interviews with parents.  
 Parents make decisions through engagement, through communicating and relating to others 
and this offers a potential mechanism for health professionals to influence decisions through 
open engagement with parents.  
 
Discussion and Conclusions 
Three parent sub-groups were identified (Single Vaccines; Medical Comorbidities and 
Natural Health). These sub-groups were further investigated and factors associated with the 
decision-making pathways of each group were identified. This resulted in the development of 
the ‘MMR Parent Engagement Framework’ as a tool for use by professionals in planning 
their interactions with parents to improve and encourage more open dialogue in order to 
positively influence parental decision-making in relation to accepting MMR or other 
vaccinations.  
 
From a commissioning perspective, embedding frameworks such as this in service 
specifications offers a more cost-effective approach to improving immunisation uptake than 
funding large, poorly targeted catch-up campaigns. It is therefore recommended that further 
research is undertaken to provide evidence of the effectiveness of the approach in practice, 
and to inform future commissioning decisions.  
 
Additional recommendations to improve the effectiveness and delivery of immunisation 
services are also made in respect of GP Practice specific factors, independent schools, 
ethnic minority communities, vaccine overload, media, and data validation.  
The study has already directly influenced changes in current practice at both a local and a 
national level. 
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CHAPTER 1: INTRODUCTION AND OVERVIEW OF THE THESIS 
 
1.1 Background to the Thesis 
Measles, mumps and rubella are infectious diseases, primarily of childhood, which at 
2013 continued to cause significant morbidity in the UK, and high morbidity and 
mortality globally (Ramsay, 2013). These infections are, however, vaccine preventable 
and there is considerable potential for them to be eradicated worldwide through the 
strategic use of organised population immunisation programmes.  
 
Measles vaccine was first introduced in the UK in 1968, but coverage for this initial 
programme was not high enough to interrupt disease transmission (Department of 
Health, 2013, Ch. 21). The introduction of a combined Measles, Mumps and Rubella 
(MMR) vaccine in 1988 proved far more effective. It was initially well received by 
parents and resulted in a significant decline in measles notifications (Ramsay, 2013). 
However, in 1998, there was controversy over the use of MMR vaccine resulting from 
speculation (in a now discredited research paper published in the Lancet) that the 
vaccine might be associated with inflammatory bowel disease and developmental 
disorders, such as autism (Wakefield et al, 1998). MMR uptake declined to less than 
80% in England by 2003/04, and in some areas 44% of pre-school and 22% of primary 
school aged children remained unimmunised. Uptake remained under 90% up to 2008, 
resulting in a gradual increase in the number of susceptible individuals in the 
population which could potentially sustain prolonged outbreaks of these diseases 
(Health Protection Agency, 2013) (See Appendix 1). 
 
In August 2008, prompted by an increase in the number of cases of measles, the Chief 
Medical Officer announced a national MMR catch-up campaign targeting all children 
between the ages of 13 months and 18 years who had either not been vaccinated, or 
who had only partial immunisation, against measles, mumps and rubella (CMO, 2008). 
18 
 
These children were invited again to attend for vaccination. It was a resource intensive 
programme involving the issuing of invites to 13,800 children in Somerset, and was 
completed by March 2009.  
 
This thesis documents the design and implementation of a research project that was 
undertaken to explore, in depth, the quantitative data available in respect of MMR in 
Somerset at the time of the 2009 MMR Catch-up Campaign, and to provide new 
qualitative data in relation to the attitudes, beliefs and experiences of MMR and 
immunisation services of a sub-set of parents’ who, at the end of March 2009, 
continued to decline the vaccination. The aim of the study was to identify the 
characteristics of parents who continued to decline MMR and any factors which 
influenced parental decision-making within this sub-set of parents; to add to the wider 
knowledge base in this area of inquiry; and to use this knowledge to improve local 
immunisation services.  
 
1.2 Purpose and Rationale for the Study 
In 2009, there was a requirement for Primary Care Trusts (PCTs) to achieve 95% 
uptake of two doses of MMR in children aged five years; this was a core public health 
target in 2009 and remains one of the current national public health outcome measures 
(Public Health England, 2015). Achieving the 95% target was considered particularly 
challenging for NHS Somerset which had one of the lowest rates of MMR uptake in the 
South West  with uptake of first dose of MMR (MMR1) at only 87% at Q4 2009 (NHS 
Information Services, 2009) (See Appendix 2), 
 
A review of the literature, particularly the unpublished documents obtained from the 
national immunisation team, provides evidence of considerable efforts by national 
health protection and immunisation leads, governmental departments, and 
researchers, to explore parental attitudes and improve communication in relation to the 
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risks and benefits of MMR with parents of children aged under five throughout the 
2000’s (Martin & Sandson, 2003; Yarwood et al, 2006; Scottish Health Feedback, 
2008). Maternal tracking studies undertaken annually by the Department of Health had 
begun to indicate a small but steady increase in acceptance of MMR by mothers of 
children aged up to five years of age in 2009 and this progress has continued (Cragg 
Ross Dawson, 2010; BMG Research, 2015). However, uptake of a complete course of 
two doses of MMR at age five continues to lag behind this improvement in primary 
course uptake, resulting in a pool of susceptible children of school age which increases 
year on year (Ramsay, 2013).  
 
The maternal tracking surveys referenced above focus specifically on parents of 
children aged less than five years. In addition, many of the previous studies have 
explicitly excluded ‘confirmed rejectors’ of MMR and those clearly opposed to 
immunisation from study samples, believing that divergent views were unhelpful, or 
had a tendency to create group conflict, or that recruiting ‘refusers’ was more difficult 
(Hershey et al, 1994; Martin & Sandsom, 2003; Yarwood et al, 2006; Scottish Health 
Feedback, 2008). As a result, parents who continue to decline MMR for their school 
aged children are, by default, a somewhat ignored and poorly understood group within 
the wider parent population.  
 
Evidence obtained from personal communications with Mary Ramsay and Jo Yarwood 
of the national Immunisation Team, and with health professionals at the national 
‘Fundamentals of Immunisation Course’ 2013, also suggest that a number of 
assumptions have been made by health professionals about this group of parents. 
These assumptions are that they form a single homogenous core of ‘refusers’ who, 
after many previous approaches, are unlikely to be persuaded to accept MMR under 
any circumstances in future. Many professionals therefore feel that there is limited 
value in engaging with them further. Parents who continue to decline MMR are also 
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assumed to be likely to have ‘alternative health beliefs’; and to have been primarily 
influenced in their decision-making by the ‘Wakefield MMR controversy’. There are, 
however, very few studies that explore parental attitudes to and experiences of 
immunisation beyond the primary schedule (Tickner, 2008). I was only able to identify 
one published study which focussed specifically on the attitudes and beliefs of parents 
of school aged children (Salmon et al, 2005) and this paper appeared to challenge 
these assumptions, but the research was undertaken in the USA and it is therefore 
unclear whether the findings are applicable to other populations or healthcare systems.  
This lack of evidence highlights the need for further investigation. 
 
An understanding of the reasons for parents persisting to decline MMR, years after the 
evidence presented by Wakefield et al (1998) was discredited and beyond the age that 
autism is clinically agreed to develop; or of what influences them to change their minds 
and accept MMR at a later date where they do so, are also significant gaps in the 
present evidence, but an understanding of these factors is essential if uptake is to be 
improved and outbreaks of disease minimised in this group of young people.  
 
‘Choosing Health’ the Public Health White Paper (2004) highlighted the need for PCTs 
to examine immunisation uptake rates and identify the differences between population 
groups and geographical areas in terms of immunisation completion rates and access, 
suggesting that closer examination of local data might reveal hidden variation and 
might help improve the situation for those most in need of vaccination. The publication 
of Public Health Guidance 21 ‘Reducing the difference in childhood immunisation 
uptake’ (NICE, 2009) added further recommendations to enable PCTs to reduce 
variations in uptake, and also provided evidence of the cost-effectiveness of efforts to 
increase uptake rates for measles vaccination programmes, especially if targeted at 
low uptake groups.  
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A detailed examination of immunisation uptake in Somerset had not previously been 
undertaken. In addition, it was identified that data collected by the Health Protection 
Agency (HPA), although useful in terms of national benchmarking, did not utilise all of 
the information that was potentially available at PCT Child Health Records Department 
or General Practice level. I considered that using this data to more accurately identify 
factors affecting these persistent decisions to decline MMR could contribute to the 
redesign and more effective targeting of immunisation services, and therefore to 
increasing MMR uptake locally. It also offered the potential for the more effective use 
of NHS resources as well as the reduction of vaccine preventable diseases (measles, 
mumps and rubella) and their consequences.  
 
The present study was designed to capture both quantitative and qualitative data in 
relation to the uptake of MMR uptake in Somerset, and to identify factors affecting 
parents’ continuing decisions to decline the vaccination.  The aim of this study was to 
chart potentially modifiable factors associated with low uptake, and thereby to identify 
interventions which could be implemented to achieve improvements in MMR uptake 
and coverage. 
 
Any information which makes possible the identification of factors which encourage 
acceptance of MMR immunisation, particularly amongst those who remain 
unimmunised, could enable more effective, equitable and cost-effective services to be 
developed locally (and potentially more widely) which is both ethically desirable and 
increasingly necessary at a time of financial constraint. Identification of factors 
contributing to persistent decline of MMR and recommendations for changes to clinical 
practice to improve uptake were therefore agreed priorities for NHS Somerset in 2009, 
and I was supported to complete the research study by the Director of Public Health, 
the Director of Nursing and Patient Safety and the Somerset R&D Consortium.  
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The Phase 1 baseline epidemiological study of MMR uptake in Somerset was a 
necessary precursor to the development of the Phase 2 survey, and was intended to 
provide a framework for the subsequent qualitative elements of the research. Phase 1 
compared the demographic characteristics of accepting and declining families (parents 
and children) across two age groups of children, to see if any were associated with the 
decline of the offer of MMR in Somerset.  
 
The Phase 2 and 3 studies were then designed to be built upon this baseline review, 
with the objective of exploring the reasons why parents in these two groups continued 
to decline MMR after 2009; and to attempt to discover what had influenced them to 
accept MMR, if they had, at the time the survey and interviews with parents were 
undertaken in 2012. These qualitative elements focussed on a sub-set of parents of 
children who were offered MMR as part of the 2009 campaign, but who continued to 
remain unvaccinated after March 2009. The Phase 1 study is therefore reported in the 
thesis as an essential and integral part of the work I have undertaken as part of this 
research process.  
 
1.3 Research Questions 
The following research questions were posed:  
 What were the social, demographic and geographic characteristics of parents / 
children who had accepted and declined MMR in Somerset in 2009? 
 Are parents who persist in declining MMR a single homogenous group? 
 Does the ‘Wakefield study’ remain a primary factor influencing parents’ of 
school age children to decline MMR in Somerset, or are there other factors at 
play?  
 How have parents’ early experiences, attitudes and behaviours in respect of 
MMR and wider immunisation services influenced their longer term decision-
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making? Have their attitudes and behaviours changed over time, or as new 
experiences occur?  
 Why do some parents persist in declining MMR, despite having information and 
experiences which appear to counteract the basis on which their initial decision 
was made? 
 What factors influence parents who have persistently declined to change their 
mind and accept MMR for their school-age children? 
 
1.4 Overview of the structure of the Thesis 
Within this first chapter of my thesis I have outlined the background and structure of my 
study. The contextual factors underpinning my thesis are further explored in Chapter 2. 
In particular, the scientific evidence demonstrating the clinical significance of measles, 
mumps and rubella are reviewed to establish the relevance of this subject, and of 
maintaining uptake within the MMR immunisation programme, within the wider context 
of public health. This chapter includes detail of the epidemiology of the diseases, the 
contribution of measles and rubella to childhood mortality, the potential for the 
eradication of these diseases, and the history of measles, mumps and rubella control 
in the UK and Europe.  
 
The evidence related to parental attitudes and behaviours in respect of immunisation 
decision-making, and specifically in respect of MMR decision-making, is reviewed in 
Chapter 3. The initial scope of this review was considerable and the resulting body of 
social science, medical and psychological literature (published and unpublished) vast. 
As a result I have focussed on reviewing evidence in the main areas of parental 
attitudes and beliefs (in relation to both MMR and immunisation per se); decision-
making and MMR; factors affecting or influencing uptake; and specifically, autism / 
bowel problems and MMR. Additional searches in respect of herd immunity, individual 
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freedom and collective responsibility and immunisation, vaccine overload, and 
compulsory vaccination were also included as these themes emerged within the data.   
 
In Chapter 4, the methodological approach and specific research methods 
underpinning my research are presented. The rationale for the mixed methods 
approach is described, as is the rationale for the use of the survey as the basis for both 
the collection of data and the development of a framework to support the subsequent 
qualitative elements of the study. The three stages of the research design are 
described and the interaction between these illustrated. The process for data collection 
and analysis is explored as are ethical aspects of the research.  
 
In chapter 5, the results of the analysis of the Phase 1 and Phase 2 categoric data are 
presented. These findings relate primarily to research question one and illustrate the 
social and demographic characteristics of parents who declined the offer of MMR in 
Somerset in 2009 and their children.  
 
Chapter 6 presents the results of the thematic analysis of the qualitative data obtained 
from Phase 2 and 3 - the parent census survey (free text comments), and semi-
structured interviews with a sub-set of parents who responded to the survey and who 
had indicated that they would be willing to participate in further research. Nine themes, 
arising from this analysis are described in depth. The findings described within this 
chapter provide evidence in respect of research questions two to six.  
Whilst much of the analysis presented in chapter 6 provides evidence which confirms 
previous research findings in relation to the beliefs and attitudes of parents, and the 
factors that influence parental decision-making in respect of MMR, new evidence is 
presented in relation to the identification of three sub-sets of parents within the 
population of persistent decliners, each with different characteristics. The information 
obtained from the thematic analysis, is then applied to develop a Parent Group 
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Framework, which it is proposed could be used to improve parental engagement with 
immunisation services.  This proposition is further developed in Chapter 7 where the 
development of an overarching strategy for communicating with parents, and of parent 
group-specific actions to improve engagement and uptake, the ‘MMR Parent 
Engagement Strategy’, is presented.  
 
Finally, Chapter 8 presents the key findings and recommendations arising from this 
thesis, and concludes with an examination of the strengths and limitations of the study, 
and of the actual and potential impact of this study on current and future immunisation 
services and clinical practice. 
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CHAPTER 2: ASPECTS UNDERPINNING THE RESEARCH - THE PUBLIC HEALTH 
SIGNIFICANCE OF MEASLES, MUMPS AND RUBELLA 
 
2.1 Background 
Measles, mumps and rubella are childhood infections which cause significant morbidity 
and mortality in the UK and globally. The purpose of this chapter is to outline the 
current evidence in relation to disease epidemiology and clinical significance for each 
of these infections, in order to highlight their importance in terms of impact on wider 
public health. The rationale for implementing population-based vaccination 
programmes is also explored, together with the cost-benefit analysis in relation to 
implementation of MMR programmes, in order to further justify this study. This 
rationale includes consideration of measles, mumps and rubella as total contributors to 
childhood mortality (worldwide and in industrialised countries); of global initiatives to 
reduce measles mortality and the incidence of congenital rubella syndrome; and of the 
potential to eradicate measles and congenital rubella syndrome.  
 
The history of Public Health interventions to reduce the incidence of measles, mumps 
and rubella infections in Europe and the UK; and the impact of the ‘Wakefield 
controversy’ are also briefly examined to establish both the relevance and necessity for 
undertaking this study.  
 
2.2 Disease Epidemiology and Clinical Significance 
2.2.1 Measles  
Measles virus (genus Morbillivirus, family paramyxoviridae) is an enveloped, single-
stranded RNA virus (Hawker et al, 2012). It is one of the most highly contagious 
viruses known and remains one of the leading causes of death among young children 
globally, despite the availability of a safe and effective vaccine, with approximately 
158,000 deaths from measles occurring in 2011 (Strebel et al, 2011), mostly in children 
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aged under 5 years. Measles occurs primarily in humans; other animals are generally 
not susceptible. Prior to vaccines becoming widely available, more than 90% of 
individuals would become infected before the age of 10 years, with most cases being 
symptomatic. The measles virus is transmitted by direct contact and via respiratory 
droplet spread. These droplets can also spread to surfaces where the virus can remain 
transmissible for up to two hours (Perviz and MacMahon, 2006).  
 
The incubation period for measles is 10 – 14 days (range seven – 18 days) from time 
of exposure to onset of rash. Individuals become infectious from about four days 
before the rash appears, until four days after becoming symptomatic (Choi et al, 2008). 
At the onset of the rash, small red spots with bluish-white centres, known as ‘koplik’s 
spots’ can be seen on the buccal mucosa. These are a diagnostic feature of measles. 
Onset of the rash is also often accompanied by a very high fever, peaking at >40 C, 
swelling around the eyes, and photophobia (Department of Health, 2013, Ch. 21).   
 
The severity of measles varies widely, and depends on a number of host and 
environmental factors. The risk of developing measles increases for those aged under 
five years, those living in overcrowded conditions, malnourished individuals (especially 
those who have vitamin A deficiency), and in those with severe chronic conditions, 
including immunosuppression (Cochi / WHO, 2011).  
 
In industrialised countries, deaths from measles are rare, whilst case fatality rates of 5 
– 10% are commonly seen in developing countries. However, severe forms of the 
disease, and even death, can occur even in previously healthy individuals. Death 
occurs in 1/5000 cases in the UK. The case fatality ratio is age-related, being high in 
very young children (<1 year), lower in those aged 1 – 9 years, and then rising again 
for teenagers and adults. Pregnant women are also at risk of severe complications, 
miscarriage, or preterm delivery (Maya et al, 2011a)  
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Otitis media, laryngo-tracheobronchitis and pneumonia are all relatively common 
complications of measles. Otitis media occurs in approximately 7 – 9% of cases; 
pneumonia 1 – 6%; and convulsions in 1 / 200 children. Measles encephalitis, 
blindness and diarrhoea are other potential complications. Persistent diarrhoea, with 
protein-losing enteropathy can occur, particularly in infants and is significant contributor 
to mortality in developing countries (Maya et al, 2011b). 
 
2.2.1.1 Measles encephalitis is probably the most significant complication associated 
with measles infection. There a number of forms which occur at different times in 
relation to the onset of the rash, as follows:  
 Post infectious encephalitis occurs at around one week after the onset of the 
rash in about 1/1000 measles cases. It is associated with demyelination and is 
thought to have an auto-immune basis (Department of Health, 2013 Ch.21).  
 A delayed type of acute measles encephalitis occurs in immune-compromised 
patients. In these patients there may not be a preceding measles-like illness, 
but there may be a history of exposure to measles several weeks or months 
previously. These patients suffer acute neurological compromise, deterioration 
of consciousness, seizures and progressive neurological damage (WHO, 
2009). 
 Subacute sclerosing panencephalitis (SSPE) is a rare, often fatal, late 
complication of measles infection, occurring in 1/25,000 cases. However, in 
children aged under two years the case rate for SSPE is around 1/8,000 cases 
and for those aged under 1 year the rate is 16 times greater than those infected 
when over five years of age (Jin et al, 2002). This complication of measles 
infection often occurs many years after the onset of the original symptoms. The 
median interval from measles infection to onset of symptoms of SSPE is 
around seven years, but can be as long as two to three decades. It may also 
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follow an unrecognised measles infection (WHO, 2009; Department of Health, 
2013 Ch. 21). There is no specific antiviral treatment for measles infection. 
 
2.2.2 Mumps 
Mumps is an acute viral illness caused by a paramyxovirus. It is characterised by the 
presence of parotitis (parotid swelling which is usually bilateral, but can occur 
unilaterally). This symptom is usually preceded by several days of non-specific 
symptoms, such as fever, malaise, myalgia and anorexia. Mumps can also occur as an 
asymptomatic infection, and commonly does so, particularly in children (Department of 
Health, 2013, Ch.28). 
 
Before MMR vaccine was introduced in 1988, more than 85% of adults had evidence 
of mumps infection. Mumps occurred as a common infection amongst school-aged 
children and was the cause of around 1200 hospitalisations per year in England and 
Wales; and was the most common cause of viral meningitis in children (Morgan 
Capner et al, 1988). Neurological complications, including meningitis and encephalitis, 
can occur or after the parotid swelling appears, and can also occur in the absence of 
any obvious swelling (Plotkin and Orenstein, 2004).  
 
Other common complications of mumps infection include pancreatitis (4% of cases); 
oophoritis (in 5% of cases in post pubertal women); orchitis (in 25% of post pubertal 
cases in men; subfertility is also a rare complication of bilateral orchitis); sensorial 
deafness (bilateral or unilateral, in 1/3400 to 1/20,000); and less commonly, nephritis, 
arthropathy, cardiac abnormalities, and death (Falk et al, 1989; Plotkin and Orenstein, 
2004). There is no specific antiviral treatment for mumps.  
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2.2.3 Rubella 
Rubella is caused by a single stranded RNA togovirus and is transmitted via 
respiratory droplet spread (Roitt et al, 1994). Although rubella has a worldwide 
distribution, it was first described in Germany and is also commonly known as ‘German 
measles’ (NaThNac, 2013). It is generally a mild, self-limiting infectious illness with an 
incubation period of 14 to 21 days. Individuals with rubella are infectious from one 
week before symptoms appear, until four days after the onset of the rash. The rash 
itself is transitory, erythematous and occurs mainly behind the ears and on the face 
and neck, both the rash, and many of the prodromal symptoms are not specific for 
rubella, and so clinical diagnosis is generally considered unreliable. 20 – 50% of all 
rubella infections are also subclinical (Miller et al, 1982; Hawker et al, 2012).  
 
Complications of rubella include thrombocytopaenia (1/3000 cases) and post-infectious 
encephalitis (1/6000 cases). In adults, arthritis, arthralgia (mostly affecting the wrist 
and the joints of the hands) and, rarely, chronic arthritis have been reported (Plotkin 
and Orenstein, 2004). However, if rubella is contracted in pregnancy it is 
indistinguishable from parvovirus B19 (Hawker et al, 2012) and can cause miscarriage, 
stillbirth and the risk of multiple birth defects (Congenital Rubella Syndrome (CRS)) in 
up to 90% of affected children (Miller et al, 1982). There is no specific antiviral 
treatment for rubella infection. 
 
2.2.3.1 Congenital Rubella Syndrome (CRS)  
CRS often presents with multiple defects, which can be transient, developmental or 
permanent. If rubella infection occurs in the first 8 – 10 weeks of pregnancy, it results 
in significant damage in up to 90% of surviving infants. The risk reduces to 10 to 20% 
between 11 and 16 weeks of pregnancy, and by 16 weeks of pregnancy foetal damage 
is rare (Hawker et al, 2012). Transient effects of maternal rubella infection in infants 
include intrauterine growth retardation; thrombocytopaenia purpura (25% have 
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‘blueberry skin’), haemolytic anaemia, heptosplenomegaly, jaundice, radiolucent bone 
disease (20%), meninogo-encephalitis (25% of cases – with or without other 
neurological sequelae) (Heymann, 2004).  
 
The most common developmental effect in infants is sensorial deafness, which occurs 
in 80% of cases and can be bilateral or unilateral. Rubella is the most common cause 
of congenital deafness in the developed world. In addition, 55% of affected infants will 
have a significant learning disability; 20% will have immune-mediated insulin 
dependent diabetes (although this may be delayed until adolescence or adulthood). 
‘Late onset’ disease can also occur at 3 -12 months, and this presents with rash, 
diarrhoea, pneumonitis. Mortality from late onset disease is high (Bantavala and 
Brown, 2003). Congenital heart disease (patent ductus atreriosus or peripheral 
pulmonary artery stenosis), eye defects (cataracts, congenital glaucoma, pigmentary 
retinopathy, severe myopia, microphthalaemia) and microcephaly are also additional 
permanent disabling consequences of rubella infection in infants (Best, 2007).  
 
The World Health Organisation estimates that there are 700,000 deaths from CRS 
every year, the highest risk being in regions where there are high rates of susceptibility 
among women of child-bearing age. In relation to the UK population, this is significant 
in terms of risks associated with overseas travel. Rubella vaccination makes CRS a 
completely preventable condition, and the primary purpose of rubella vaccination 
programmes is therefore to prevent congenital rubella infections (WHO, 2008). 
 
2.3 Measles, Mumps and Rubella as total contributors to Childhood Mortality 
(worldwide and in industrialised countries) 
2.3.1 Avoidable Mortality 
The Centre for Health Economics describes the concept of ‘avoidable mortality’ as ‘all 
those deaths that, given current medical knowledge and technology, could be avoided 
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by the healthcare system through either prevention and / or treatment’ (Castelli and 
Nizalova, 2011). 
 
The earliest studies associated with the concept of the ‘avoidability’ of death are the 
‘confidential enquiries’ which involved the investigation of maternal deaths in the UK 
(MacFarlane, 2004) and the USA (Holland, 2009). During the 1970s, however, Rutstein 
et al (1976) brought together experts from medicine, epidemiology, public health and 
other related disciplines to work together in a systematic way to identify conditions for 
which it could be agreed that death or disability should not occur if timely and effective 
medical care had been administered (Charlton et al, 1983). These investigators 
identified 91 conditions (termed ‘sentinel health events’) which were considered to be 
‘clear-cut immediate use’ indices of the quality of healthcare, and which by definition 
should not occur in effective modern healthcare system. Death due to measles in 
children aged 1 – 14 years was included as one of the original ‘single case indexes’ 
due to the availability of a relatively safe, effective vaccine (even in the 1970s) which 
confirmed it as a preventable infectious disease (Wolfson et al, 2008;Castelli and 
Nizalova, 2011). 
 
2.3.2 Measles Case Fatality Ratios 
Global and UK deaths from measles have decreased significantly over the past few 
decades as a result of improved immunisation coverage and also as a result of 
decreases in measles case fatality ratios – that is, the numbers of individuals who die 
from measles or its complications as a proportion of all those who acquire measles 
infection. Studies do consistently document that cases fatality ratios for measles are 
highest in unvaccinated children under the age of five years, and in outbreaks. The 
lowest case fatality rates occur in vaccinated children, regardless of setting (Maya et 
al, 2011a; Wolfson et al, 2007; Centres for Disease Control and Prevention, 2009).  
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Risk factors for measles deaths include diarrhoea, respiratory complications (including 
pneumonia), otitis media and encephalitis. Respiratory complications are more directly 
associated with risk of death than diarrhoeal infections, and one study found that 
pneumonia occurred more frequently in ‘mild’, unvaccinated cases, than among severe 
cases (Department of Health, 2013, Ch. 21; WHO, 2009).  
 
The majority of studies also suggest that in vaccinated children milder disease is 
associated with lower CFRs and fewer complications than in unvaccinated children 
(Wolfson et al, 2007; Maya et al, 2011a).  
 
2.4 The Potential for the Eradication of Measles and Congenital Rubella 
Syndrome 
2.4.1 Eradication of Measles 
Control of infectious diseases through the strategic use of population immunisation 
programmes is a key public health priority (CMO, 2008; CMO, 2013). Successful 
immunisation programmes can result in diseases being eliminated or even, ultimately, 
being completely eradicated. Measles elimination refers to the interruption of measles 
virus transmission within a defined geographic area, such as a country or a region of 
the WHO, whereas measles eradication is the global interruption of measles virus 
transmission such that control efforts could be completely stopped in all areas (Keegan 
et al, 2011). 
 
Success in measles mortality reduction since the 1960s has mainly been due to 
increased vaccination coverage, which interrupts transmission of the virus between 
susceptible individuals and has been made possible by the availability of relatively safe 
and effective vaccines. Following systematic reviews of this evidence, the World Health 
Organisation (WHO) initiated a programme of work to evaluate the feasibility of 
achieving the global eradication of measles (Cochi / WHO, 2011) and following this 
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evaluation, the 2010 Global Consultation on the feasibility of Measles Eradication 
concluded that there are currently no known technical barriers to measles eradication; 
that measles can and should be eradicated; and that ‘global eradication by 2020 is 
feasible given (the then) measurable progress towards the 2015 targets’ (Moss and 
Strebel, 2011).  
 
2.4.2 Eradication of Congenital Rubella Syndrome 
Several safe and effective rubella vaccines have been licensed for use since 1969, 
however, use of Rubella Containing Vaccines (RCVs) was primarily limited to 
industrialised countries until the 1990s (Department of Health, 2013, Ch. 21/Ch. 28). 
Significant morbidity and costs result from infants born with Congenital Rubella 
Syndrome and there is much evidence that this can be avoided by the introduction of 
RCV into the routine immunisation programme, particularly when combination vaccines 
are used. The greatest decrease in rubella cases has, for example, been seen in the 
Americas, which have also succeeded in sustaining elimination of measles, where 
cases decreased almost 100% from 39,228 to 18 between 2000 and 2009 (Strebel et 
al, 2011). In Europe, the number of cases decreased by 98% over the same period, 
from 621,039 to 11,623 as coverage of RCV improved across the region (WHO 
Europe, 2003). 
 
In light of these issues, the evidence suggests that any programme of eradication of 
measles should also be used to accelerate rubella control and the prevention of 
Congenital Rubella Syndrome. The WHO Strategic Advisory Group of Experts (SAGE) 
and the World Health Assembly (WHA) both endorse the use of safe and effective 
combination vaccines, such as MMR, to achieve these goals. (WHO, 2010).  
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2.5 Public Health interventions to reduce the incidence of Measles, Mumps and 
Rubella infections in Europe and the UK 
 
2.5.1 Introduction of Measles vaccines 
Notification of measles infections began in 1940 across the UK, at which time 
notifications were running at between 160,000 and 800,000 per year. Peaks occurred 
every two years, with around 100 deaths being attributed to measles each year 
(Osbourne et al, 2000) (See Appendices 3 and 4)  
 
Measles vaccine was first introduced in the UK in 1968, but coverage remained low up 
to the late 1980s, and was not high enough to interrupt disease transmission (Vyse et 
al, 2002). Annual notifications remained at around 50 – 100,000, and morbidity and 
mortality remained high (Ramsay et al, 2003). It is reported that on average 13 acute 
measles deaths occurred each year between 1970 and 1988. Whilst this had a 
significant impact on those who could not be immunised, such as children in remission 
from acute lymphatic leukaemia, more than half of these deaths occurred in previously 
healthy unimmunised children (Department of Health, 2013, Ch.21). 
 
MMR was introduced in 1988, for children aged 18 months. Coverage rose to above 
90%, transmission was interrupted, and notifications dropped to very low levels (de 
Melker et al, 2001). As previously described, this reduction in measles transmission 
meant that children were no longer exposed to wild-type measles infection, and, if 
unimmunised, remained susceptible. Sero-prevalence studies in 1993 confirmed that a 
higher proportion of school-aged children were susceptible to measles than in 1986/87, 
raising the possibility of the resurgence of measles infection in this age group (Ramsay 
et al, 2003). In 1993/94, a measles outbreak in Scotland resulted in 138 children being 
admitted to one hospital, and this prompted the implementation of a national 
vaccination campaign to prevent a further epidemic.  
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Following this campaign, measles transmission fell seven fold in this age group and 
endemic measles transmission was effectively interrupted (Gay, 2000). Between 1995 
and 2003, there were just 12 confirmed deaths attributable to measles and all were the 
result of the late effects of measles acquired before 1995. The reduced incidence of 
measles also brought about the almost complete disappearance of SSPE in England 
and Wales (Jin et al, 2002).  
 
2.5.2 The Development of Effective MMR Immunisation Strategies 
There are a number of considerations when developing effective MMR immunisation 
strategies. These include timing of the immunisations, the possibility of vaccine failure, 
and also the need for any immunological ‘boosting’. The development of high avidity 
antibody response is also essential for the development of protective immunity to 
measles. If 95% of individuals are immunised and 95% seroconvert, the population 
protective effect is 90%. Any lower vaccination coverage further reduces this protective 
population effect (Carabin et al, 2003).  
 
Scheduling of immunisations therefore has to reflect a balance between leaving a 
period when the individual may no longer have passive immunity (for example from 
maternal antibodies), when he or she may therefore be susceptible to natural wild type 
virus, and the timescales required for effective sero-conversion to provide protective 
effect (Roitt et al, 1994). Current UK scheduling of MMR immunisation at 12-13 months 
reflects the assessment of these factors (Department of Health, 2013, Ch.11).  
 
Following vaccination there is evidence of the long-term persistence of neutralising 
antibodies and long lasting protection against measles (Janeway and Travers, 1994).  
However, it is recognised that 5-10% of children fail to respond to the first dose of 
MMR. Studies on revaccination of these children, however, show that over 97% 
develop immunity after a second dose (interquartile range 87 – 100%) (Pebody et al, 
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2002). For these reasons a delivery strategy involving two routine doses of MMR is 
used in almost all national campaigns globally. Second doses are also a key element 
of supplementary immunisation activities, such as catch-up campaigns (Pebody et al, 
2002; Carabin et al, 2003; Gay, 2004). 
 
A two-dose MMR schedule was introduced in the UK in 1996. Coverage remained at 
sufficiently high levels following introduction of the second dose and it appeared that 
the UK was on target to achieve indigenous elimination of measles (Stage III) by 2010, 
as planned (WHO, 2009).  
 
2.5.3 The impact of the ‘Wakefield’ controversy 
In the late 1990s, controversy over the safety of the MMR vaccine resulted from 
speculation, in a now discredited research paper, that measles vaccine given as MMR 
might be associated with inflammatory bowel disease and developmental disorders, 
such as autism (Wakefield et al, 1998). These were only speculations based on 
observations of a very small sample of 12 children, but the study received very wide 
media coverage. In addition, Dr Andrew Wakefield added a suggestion at the press 
conference that accompanied the release of his research, again without any evidence, 
that he would recommend that parents seek single (monovalent) vaccines in 
preference to MMR until any potential link could be discounted. 
 
MMR uptake subsequently declined to 80% in England in 2003/04, and in some areas 
44% of pre-school and 22% of primary school children remained unimmunised. Uptake 
remained under 90% up to 2008, resulting in a gradual increase in the susceptible 
individuals in the population to levels which could sustain prolonged outbreaks of the 
disease (CMO, 2008).  
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Monovalent (single) vaccine was not available, and was not supplied as part of the 
national programme. Parents were, however, able to acquire monovalent vaccines 
from private healthcare providers, many of whom were set up opportunistically to 
provide this service. The current recommendations remain that children who have 
received single vaccines should also be immunised with MMR to ensure adequate 
protection against measles, mumps and rubella (Department of Health, 2013, Ch.11). 
This is because it is difficult to be confident that children who have received single 
vaccines have been given a product of equivalent safety and efficacy. In particular, the 
MHRA have objected to the importation of some poor quality single mumps vaccines 
during this period. In addition, many single vaccine providers were not licensed with 
the Healthcare Commission, and legitimate concerns were raised about the storage 
and mixing of vaccines of one very large provider (Ramsay, 2013). As MMR can safely 
be given to children known to be immune to any of the antigens, it is recommended 
that two doses of MMR are given to any child with an incomplete history of 
immunisation to provide long lasting protection against measles, mumps and rubella.  
 
2.5.4 The history of Mumps and Rubella control in the UK 
Rubella vaccine had been given as part of a selective UK immunisation programme to 
teenage girls and to women of childbearing age, from 1970, to prevent rubella 
infections in pregnancy. Although the initial selective programme was effective in 
reducing the number of cases of CRS and terminations due to CRI, rubella in 
pregnancy continued to occur because a small number of unimmunised women could 
still acquire rubella infection predominantly from their own, or their friends’, young 
children, but also from imported cases, or from overseas travel, or from other 
unimmunised individuals (Department of Health, 2013, Ch.23). The universal MMR 
programme, introduced in 1988, aimed to interrupt the circulation of rubella among 
both male and female young children, preventing exposure of susceptible women to 
the most common source of infection (Strebel et al, 2011). 
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Cases of CRS in the UK and Ireland are monitored via the National Congenital Rubella 
Surveillance Programme (University College London Institute of Child Health, 2015). 
Since 1991, only 1/3rd of CRS infants have been born to UK women who acquired the 
infection in the UK. The remainder were born to women from overseas who acquired 
rubella in their country of origin, or to women who acquired the infection whilst 
travelling to other countries (European Centres for Disease Control and Prevention, 
2013). Recent reports of two new cases of CRS in UK born women have raised further 
concerns. These cases occurred in 2015 in unimmunised UK born young women, one 
of who acquired the infection whilst on holiday abroad and the other who acquired 
rubella from a male sibling who had himself become infected whilst travelling (Public 
Health England, 2015b). All of these young people were in age groups eligible for 
MMR immunisation and these cases were therefore entirely preventable.  
 
A single dose of mumps vaccine confers 60 – 90% immunity against mumps infection. 
Two doses are therefore necessary to achieve effective individual and population 
immunity (Health Protection Agency, 2005). Between 1999 and 2008, the number of 
confirmed mumps cases increased, mostly in adolescents or young adults who were 
too old to have MMR in 1988, or to have been offered a second dose in 1996 
(Ramsay, 2010). Outbreaks frequently occurred in higher education establishments, 
with most of these individuals believing that they had been immunised with a mumps 
containing vaccine in the past (CMO, 2008).  
 
However, there was no routine mumps immunisation programme before 1988, and the 
1994 MR campaign was not able to include mumps because of problems with MMR 
vaccine supply. These individuals, therefore, may either have had two doses of MCV, 
one of rubella, but no mumps vaccine. Others may have had only one MMR (therefore 
one mumps vaccine) which did not provide sufficient protection. During the mid-1990s 
there were also additional issues with both availability of the Leningrad strain of 
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vaccine, and efficacy concerns with the Rubini mumps vaccine strain, which also 
further impacted on coverage and population immunity to mumps (Strebel et al, 2011).  
 
These events mean that there are a considerable number of older children and young 
adults within the UK population who are not immune to mumps or rubella and who 
require immunisation to ensure adequate protection. MMR catch-up campaigns have a 
primary aim of increasing coverage of measles vaccine, however, the use of 
combination vaccines have the added advantage of also increasing population 
immunity to both mumps and rubella at the same time, further increasing the clinical 
and cost-effectiveness of these programmes.  
 
2.6 The Cost Effectiveness of MMR Immunisation Programmes 
The NHS has to take cost-effectiveness, equity and access in to account when setting 
priorities. The NHS is committed to promoting access to services, reducing inequalities 
in health, and to using its resources in the most cost-effective ways.  
 
There is robust evidence to confirm that measles immunisation is one of the most cost-
effective public health interventions. Studies in the Americas, where coverage of >95% 
was achieved in both routine programmes and catch up campaigns, show that 
considerable cost savings were achieved when compared with moderate coverage 
(85%) using routine programmes alone (Zhou et al, 2004). Immunisation with either 
two routine doses, or two doses with a catch up campaign, have also been found to 
have a cost to benefit ratio >1 in Canadian, US and Japanese studies (Pelletier et al, 
1998; Zhou et al, 2004; Takahashi et al, 2010), and the authors of these studies have 
all concluded that, in general, programmes that provide two doses of measles vaccine 
have been found to be highly cost-effective, regardless of the method of delivery of 
these doses, and that good measles control is likely to save money, when compared 
with poor control (Choi/WHO, 2011). It has also been found that the addition of a one-
41 
 
off catch-up campaign to reduce susceptibility in pre-adolescent and adolescent age 
groups is cost-saving when past coverage is low (<70%), and even where past 
coverage is >90% for more than a decade, it is suggested that this strategy could be 
implemented at acceptable cost to the individual and with net savings to society 
(Beutels and Gay, 2003). 
  
Zwanziger, Szilagyi and Kaul’s (2008) economic evaluation of 14 primary studies, 
however, concluded that supplementary immunisation programmes (catch up 
campaigns) designed to control measles are unlikely to be cost-effective unless an 
outbreak is taking place. This conclusion is particularly relevant in areas where pre-
school immunisation rates exceed 70% and suggests that any such immunisation 
programmes must have a focus other than just increasing immunisation rates – for 
example, identification of hard to reach populations, or areas with very low 
immunisation rates.  
 
The 2011 WHO evaluation of the cost-effectiveness of measles eradication (Strebel et 
al) provided an economic analysis at both country and global levels for the ultimate 
goal in measles control. These studies demonstrate that measles eradication is highly 
cost-effective regardless of country income levels; is cost-saving in those countries that 
have already eliminated indigenous measles transmission; and compares favourably 
with almost any other investment in health. The use of combination vaccines, such as 
MMR, further increase the potential cost-effectiveness of these programmes, through 
the additional benefit of preventing CRS  and mumps infections (Carabin et al. 2003; 
Carabin and Edmunds, 2003). 
 
Keegan et al (2011), also reporting for the WHO, estimated that global eradication of 
measles would cost $5 – 8 billion. This is less than the cost of eradicating polio and 
malaria, but more than the Yaws, Smallpox and Guinea Worm eradication 
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programmes. However, the financial crisis that started in 2008, poses significant 
challenges to financing a measles eradication programme at this time. This means that 
the threat of imported cases will remain, and high coverage rates will therefore need to 
be maintained in the UK to avoid sustained outbreaks and epidemics for the 
foreseeable future.  
 
2.7 Summary – why the research is needed 
The evidence provided in this chapter has clearly demonstrated that measles, mumps 
and rubella are childhood infections which cause significant morbidity and mortality in 
the UK and globally. All three of these diseases are vaccine preventable and deaths 
and serious illnesses that result from these infections should be considered avoidable. 
Vaccinated children have lower Case Fatality Ratios for measles, and where disease 
does occur vaccinated children have milder illness and suffer fewer complications. 
Global initiatives exist to reduce measles mortality, and to reduce the incidence of 
congenital rubella syndrome, and it is biologically feasible to eradicate these diseases 
– however these initiatives will potentially be de-railed if immunisation coverage 
continues to fall.  
 
There is a large body of evidence (both historical and clinical) to support the use of 
MMR vaccine, and effective organisational infrastructures in the UK to deliver, monitor 
and evaluate the effectiveness of national and international MMR immunisation 
programmes. These programmes are highly cost-effective, but cost and clinical 
effectiveness both depend on maintaining high population uptake and coverage. 
Evidence from recent outbreaks highlights the potential consequences of failing to 
maintain uptake and coverage at sufficiently high levels to prevent community 
transmission, and confirms the relevance of this topic as a contemporary public health 
priority. Immunisation uptake, specifically requirements for Primary Care Trusts 
(PCTs), and now NHS England local teams, to achieve 95% uptake rates for childhood 
43 
 
immunisations such as MMR, therefore remains a core measurement of public health 
performance in the UK (NHS England, 2013; Health Protection Agency, 2013).  
 
The development of MMR immunisation programmes in the UK reflects progress in 
both applying the approaches described in the WHO Plan and in working towards the 
overarching goal of eliminating indigenous transmission of measles and rubella. This 
national organisational infrastructure has delivered vaccine uptake rates which have 
generally remained high across the majority of programmes. However, offers to 
provide vaccination via these programmes are not universally accepted by parents 
(Yarwood et al, 2005) and, in addition, events have occurred periodically which have 
resulted in falls in uptake for specific programmes, most recently the ‘Wakefield 
controversy’ and MMR.   
 
The number of measles and mumps cases remained at high levels during 2007 and 
the MMR Catch-up Campaign, was initiated following a series of outbreaks of measles 
in an attempt to return to Stage III levels of control, in 2008 / 09. Significant progress is 
still required, even in 2013, for the UK to move from the current stage of ‘approaching 
measles and rubella control’, to the WHO goal of achieving elimination. As part of this, 
developing a better understanding of ‘hard to reach’ groups, such as those who have 
persistently declined MMR beyond school entry age, will be key if services are to be 
managed more effectively and communication materials and activities are to be 
produced which better meet the needs of these populations.  
 
Chapter 3 provides an overview and critique of the current evidence in relation to 
parental beliefs, attitudes, experiences, and other factors affecting parental decision-
making in respect of MMR, which add to the scientific and epidemiological evidence 
presented in this chapter to underpin this area of inquiry. 
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CHAPTER 3: LITERATURE REVIEW AND AREAS FOR FURTHER 
RESEARCH 
 
3.1 Introduction 
The national and international public health significance of measles, mumps and 
rubella infections as important causes of childhood morbidity and mortality, and the 
potential for these diseases to be eliminated if appropriate strategies are employed to 
achieve the required levels of population immunisation uptake, has been clearly 
demonstrated in the previous chapter.  
 
There is a wide body of UK and international evidence examining parental uptake of 
childhood immunisations. This includes both qualitative and quantitative studies 
exploring attitudes and beliefs, and other factors, which may influence parental 
decision-making in relation to immunisation, and specifically the MMR vaccine. 
This chapter provides a comprehensive review of the existing evidence, with the 
specific aim of outlining the context and further justification for the present research.  
 
Refusal to accept vaccination (and under-vaccination) may theoretically occur for a 
number of reasons. Firstly, this could be related to logistical barriers, such as lack of 
support, childcare or transport – factors which may prevent parents from physically 
accessing these services (Morrow et al, 1998). Secondly, it might be related to parental 
concerns about the safety of vaccines, or a particular vaccine (Mills et al, 2000). 
Finally, there could be other, currently unrecognised, reasons why parents do not 
accept these offers. The existing evidence for each of these propositions will be 
explored.   
 
45 
 
This literature review is divided into sections, each designed to add evidence to 
underpin the framework upon which my thesis is developed.  The evidence in respect 
of parental attitudes and beliefs (for immunisation per se and more specifically in 
relation to MMR) is examined in Section 3.3. Evidence in respect of immunisation 
decision-making, and specifically how parents make decisions to accept or decline 
MMR, is explored in Section 3.4. Section 3.5 provides a summary of the available 
evidence base in respect of any other factors that have been identified that may affect 
or influence uptake. The relevance of this evidence to the Somerset context is explored 
in Section 3.6, as is evidence of any previous methodologies used to investigate this 
area of inquiry. The limitations and gaps in the current evidence base are discussed in 
Section 3.7 in order to demonstrate the relevance of the research questions which 
underpin the current study. The chapter then concludes, in Section 3.8, with a 
summary of the rationale for the current study based on the evidence reviewed. 
 
3.2 Search Strategy & terminology 
The initial scoping search included very broad topics, such as the psychological theory 
underpinning parental health beliefs, health belief scales or models, health locus of 
control, normative theories of decision-making, cognitive psychology, social cognition 
and informed decision-making, as well as an investigation of the literature relating to 
the diseases themselves.  It is recognised that there is a large body of literature related 
to parental decision making in general, however, in order to manage the scope of the 
review the search was narrowed and was focused on evidence related to parental 
attitudes, beliefs and decision-making and immunisation. It is acknowledged that a 
narrative literature review was completed and that there may be limitations as a result.  
 
The search terms were then refined and specific searches related to immunisation 
uptake and MMR were undertaken using the Cochrane Database of Systematic 
Reviews; ScienceDirect;  PubMed; AMED;  EMBASE; MEDLINE; PsychINFO;  British 
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Nursing Index and CINAHL. Searches were restricted to English language publications 
dating from 1980 to present.  
 
Original studies, reports, evaluations and systematic reviews in English were included 
in the review of published literature and those which only provided secondary reviews 
or commentary on other articles were excluded. All methods and types of research 
evidence were included. The articles were then filtered and all duplicates removed. 
The organisation of immunisation services in the UK, and the specific social, 
demographic and environmental characteristics of the county of Somerset were also 
considered. See Appendix 5 for MeSH terms used within the search strategies, and the 
search results.  
 
The original searches were run in December 2009 and repeated periodically as the 
study progressed to identify additional papers published during the course of the 
research. The final search was completed in December 2014 prior to submission.   
 
All available English immunisation data sources (McKesson Careplus, COVER, 
ImmForm, Open Exeter) were reviewed and additional searches were also performed 
as the study progressed in relation to: 
Personal / Individual freedom and MMR 
Rurality and Immunisation / MMR 
Collective responsibility and MMR 
Herd Immunity and MMR 
Vaccine Overload and MMR  
Compulsory vaccination  
 
The information obtained from these later searches was used to explore evidence in 
relation to the themes which emerged from the preliminary qualitative data analysis 
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and to support the development of codes to inform the final framework for the thematic 
analysis described in Chapter 5.  
 
Hand searches of the articles and resources were undertaken to identify any additional 
secondary sources for inclusion. Unpublished academic and policy documents were 
identified via conference proceedings; via recommendations from researchers in the 
field; and via a search for previous post-graduate / PhD research on the subject. Dr 
Mary Ramsay and Jo Yarwood, of the Public Health England National Immunisation 
Team, kindly provided access to internal departmental documents relating to research 
evaluations of the Childhood Immunisation Programme Communication Campaigns; 
the tracking surveys of mothers’ attitudes to childhood immunisation (1991 to present); 
Health Education Authority England meeting notes and presentations; and the 
evaluations of the NHS Scotland ‘MMR Discussion Pack’.  
 
Whilst the information contained within the academic and policy documents remains 
unpublished, these studies involved relatively large, matched and segmented national 
samples of parents and the authors and investigators followed robust qualitative 
methodologies to obtain the data presented. These documents therefore provided an 
extremely valuable additional source of data on the subject. 
 
It is acknowledged that a number of potentially influential ‘anti-vaccination’ groups exist 
within the UK and on social media, however, very few resources promoted by these 
groups are published in academic publications. Searches were undertaken of eGroups 
and websites such as ‘JABS’ and ‘What the Doctors Don’t tell You’ to identify any 
potentially relevant themes arising from these sources. It should be noted that,  
although there appeared to be potential for themes to be identified from these sources, 
much of the information supporting these themes was found to be anecdotal and / or 
subjective in nature, or related to single incidents or individual cases, without the 
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application of any robust methodology. This prevented any critical analysis or 
assessment of the wider relevance of these materials and therefore, whilst these 
sources are acknowledged, they are not included further within the evidence described 
within this thesis. 
 
3.2.1 Clarification of terminology used within the evidence and in this thesis 
The research presented within this thesis focusses on a group of children whose 
parents have persistently declined the offer of MMR beyond school entry age. These 
children and parents are referred to using a variety of terms in both the published and 
grey literature. These terms include ‘confirmed rejectors’, ‘refusers’, ‘non-acceptors’, 
‘unimmunised children’ and ‘persistent decliners’. Whilst these terms are reported 
within this review as they appear in the evidence referenced, it should be clarified that 
these are the same population group as studied within the present research and who 
are referred to by the researcher as ‘unimmunised’ or as ‘persistent decliners’.  
 
3.3 Parents Attitudes and Beliefs about Immunisation 
The next sections provide an overview of evidence obtained in respect of parental 
attitudes, beliefs and decision-making in relation to immunisation (and specifically to 
MMR) and consideration of other factors which may impact on parents’ decisions to 
accept or decline MMR vaccination. 
 
Childhood immunisations are not mandatory in the UK, they are recommended by the 
NHS and are provided free of charge, but it remains a parent’s choice whether to 
accept or decline this offer for their child. Parents’ attitudes and beliefs therefore have 
the potential to play an important part in determining the outcome of that choice and 
exploration of these parental attitudes and beliefs subsequently forms the basis of a 
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large segment of the literature reviewed relating to parents’ acceptance or rejection of 
immunisation.  
 
Examination of the literature, and most specifically the unpublished government policy 
documents, resulted in the identification of a number of themes associated with 
parental attitudes and beliefs in respect of immunisation. These included: vaccine 
safety; parental knowledge of immunisation and the diseases they protect against; the 
risks and benefits of immunisation; and in relation to MMR, assessment of specific 
risks associated with autism and bowel disease. These themes will now be explored.  
 
3.3.1 Balancing vaccine safety and the risk of disease  
3.3.1.1 Vaccine safety 
In England, tracking surveys of mothers’ attitudes, experiences and beliefs about 
immunisations, undertaken for the Department of Health, provide a unique body of 
evidence. The information obtained from these surveys has been based on nearly 
30,000 interviews used to gather regular feedback from parents and to inform the 
strategic planning of the childhood immunisation programme in England from 1991, 
and has been continued on an annual basis to the present day. The outputs from these 
large population studies suggest that whilst the majority of parents consider 
immunisation to be generally safe, the decline in the incidence of the childhood 
diseases they protect against may have resulted in an increased focus on vaccine 
safety and distortion of the relative assessment of risks and benefits (Keane et al, 
2005; Yarwood et al, 2005).  
 
Smailbegovic, Laing & Bedford (2003) identified that MMR and MenC vaccines were 
the most frequently omitted due to concerns over vaccine safety. A systematic review 
of 15 qualitative studies exploring parental beliefs and attitudes by Mills et al (2005) 
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reported that concerns about adverse effects of vaccines were consistently identified 
as a barrier to childhood immunisation. Studies conducted in Sweden (Dannentum et 
al, 2001), New Zealand (Hamilton et al, 2004) and Italy (Impicciatore et al, 2000) have 
all cited similar results adding to the robustness of this assertion.  
 
A variety of methodologies have been used to explore parents’ perceptions of vaccines 
and vaccine safety. Streefland et al (1999) and Streefland (2001), for example, drew 
on ethnographic material from six countries to examine ‘vaccine acceptability’ as 
perceived by parents and other stakeholders; Evans and Bostrom (2002) highlighted 
the importance of personal factors and cognitive processes, such as beliefs and 
‘decision-making shortcuts’, in a review of immunisation risk communication in the 
USA; and in a large prospective UK study, Samad et al (2006) found that (inaccurate / 
negative) maternal beliefs about vaccines and immunisation were, the predominant 
reason for infants not receiving any vaccinations at nine months of age. These studies 
each provide evidence confirming the role of parental attitudes, perceptions and beliefs 
in respect of the assessment of the relative benefits and risks associated with 
immunisation, factors which appear to be highly significant in enhancing, or conversely 
reducing, parents’ willingness to accept vaccinations such as MMR. 
 
In addition, evidence suggests that immunisation, as a policy, appears to be generally 
trusted in the UK and that most parents believe in both the value and the importance of 
the national programme (Gellin et al, 2004; Wardle McLean, 2004; Keane et al, 2005). 
This is important because other authors have suggested that national policies and 
legal frameworks can directly influence parental health beliefs in both positive and 
negative ways – for example, by encouraging them to think of immunisation as 
necessary and beneficial, or alternatively as being something that is forced on them, 
and/or deserving of parental resistance (Sturm et al, 2005).  
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Ramsay et al (2002) reported that whilst an increase in mothers’ concerns about MMR 
safety was identified, the majority of those interviewed in 2001 still intended to fully 
immunise another child in the future. Evaluations of health education immunisation 
communication campaigns in England (Malam & Muir, 2002; DDB, 2004; Wardle 
McLean, 2004; Wardle & Sancho, 2004) also appear to confirm, however, that whilst 
the ‘silent majority’ of parents are still immunising, parents are generally now sensitised 
to potential problems with immunisations. It is suggested that many parents remain 
anxious about vaccine safety, especially in relation to MMR, and 1 in 5 parents believe 
that the MMR vaccine poses a greater risk than the diseases it protects against 
(although it appears that this concern reducing over time) (Yarwood, 2005; BMG 
Research, 2015).  
 
Whilst the tracking surveys have shown that in recent years there has been a gradual 
and sustained increase in parents’ confidence in the safety of MMR, the responses 
continue to remain below the confidence levels seen in 1998 ( Yarwood et al, 2007; 
BMG, 2015). MMR also remains the vaccination that is most often delayed – with 
concerns about safety remaining the most frequently cited reason for the delay (Cragg 
Ross Dawson, 2010).  
 
Concern about vaccine safety is not confined to the UK, but it does appear to be a 
more significant factor for UK parents than for parents in other countries. In a large 
international survey of lay and professional attitudes and beliefs, conducted in six 
European countries (Pasteur Merieux MSD,1998) the British public were found to be 
more interested in the features of vaccines than the diseases they protected against or 
disease epidemiology; they had more concerns about the general side effects of 
vaccines, and had less enthusiasm for the development of future vaccines than 
members of the public in any of the other countries. This survey was undertaken 
before the MMR controversy became widely reported in the media and suggests that 
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there may have been pre-existing concern and suspicion about vaccine safety on the 
part of the British public. This may explain, in part, firstly why controversies, such as 
that relating to Wakefield’s 1998 publication, may have had a much more significant 
impact in the UK than in other countries, and why, despite considerable evidence 
refuting any links between MMR and autism, parental concerns still persist within the 
UK. These issues will therefore be investigated further within this study. 
 
The evidence reviewed appears to suggest that parental fear about vaccine safety 
forms a barrier to high immunisation uptake. What these studies do not reveal, 
however, is what strategies might contribute to allaying these fears and act as 
reassurance to parents and encourage them to change their minds and accept 
immunisations such as MMR. The present study aims to explore these questions. 
 
3.3.1.2 Parental perceptions of the relative risks of immunisation and the 
diseases they protect against 
Socio-environmental factors include culturally based beliefs about the nature of 
diseases and immunisation and encompass factors such as parents’ knowledge of the 
relevant diseases, or their perceptions of the child’s susceptibility to those diseases 
(Mays et al, 2004).  Whilst a positive attitude may be associated with higher uptakes of 
childhood immunisations, Impicciatore et al (2002) found that the most common reason 
for not immunising was the belief that it was not considered important. Parents’ 
perceptions of the importance of immunisation, and therefore of the relative risks 
associated with vaccination or disease, relates to their knowledge about infectious 
diseases and understanding of how immunisation works.   
 
Perceptions of the risks of disease and disease severity appear to be important, but 
vary widely. Whilst some focus group studies have found that most parents were 
poorly informed about the diseases that their children were being vaccinated against 
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(Cotler et al, 2003), there does appear to be considerable evidence that parents are 
more accepting of vaccines that offer protection against diseases which are perceived 
to be ‘serious’ than those that are perceived to be less serious (Smailbegovic et al, 
2003; Yarwood et al, 2005; Bedford & Lansley, 2007). Whilst there is some evidence to 
suggest that parents may be concerned about measles, for example, other research 
has indicated that parents generally do not consider the diseases that MMR protects 
against to be serious.  Parents appear to be more strongly influenced by the perceived 
risks carried by vaccines, rather than balancing the overall risks and benefits of 
vaccinating against not vaccinating, and this may significantly impact on parental 
decisions relating to risks and benefits associated with these immunisations (Pareek & 
Pattison, 2000; Yarwood et al, 2005; Bedford & Lansley, 2007).  
 
Parents perceptions may develop or be reinforced by a number of factors. Reviews of 
sociological theory and social cognition models in the wider literature refer to 
constructs underpinning preventive health behaviours, some of which may be relevant 
to interventions such as immunisation. Within models, such as the Health Belief Model 
(Rosenstock, 1959), social norms – such as the opinions held by peers, or groups that 
are important to the person making the decision – significantly influence the outcome 
of the decisions, to the extent that people will ‘have their children vaccinated (or not) 
because everyone else does and it seems the right thing to do’ (Streefland et al, 1999). 
Social group norms, therefore, form an intrinsic part of the constructs as applied to 
immunisation (Anderson et al, 1997; Prislin et al, 1998) and may also be relevant to the 
current investigation. 
 
The evidence to support the theory that perceived risks associated with vaccines are 
far more likely to be the focus of parental anxiety than any risks associated with 
specific diseases (Chen, 1999) appears to be robust. Mathematical modelling 
approaches have also been used to demonstrate that the impact of any such perceived 
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risk is likely to persist long after a vaccine ‘scare’ has occurred (Baush & Earn, 2004). 
These findings may be particularly relevant to identifying persistent parental attitudes 
affecting uptake of MMR in populations reviewed several years after the impact of the 
initial Wakefield publication, and these parental perceptions will be explored in the 
present study.  
 
3.3.2 Vaccine overload and the challenge to immature immune systems 
A further concern about MMR appears to centre on speculation that giving children 
three antigens in a single vaccination is ‘too many for the immune system to cope with’ 
(Poltorak et al, 2005). Pettigrew & Hunt (2006) also found that parents were likely to 
delay their child’s MMR if they had a minor illness, largely due to the belief that the 
vaccination would ‘overwhelm the child’s already compromised immune system’. 
Concerns that the vaccine places stress on the child’s ‘immature’ immune system; 
whether a child’s immune system is mature enough to ‘cope’ with this combination; and 
whether some children’s immune systems are less able to cope, making them more 
prone to long term damage from the vaccines, were common themes in previous UK 
focus group studies involving parents who had refused MMR (Evans et al, 2001; Hilton 
et al, 2006). Parental concerns relating to perceptions of their child’s ability to cope 
with vaccination appear common and this is further supported by the findings of 
ethnographic research, undertaken amongst mothers in Brighton, which confirmed the 
importance of lay theories of immunisation, particularly with regard to ‘vaccine 
overload’ in the context of individual ‘weakness’ (Cassell et al, 2006). 
 
Corr Willbourn’s ‘Conceptual Framework Research Among Mothers’ (2004), 
undertaken to inform the Department of Health immunisation communication strategy, 
confirmed that parental knowledge of how immunisation works was generally poor. 
This study (involving both interviews and focus groups with parents across the UK) 
found an almost universal belief that immunisation was a process of giving the child ‘a 
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little bit of the disease’. Whilst there is some logic to this, the principles of immunisation 
are far more complex and this explanation is too simplistic to be technically correct.  
 
The parents within the Corr Willbourn (2004) study were found to have a deep 
commitment to their child’s welfare and were doing what they considered was best for 
them, but this analogy was problematic and contributed both to misunderstanding and 
to perpetuating the concept that the body was being challenged or overloaded with 
‘lots of little bits of disease’ when multi-valent vaccines were used. This then resulted in 
‘vulnerability to disease’ and ‘vulnerability to immunisation’ being conflated in parents’ 
minds and a ‘degree of free-floating anxiety’ remaining which the authors suggest 
could easily attach to another issue (or another multi-valent immunisation) even if 
concerns about MMR were attenuated. The authors concluded that this is of particular 
importance given the volatile nature of parental perceptions in this area, and also 
provides evidence of the potential dangers of trying to over-simplify explanations when 
attempting to reassure parents, since these explanations themselves can be 
misinterpreted and can add to the complexity of evidence that parents’ themselves 
have to consider when making decisions on behalf of their children.  
 
There do, however, appear to be some inconsistencies between parents’ views and 
actions in respect of immunisation, perhaps associated with the poor levels of parental 
knowledge and understanding of both the vaccines and of vaccine preventable 
diseases previously identified. Hilton et al (2006) in Scottish focus group studies, for 
example, found that parents who were concerned about vaccine overload in relation to 
MMR had, in the main, taken their child for the combined DTP vaccine at 2, 3 and 4 
months and seemed unconcerned about the multi-valent nature of these vaccinations 
or of any potential for these to ‘overload’ the immune systems of very young infants.  
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Both vaccine safety and parental perceptions of the relative risks associated with 
vaccination and diseases / disease severity appear to be significant factors of 
relevance to the present investigation. A limitation of the evidence reviewed so far, 
however, is that the studies almost universally provide a ‘snap-shot’ of parents’ 
attitudes and beliefs at just one particular point in time, that is, around the time of the 
original offer of the primary immunisations at 13 months (first dose) or 31/4 – five years 
(second dose).  
 
Whilst samples are matched across the waves of the tracking surveys, for example, 
these studies involve a different group of parents, approached at the same defined 
decision point, for each new round of the survey. This is useful for providing trend data 
and comparators, but does not provide any evidence in relation to the persistence of 
these parental attitudes, or of whether and how these attitudes may change over time. 
Further research to gain insights into whether these concepts continue to influence 
parents’ decisions longer term, and for older children, is of particular relevance to 
prevent the development of susceptible pools of unimmunised children and young 
people as the childhood immunisation programme continues to develop. The present 
study therefore aims to explore whether similar attitudes and perceptions persist for 
parents of older, school-aged children. 
 
3.3.3 Perceived risks related specifically to MMR - the ‘Wakefield controversy’ 
In 2009, a significant theme within the literature related to a hypothesis proposing the 
possibility of a ‘new variant’ of autism involving developmental regression and bowel 
problems, temporally associated with administration of MMR vaccine. Originally 
published as a study in the Lancet, a highly respected and influential medical 
publication,  ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive 
developmental disorder in children’ (Wakefield et al, 1998) triggered a wave of public 
concern and media interest and this widely regarded as the primary cause of the rapid 
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and persistent fall in MMR uptake in subsequent years.  The potential impact of this, 
particularly on parents making decisions about MMR at that time, cannot be 
underestimated, but further research is required to explore whether it remains a key 
contributory factor influencing parents of older, school age children who continue to 
persistently decline the MMR vaccine many years after this event.  
 
Wakefield’s research was formally retracted by the Lancet in 2010 and there is now 
considerable evidence refuting any link between MMR, autism and inflammatory bowel 
disease. This evidence will now be examined to further understand the potential 
influence of this episode on parental perceptions in relation to MMR.   
 
Following the publication of the Wakefield research in 1998, a number of theories of 
immunisation as a risk factor, and/or theories of autoimmunity as a predisposing 
genetic risk, were proposed to explain the perceived correlation between the use of 
MMR and the rapid increase in cases of autism over time (Borchers et al, 2002; Mehta 
& Munir, 2003; Chez et al, 2004).  
 
Whilst a very small number of molecular studies have suggested that such a 
development – or, more specifically, the possibility of the involvement of an 
environmental risk factor or an autoimmune mechanism – is biologically plausible and 
cannot be ruled out in a very small number of cases of autism (Singh et al, 2002), there 
is no significant evidence to demonstrate a specific link with MMR (Taylor et al, 2002; 
Smeeth et al, 2004). Any biological link would be equally applicable to other viruses, 
for example rubella, and would have to relate to any measles-containing vaccine, not 
solely the measles component of MMR. Such a link would therefore also contraindicate 
the use of single vaccines as a safer alternative. More recent studies, using the most 
sensitive techniques, have failed to detect vaccine virus in biological assays from 
children with autism (Afzal et al, 2006; D’Souza et al, 2006).  
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Conversely, this review identified a large body of accumulated evidence, from 
molecular biology to complex epidemiological studies, matched case-control studies, 
comparative, prospective and retrospective cohort studies, clinincal trials, reviews of 
unintended adverse events in healthy young people, case note reviews / linked 
hospital discharge studies, ecological studies, and time trend analyses, all conducted 
by independent researchers, that have been unable to establish a causal link between 
MMR and autism (Fombonne & Chakrabati, 2001; Kye et al, 2001; Coffin, 2002; 
Makela et al, 2002; Masden et al, 2002; Phelan, 2002; Taylor et al, 2002; Thjodleifsson 
et al, 2002; Smeeth et al, 2004 Chen et al, 2004). In addition, systematic reviews of the 
literature have failed to identify any links between Crohn’s Disease, ulcerative colitis, 
autism or aseptic meningitis and MMR (Jeryl-Lyn strain) (Jefferson et al, 2003; Miller E 
et al, 2005; Demecheli et al, 2005). 
 
Additional compelling evidence is obtained from a whole population study undertaken 
in Japan, where MMR was withdrawn in 1993, effectively creating a large natural 
experiment (Honda et al, 2005). The series of studies that followed found that there 
was no effect of the withdrawal of MMR on subsequent rates of autism over time 
(Takahashi et al, 2003). There has also been found to be no correlation between the 
rate of autism and MMR vaccine coverage in the UK or the USA (Dales et al, 2001; 
Kaye et al, 2001) and there is no evidence of a clustering of the onset of symptoms of 
autism in the period following MMR vaccination (DeWilde et al, 2001; Makela et al, 
2002). There is, however, some evidence of recall bias in cases where parents 
retrospectively attribute causation to MMR (Andrews et al, 2002; Lingham et al, 2003), 
and also evidence that the likelihood of parents reporting a link with administration of 
MMR increased significantly after 1998 (Lingham et al, 2003). 
 
There is no doubt that the recorded rates of autism have increased over the past 30 
years, and that there is an urgent need for research into the causes and potential 
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treatment for this lifelong condition. However, whilst the research is not able to 
definitively rule out a potential environmental or autoimmune mechanism for all cases 
of autism, cases of regressive, degenerative autism are very rare, and there do not 
appear to have been any increase in rates of this specific form as a proportion of all 
diagnosed cases over time (Al-Ayadhi, 2005). Whilst this provides good evidence that 
this cannot be the explanation for the large increase in cases of autism in recent years, 
the fact that these are very rare occurrences means that they would be too small in 
number to be identified in epidemiological studies (Lingham et al, 2003). Consequently, 
the possibility remains technically open, and the debate in respect of causation cannot 
be concluded for this extremely small group of children. Unfortunately, these children 
continue to remain the subject of case reports in online media and grey literature 
sources, particularly those associated with ‘anti-vaccination’ groups.  
 
An exploration of the wider literature, however, does provide credible alternative 
explanations for the increase in autism, not least that the increase is most likely to 
have resulted from increased public and professional awareness following better 
recognition and assessment, and the broadening of diagnostic criteria for the disorder 
(DeStephano, 2002; Wing & Potter, 2002; Rutter, 2005). Greater public awareness is 
also reflected in increased media coverage; but, unfortunately, studies which have 
reviewed this coverage tend to conclude that there is significant negative stereotyping 
of the disorder and of individuals affected by it, and that there is a lack of support 
available for parents of these children (O’Dell & Brownlow, 2005). This, in turn, is 
shown to affect parents’ concerns about the possibility of having an autistic child, 
especially in relation to the safety of the vaccine and them making an active decision to 
accept this for a child who is apparently healthy and unaffected (Speers & Lewis, 
2004).  
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Some authors also conclude that the lack of a robust defence of MMR, until the 
publication of the second Cochrane Review in 2005, acted to further undermine public 
confidence and that ‘the media’s critical scrutiny of those supporting MMR was not 
matched by a critical examination of the case against it, and that the public was, as a 
consequence, often misinformed about the level of risk involved’ (Speers & Lewis, 
2004, p. 175). 
 
Research published since 2009, including a further Cochrane Review and a meta-
analysis both published in 2012 (Demecheli et al; Hobson et al), confirm the absence 
of any causal link, and in fact suggest that the odds of being diagnosed with ASD are 
substantially smaller for those who receive MMR. There has also been significant 
coverage of failed legal cases and professional action against Dr Wakefield by the 
GMC, which resulted in the subsequent retraction of the original article by the Lancet in 
2010. 
 
Given the substantial body of published evidence demonstrating that MMR is not 
correlated with the development of autism, the ages of the children, and the time 
elapsed since the initial offer and the new evidence refuting this link, a key question 
remains of relevance to the current study – was this still the key contributory factor 
influencing the parents’ decisions to decline MMR in Somerset after 2009?  
 
3.3.4 Summary of evidence relating to parental attitudes and beliefs 
From the studies reviewed so far, it is reasonable to suggest that scientific and medical 
evidence appear to play little part in parents’ decisions in respect of MMR, with 
parents’ own assessments of the relative acceptability of the vaccination and possible 
outcomes being of far greater significance. Previous experience – either of the 
diseases or of children with autism – was also found to be a significant factor and 
whilst some parents have reported that they did not receive information on the 
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rationale, benefits and risks of MMR; many felt that the information they did receive 
from the NHS did not bear any relation to their real life local circumstances  
MacDonald (2004),   
 
The cultural context of MMR rejection is another key concept highlighted. In the 
ethnographic study undertaken in Brighton (Cassell et al, 2006) for example, the 
authors concluded that decision-making in respect of immunisation was a complex 
culturally rooted activity, and that parental attitudes and beliefs were poorly 
understood. It has also been suggested that research in this area holds great promise 
for promoting the public health of children and their families, but that there is little or no 
information on how these attitudes change over time or what influences these changes 
where they occur (Sturm et al, 2005). Further research may provide insights into these 
factors and in doing so provide direction to guide how the providers of these services 
can effectively engage with parents, thereby bridging the gap between policy 
recommendations and parents’ actual decisions. This is particularly important at a time 
when there are so many new vaccines in development.  
 
The present study will explore socio-environmental, parent-specific and personal 
characteristics (such as beliefs and attitudes) in relation to immunisation in general, 
and specifically in relation to MMR, in order to establish whether the same 
characteristics – health beliefs, social norms, and perceived risk – apply equally to a 
population of parents in Somerset who are, by default, ‘persistent decliners’ of MMR 
vaccine. 
 
3.4 Parental decision-making and MMR  
3.4.1 Conflicting evidence and ‘decisional conflict’ 
The evidence explored in the previous sections of this literature review suggests that 
immunisation decisions almost inevitably involve the weighing up of the risks and 
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benefits of vaccinating the child, against not doing so (Cassiday, 2007). There are, 
however, considerable inconsistencies and contradictions within the evidence.  
 
Parents’ consistently report that the potential to cause physical pain to their child 
through the process of immunisation is considerably distressing and anxiety provoking 
(Bennett & Smith, 1992; Harrington, Woodman & Shannon, 2000; Smailbegovic et al, 
2003; Mills et al, 2005). Combination vaccines, such as MMR, offer a potential solution 
to this and to the addition of new vaccines to the national schedule (Kaslap-Petraco & 
Parsons, 2003) by reducing the number of clinic visits and the distress of multiple 
injections. It may also increase vaccine coverage and reduce the potential for the child 
acquiring serious disease in the intervals between single doses (Andeae, Freed & 
Katz, 2004; Bedford & Lansley, 2007). However, despite these advantages, and their 
acknowledged distress and anxiety in respect of causing pain, parents’ concerns when 
assessing the initial offers of MMR appear to continue to centre on the simultaneous 
administration of the three antigens and this creates a dilemma for parents when 
making decisions for their children (MacDonald, Henderson & Oates, 2004).  
 
Leach et al (2006) suggest that this ‘decisional conflict’ appears to be a key factor, 
which is only resolved by parents in reference to considerations of either the specific 
vulnerability of the child to the diseases, the effects of the vaccine, a desire for choice, 
or to what parents regard as values in respect of ‘good’ parenting. Other authors have 
suggested that the suggestion of harm, occurring as a result of immunisation 
(‘commission’), may be less acceptable to parents than harm occurring as a result of 
not immunising (‘omission’) (Wroe et al, 2005). This possibility of ‘omission bias’, may 
be one of a number of ‘emotion-related’ variables which are currently poorly 
understood and require further exploration in order to establish what motivates parents 
when deciding to accept or decline immunisation for their children.  The literature also 
suggests that parents use a number of different strategies to make sense of risk issues 
63 
 
in health, particularly in respect of MMR, and that this may involve roles for both social 
networks and the media as sources of information and in reinforcing parental 
understanding and belief (Cheater, 2006). 
 
3.4.2 The role of past experience in immunisation decision-making 
Weighing up risks and benefits may also rely to some extent on personal experience. 
Qualitative interview studies, undertaken in Scotland, have identified prior experiences 
of disease as the primary determinants of MMR decisions, with parents who had direct 
experience of autism, or who believed their child to be autistic, more likely to decline 
and those who had observed the negative impact of vaccine preventable diseases 
more likely to accept vaccination (McMurray et al, 2004). Ethnographic studies by 
Poltorak et al (2004) provided further evidence that mothers bring to parenthood very 
diverse experiences and found that parents drew on the history of immunisation 
decisions, and their experience of this within their own family and in other families 
known to them, when making decisions about MMR. Both studies were, however, 
small in scale and it is unclear whether these findings can be more widely generalised.  
 
Published research in respect of the role of immunisation services in relation to uptake 
appears to be even more limited, but there is some evidence to suggest that adverse 
experiences of immunisation services can result in deferral of future visits or in 
defaulting and non-attendance (Harrington et al, 2000). Cassell et al (2006), however, 
suggest that, whilst previous negative experiences may discourage parents, for some 
‘non-compliers’, the decision to refuse all immunisations is made very early on,  
perhaps even before their baby is born. For this group of parents, refusal appears to be 
completely unrelated to their experience of or satisfaction with the immunisation 
service. This suggests that there may be differences within the group of parents 
currently identified as a single group of ‘persistent decliners’ and this warrants further 
investigation.  
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Past experience, both positive and negative, may play an important part in parents’ 
decision making, however, what remains unclear, is whether the influence of these 
experiences or behaviours, persists long term; and whether this then changes over 
time, or as new experiences occurs? In addition, why do some parents persist in 
deferring, despite having experiences which counteract the decisions previously 
made? 
 
A final consideration relates to findings by Evans et al (2001), who identified that, in UK 
focus group studies, because responses relied on self-report, personal experiences 
were not necessarily ‘good predictors’ of immunisation status. They report that 
quantitative research using objective measures is needed to enable further 
clarification. These issues have been considered when designing the present study. 
 
3.4.3 Other factors influencing parental decision-making 
3.4.3.1 The influence of the media 
As stated previously, adverse publicity about MMR has been shown to raise doubts in 
the minds of people who had not previously questioned the safety of immunisation 
(Evans et al, 2001; McMurray et al, 2004). Pareek & Pattison (2000) found that 
mothers obtained information from the media, especially from magazine style TV 
programmes such as GMTV. However, Mac Donald et al (2004) found that parents 
who declined MMR were more likely to rely on information from the internet, than from 
health care professionals or other media sources. In an Australian study, Bond et al 
(1998) reported that anti-vaccination material reported in the media caused mothers to 
question their decisions and contributed to feelings that important information was 
being withheld from the public. There is robust evidence from multiple sources of the 
significant influence of both print and digital media on parental attitudes towards 
acceptance or refusal of immunisation from the earliest points of programme 
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introduction (Davies et al, 2002; Leask & Chapman, 2002and Wolfe et al, 2002). 
However, parents’ views of the media vary widely.  
 
In a Scottish focus group study, for example, whilst some parents viewed journalists as 
important providers of information, others viewed them as ‘scaremongers’ (Hilton, 
Pettigrew & Hunt, 2007). Attention surrounding MMR therefore appears to have 
highlighted to some extent the negative role of the media in vaccine scares. These 
studies provide further evidence of the difficulties parents find in identifying reliable 
sources of information on risks and benefits and of then balancing these to be able to 
make the required decisions about immunisation (Petts et al, 2003).  
 
Social media has also now become integral part of modern communications. Parents 
do not just use the internet to acquire information; they also use it to share their 
opinions and concerns through social conversations. Skea et al (2008), in a review of 
online chat room discussion confirms that ‘avoiding harm to others’ is an important 
consideration for parents. However, this is again couched in terms of individual 
susceptibility: a clear distinction is made between vulnerable and healthy children, and 
this has implications for which children should ‘bear the burden of vaccination’. Parents 
were, for example, very critical of those who did not vaccinate healthy children.  
 
There is also a need for more research in respect of how parents make the distinction 
between vulnerable and healthy children, since there has been some evidence of 
uptake being negatively impacted where parents and professionals had 
misconceptions about the risk of adverse events, or where ‘spurious contraindications’ 
to immunisation, including concerns about concurrent respiratory conditions, allergies, 
or minor illnesses, have been applied (Watson et al, 2007; Ozkaya, 2011; Fox et al, 
2012; Munro, 2013; Parella et al, 2013). It should also be noted that, in many of these 
studies, parents who were critical of the decisions of other parents were equally able to 
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rationalise why their particular child (and decision) were acceptable exceptions, based 
on perceived individual vulnerability factors. 
 
3.4.3.2 Distrust in the Government 
A review of the chronological history of vaccine development (Warren, 2000) confirms 
that anti-vaccination attitudes existed many years before the MMR controversy. The 
1802 caricature of Jenner inoculating patients in Figure 1 below, for example, 
demonstrates the early concerns of patients when Jenner first proposed vaccination 
against smallpox using cowpox vaccine that it would make them sprout cow-like 
appendages:  
 
 
Figure 1: "The cow pock" by James Gillray - Library of Congress, Prints & Photographs Division, LC-
USZC4-3147 (colour film copy transparency), archival TIFF version  
 
Reviews in relation to media coverage of vaccines in Australia in the 1990s have 
identified several key anti-vaccination themes. These included conspiracy theories of 
‘cover-ups’ relating to the withholding of information from the public, portraying 
vaccines as dangerous chemicals or toxins which poison the body, or regarding 
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vaccines as a form of Governmental control, or a threat to civil liberty (Leask & 
Chapman, 1998).   
 
There is also evidence to suggest that distrust in the UK government, and 
consequently a lack of confidence in statements issued by the Government about the 
safety of MMR, may have more recently adversely impacted on parental decision-
making, particularly among parents who refuse MMR. (Evans et al, 2001; Cassell et al, 
2006; Cassiday et al, 2006; Hilton et al, 2007). 
 
3.4.3.3 The role and influence of Health Care Professionals 
In terms of trust, whilst some parents remain sceptical about reassurances of MMR 
safety made by the Department of Health (Evans et al, 2001), the tracking surveys 
undertaken between 1996 and 2006 provide robust evidence that mothers were more 
likely to trust information given by health care professionals and the NHS than the 
Government and that they continue to see Health Care Professionals (HCPs) as a key 
source of information and advice about immunisation (Impicciatore et al, 2000; Smith 
et al, 2001; Smailbegovic et al, 2003; McMurray et al, 2004; Heininger, 2006).  
 
However, if doctors or nurses appear to lack confidence in the programmes, there is 
evidence that this is likely to be reflected in reduced uptake. The complexity of the 
current schedule and negative publicity, particularly in respect of MMR is, however, 
reported to have resulted in a reduction in professional confidence, and knowledge in 
this area of work (Smith et al, 2001), which consequently may have an effect on 
parents’ experience of the process.   
 
In two focus group studies undertaken in Australia, Leask et al (2006) found that the 
family doctor was considered an integral point of reference in both immunisation 
decision-making and in the ‘negotiation of risk messages’. Bond et al (1998) found that 
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mothers valued doctors who took the time to explain procedures and discuss risks and 
appreciated staff that listened to them and ‘credited them with common sense’. Evans 
et al (2001) also found that doctors and health visitors who discussed immunisations 
openly were highly valued, whilst those who ‘sat on the fence’ were viewed most 
negatively by parents.  
 
Parents frequently report that HCPs are the most helpful source of advice, however, a 
significant number remain dissatisfied with some aspect, for example believing the 
information to be biased, or lacking objectivity, or that some information may be being 
withheld (Smailbegovic et al, 2003). Others, particularly those who decline MMR, 
remain concerned about GPs receiving payments for immunisations or them having to 
meet targets for uptake (Evans et al, 2001; Sporton & Francis, 2001). The same 
studies identified a desire for HCPs to provide more balanced information for parents, 
with many finding it difficult to have an open discussion with professionals about the 
risks and benefits of immunisation.  
 
Poor communication and unpleasant staff have therefore been identified as barriers to 
immunisation (Mills et al, 2005). Qualitative interviews have also revealed that a lack of 
empathy from doctors involved in immunisation was considered unacceptable and that 
mothers valued attempts by them to acknowledge the pain and to engage with the 
child (Harrington et al, 2000).  
 
Given this evidence, it is likely that issues of trust and parental satisfaction with both 
the amount and the quality of information received are key factors in determining 
whether or not parents will take their children for their immunisations.  Similarly, the 
‘MMR contact’ with health care professionals appears to be of crucial importance in 
determining outcome and therefore needs to be effective since Martin et al (2001) also 
found that: 
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“If a parent remains undecided after a discussion with a health professional, it is likely 
that this will not change and there is little gain in referring them to someone else. This 
may be counter-productive and, at worst, stiffen resolve not to vaccinate and, at best, 
maintain the parent in a state of continuing indecision” (p 38). 
 
To date, the Government’s responses to falling immunisation uptake rates appear to 
have been based on providing more information to the public, overtly using language of 
risk. These strategies are apparently based on a number of assumptions which may 
not be entirely valid (Hobson-West, 2003). For example, it is assumed that individuals 
make decisions through a comparison of individual relative risks, that the current public 
concern is due to misunderstanding or miscalculation of risk, and that therefore 
reducing these knowledge deficits by providing more information is the best response 
to improve vaccine acceptance (Cunliffe, 2004). The evidence presented here 
suggests that the process may be far more complex and may therefore require a 
different approach, particularly for those parents who persistently decline. 
 
Whilst professionals do need to be accurately informed, in order to be able to assist 
parents in making their decisions, they also need a better understanding of the 
dynamic nature of immunisation decision-making, so that they can help to identify more 
effective methods of promoting childhood immunisation to groups at risk of non-
compliance. Streefland (in Vernon, 2003) suggests that immunisation policy needs to 
move from the current situation, which largely assumes passive population 
compliance, to a policy where people are actively involved and their views are 
respected. This can only be achieved where these views are better understood by 
policy makers and this study aims to provide further evidence to improve that 
understanding.  
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Between 2009 and December 2013, there was an increase in the number of studies 
investigating parental attitudes and beliefs, and in using new models to develop 
predictors of vaccination outcomes (for example, Tickner et al, 2010 – Immunisation 
Beliefs & Intentions Measure, based on the theory of planned behaviour; and Schultz & 
Nakamoto’s Extended Health Empowerment Model, Diviani et al, 2012). These studies 
appear to confirm the strong influence of parental attitudes on vaccination intention. 
 
The most significant new area of investigation over the past three years, however, 
relates to studies exploring the role and impact of HCPs, and the development of 
potential interventions to improve access and delivery of immunisation information. 
Whist it appears generally acknowledged (and is evidenced in this review) that HCPs 
can be a credible source of information for parents seeking informed decision-making, 
and are well-placed to challenge myths and promote the benefits of immunisation 
(Kassianos, 2010; Schonberger, 2012;Hill & Cox, 2013), Simone (2012) identified that 
gaps in health care professionals’ knowledge and poor communication could actually 
be detrimental to achieving high uptake, while Redsell et al (2010) found that the 
approach of some professionals could act as a psychological barrier to accepting 
vaccination. This author also suggested that further work to identify parental factors 
that may point to ways of making positive adjustments to these approaches – such as 
the research undertaken within this thesis – could help to facilitate more effective MMR 
promotion activities in future. 
 
There is, however, no consensus about how best to alter current approaches in order 
to address falling uptakes. Some investigators have continued to focus on the need to 
overcome potential barriers by improving the knowledge of both parents and 
professionals through better education and provision of information (Anderberg et al, 
2011; Fox et al, 2012; Harrisen et al, 2012). Others have investigated specific 
interventions to improve uptake, with a focus predominantly on structural changes to 
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improve the organisation of immunisation services, including provision of improved 
call/recall, leaflets and parent meetings, telephone follow-up of postal invites, 
commissioning of care packages, development of incentivized GP practices and 
networks, and innovative use of information technology (Jackson et al, 2011; Cockman 
et al, 2011; Goodyear-Smith et al, 2012).  
 
New and potentially interesting areas of study include development of the ideas around 
communicating concepts of ‘benefit to others’ and ‘herd immunity’ in ways that are 
understandable and compelling to parents, and using this as a motivational tool to 
increase uptake (Quadri-Sheriff et al, 2012). Equally, there is the exploration of 
concepts of health literacy, health empowerment and information searching behaviour 
in relation to immunisation (Diviani et al, 2012) which also has the potential to be 
incorporated and further explored in this study.  
 
Several studies have suggested that parents may benefit from social engagement with 
professionals, and that attention should be paid to parental ‘storytelling’ when making 
policy decisions (Vernon, 2003; Leach et al, 2006). Since there were only a small 
number of such studies identified, further research is needed to confirm the validity of 
these concepts, and to ascertain whether these ideas can be extrapolated to other 
contexts and populations. The integration of qualitative and quantitative approaches, 
as proposed in this study, may produce a richer vein of evidence about factors, such 
as these, which may be associated with parental decision-making. 
 
3.5 Evidence of other factors affecting or influencing uptake of immunisations 
Whilst some authors conclude that parental attitudes, and perceptions of control, are 
significantly associated with immunisation uptake (Prislin et al, 1998), or are sufficiently 
reliable to be used as predictors of completion of childhood immunisation programmes 
(Gore et al, 1999), others have highlighted limitations in the use of these models 
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suggesting that socio-demographic and financial factors, or access / barriers to care, 
may be more predictive of immunisation outcome (Strobino et al, 1996; Bates & 
Wolinsky, 1998).  
 
From the evidence reviewed to date it is possible to identify six consistent and 
interacting factors related to acceptance of childhood immunisation, as follows: 
Parent - specific personal factors (e.g. attitudes, beliefs, social group norms, 
geographic, demographic and social characteristics, including religious and moral 
objections) (Streefland, 1999; Evans & Bostrom, 2002; Leask & Chapman, 2002; 
Sturm et al, 2005; Cassell et al, 2006) 
 
Attitudes and practices of healthcare providers (e.g. whether providers recommend 
vaccination or not; whether there has been effective risk/benefit communication with 
the parents; whether phone or other reminders are given) (MacDonald, 2004; 
Fitzpatrick, 2004; Deady & Thornton, 2005; Rosen-Schikuta et al, 2007) 
Access to healthcare (e.g. vaccine cost and availability, transport, convenient clinic 
hours) (Strobino et al, 1996; Bates & Wolinsky, 1998; Harrington et al, 2000; Niroshan 
et al, 2003; Henderson et al, 2004; McMurray et al, 2004; Yarwood et al, 2005). 
Policies, interventions and action at political and societal level (e.g. legal mandates to 
immunise) (Sporton & Francis, 2001; Smith et al, 2001; McMurray et al, 2004; Wood-
Harper, 2005) 
 
The physical environment such as background prevalence of the disease & history of 
previous public health efforts (e.g. the length of time since a disease last caused 
significant outbreaks, or whether there is effective medical treatment for the disease) 
(Bond et al, 1998; Fitzpatrick, 2004; Petts & Niemeyer, 2004; Cameron et al, 2007). 
The issue of balancing individual freedoms and collective responsibility (Vernon, 2003; 
Skea et al, 2008; Perisic & Bauch, 2009) 
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Two large UK population based studies published around the time of the MMR debate 
and subsequent ‘Catch-up campaign’ (Friederichs et al, 2006; Bedford et al, 2009) 
have indicated that there may also be specific social or demographic factors 
associated with partial or no immunisation. For partial immunisation, factors include 
lone parents, large family size, residing in a disadvantaged area, smoking in 
pregnancy, ethnicity, teenage mothers, or a history of the child having at least one 
hospital admission. For no immunisations these include older (> 40 years) mothers and 
more highly educated mothers. These findings are also supported by further research 
(Reading, Surridge & Adamson, 2004; Cassiday et al, 2006; Hawker et al, 2007). 
 
For MMR, studies suggest that the pattern is slightly different, in that the factors below 
are actually more likely to result in no immunisation: 
Mother more highly educated 
Mother over 34 years of age 
Larger family size 
Mother under 20 years 
Lone parent 
Maternal smoking in pregnancy 
 
Of these factors, mothers who are highly educated and those over 34 years of age 
appeared to be of greatest significance (Friederichs et al, 2006; Samad et al, 2006; 
Hilton et al, 2007; Bedford et al, 2009). These additional social and demographic 
factors are explored in the context of the population of Somerset, within this thesis. 
 
3.6 Gaps in the current evidence base and areas for further research 
3.6.1 Evidence from a UK context 
Much of the published evidence examined in this review predominantly originated from 
the US, Australia, New Zealand, or Europe. Searches in relation to parents’ attitudes 
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towards MMR yielded very few original UK published studies. Five UK studies were 
identified which were of particular relevance, and these were reviewed in detail. These 
included a focus group study undertaken in Avon and Gloucestershire (Evans et al, 
2001), a study using parental questionnaires in Hackney, London (Smallbegovic, 
2003), a qualitative interview study undertaken across five GP practices in Leeds 
(McMurray et al, 2004), an ethnographic survey of mothers in Brighton (Cassell et al, 
2006), and a focus group study undertaken in Scotland (Hilton et al, 2006). A review of 
previous PhD theses (Hilton, 2005; Tickner, 2008; and Kaur, 2011) provided useful 
additional insights; and evidence from the ‘Millenium Study’ (Bedford et al, 2005), from 
Health Education England, Scottish Health Feedback, and the evaluations of the 
Department of Health campaigns were also reviewed in detail. Whilst these studies 
used robust methodologies, and have identified some apparent themes, the sample 
sizes in many of the studies were relatively small (particularly in the published studies), 
or the contexts limited, and the evidence produced may not therefore be more widely 
generalisable. 
 
Searches in relation to rurality (‘rural’ AND ‘immunization’ or ‘MMR’) produced even 
fewer UK studies, instead primarily yielding evidence from developing countries, the 
findings of which are not easily applicable to modern developed administrations. This is 
relevant because Somerset is a rural county in England, and there is very little 
evidence relating to the rural UK context. However, studies undertaken in Ireland did 
suggest that there may be a potential link between mothers living in rural areas and 
lower uptake rates for childhood immunisation, and therefore a need for further 
investigation (Lowery et al, 1998). Additional research is therefore required within the 
UK context to confirm and add robustness to the findings of these previous studies, 
particularly in rural UK contexts.  
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3.6.2 Evidence in relation to populations who decline immunisation 
The studies noted in 3.6.1 above differ from the present study in that they all focus on 
whole populations of parents (that is they included both those who have accepted and 
those who have not yet accepted the offer of MMR) rather than focussing on those who 
had persistently declined the offer of immunisation. In fact, within the majority of 
studies reviewed (including the national policy sources) ‘confirmed rejectors’ and those 
clearly opposed to immunisation were almost universally explicitly excluded from the 
study samples – the most common justification being that divergent views were 
unhelpful and had a tendency to create group conflict (Corr Willbourn, 2004) and/or 
that recruiting ‘refusers’ proved more difficult, with parents of these children being 
considered less likely to complete the surveys (Hershey et al, 1994; Martin & Sansom, 
2003; Scottish Health Feedback, 2008).  
 
Gust et al (2005) highlighted a further common feature of surveys and other research 
in relation to attitudes in respect of MMR and immunisation, that is, the tendency to 
categorise parents in a dichotomous way – either for or against immunisations. 
Communication and marketing campaigns, however, depend on effective audience 
segmentation. Audience segmentation is the process of dividing people in to groups 
based on shared characteristics so that interventions can be tailored to best address 
their needs (Gust et al, 2005). Gurnig (1989) suggests that the same criteria for 
segmenting populations for marketing can also be used to address and target public 
health efforts, however, for this ‘social marketing’ to be successful: 
 
‘In general, segments must be definable, mutually exclusive, measurable, accessible, 
pertinent to an organisational mission, reachable with communication in an affordable 
way and large enough to be substantial and to service economically’ (p.203). 
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Investigation of the beliefs and attitudes of parents who persistently decline may 
therefore yield important insights that may have been omitted from previous research 
and which may be of significance in identifying the differential effect of current 
universal interventions aimed at increasing uptake across different groups and also the 
most effective and cost-effective ways of modifying existing services to increase 
vaccine uptake particularly among children and young people whose parents have 
persistently declined the offer of MMR. This will be vital if uptake is to be improved 
within this group in future (NICE / Department of Health, 2009).  
  
3.6.3 Evidence in relation to school-age children of parents who persistently 
decline MMR 
A further finding is that the majority of studies which have explored parental factors 
(including the unpublished communication research evaluations and the national 
tracking surveys) have done so with parents of very young children (under 5 years of 
age and typically 12 – 39 months) who remain in the age groups for primary courses of 
immunisation. There appear to be very few studies which have specifically followed-up 
cohorts of older children of parents who declined the initial primary schedule offer of 
MMR, and who continue to remain unvaccinated a number of years later, or those 
which explore what influenced these parents to change their mind and accept MMR at 
a later date, where they did so. 
 
A single study focussing on school age children was identified in the current literature 
review (Salmon et al, 2005). This study appeared to confirm that parents of these older 
children shared the same concerns in respect of vaccine safety / overload; ethical, 
moral and religious issues related to vaccine development (aborted cell lines, animal 
testing, etc); difficulties in assessing relative risk; and lack of trust in drug companies, 
professionals and government. However, the study was conducted in the US where a 
very different healthcare system and mandatory immunisation programme exists.  
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Further studies are therefore needed to establish if these findings are applicable to 
other populations and health systems, including the UK.  
 
In the absence of this evidence, there is currently no distinction in terms of current 
professional understanding between those who are delayed – since most parents do 
accept immunisation by the time children enter school – and those who remain 
unvaccinated beyond school entry and into young adulthood. This is of particular 
importance because of the potential for clustering of susceptible older children at 
secondary school, colleges and universities. In addition, there are suggestions that 
concern and mistrust may persist beyond the initial offers of MMR, creating a brief but 
significant cohort effect which may impact on public health across future generations.  
 
As parents who continue to decline MMR, especially those with children above school 
entry age, appear to have been excluded from most of the existing evaluations and 
published research to date, existing knowledge about them is quite limited and there is 
a tendency to group them together as a single entity. However, given the cumulative 
nature of unvaccinated populations, they have over time become a significant group 
both in number and in consequence for the development of susceptible populations. 
Existing knowledge of audience and population segmentation, as described in 3.6.2, 
suggests that this group of parents can, very likely, be categorised beyond this. 
Identifying any potential sub-groups within group would offer the potential to improve 
communications and tailor interventions more effectively to address specific concerns 
and needs of these parents (Gust et al, 2005). It is therefore important to establish 
whether this is a single homogenous group or whether sub-groups exist within this 
population which can then be categorised and targeted more effectively. 
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3.7 The local context - why is this relevant to Somerset? 
Somerset is a rural county in the South West of England. It borders Bristol and 
Gloucestershire to the North, Wiltshire to the East, Dorset to the South East and Devon 
to the South West. Agriculture is a major business in the county. Unemployment is 
lower than the national average, with the largest employment sectors being retail, 
manufacturing, tourism and health and social care. Population growth in the county is 
also higher than the national average, although the greatest increase in population age 
groups aged over 75.  
 
The population predominantly lives in small market towns, across a geographical area 
covering 1332 square miles and environments which range from remote moorland 
(Exmoor), to open agricultural land (South Somerset), and wetland (the Levels). There 
are also three main urban centres in Taunton, Yeovil and Bridgwater. Whilst indicators 
of population health for Somerset generally rate above national average, there are 
significant pockets of deprivation. These are associated with the urban centres and 
also, less easily identified areas of rural deprivation. Families tend to have high levels 
of car ownership, which tends to skew traditional measures of deprivation; however, 
car ownership is generally a necessity rather than a luxury because of poor local 
infrastructure, and especially access to public transport. 
 
A number of these factors may be related to the levels of immunisation uptake in 
Somerset – for example, by impacting on parents’ ability to access immunisation 
services, or by influencing decisions about whether to accept or refuse it. Somerset 
has relatively low levels of uptake of childhood immunisations, including MMR, when 
compared with other areas in the South West (See Appendix 2). 
 
General Practice is the cornerstone of childhood immunisation service delivery in the 
UK, and it has a good record of delivering high levels of vaccine uptake across most 
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programmes. However, wide variations in immunisation uptake exist between general 
practices in Somerset, as in other PCTs, and an initial review of local data had 
indicated that some practices maintain remarkably high uptake for all immunisations, 
including MMR, despite the generally low overall uptake figures for the county. In some 
cases, however, even practices in very close proximity to each other (adjoining 
premises) have been found to have very significantly different uptake rates (Lamden 
and Gemmell, 2008; Somerset Joint Strategic Needs Assessment, 2008; Glastonbury 
and Street Needs Assessment, 2009). It is therefore crucial to identify whether these 
variations can be attributed to any of the characteristics previously described – and, if 
not, what other characteristics are salient – to be able to develop appropriate 
interventions to address these issues.  
 
Uptake within Somerset does not, on initial review, seem to be linked to deprivation, 
practice size, or the number of staff (GPs or Practice Nurses) that are available; and 
there are no easily identifiable characteristics of high uptake practices or areas 
(Somerset JSNA, 2008). Studies have, however, previously demonstrated a strong 
negative association not only between uptake and professional confidence, but also 
between uptake and access to housing and /or other services; and this may be 
particularly relevant in large rural counties such as Somerset (Peckham et al, 1989; 
Samad et al, 2006). It is not known whether the association with the specific factors 
cited above is the same for rural populations, or those in areas with less ethnic and 
economic diversity, such as Somerset and this requires further investigation. 
 
3.8 Concluding the case for the research 
High coverage of population childhood immunisation programmes, such as MMR, are 
both clinically and cost-effective. The challenge for the NHS is therefore to identify 
potentially modifiable factors associated with low uptake, and then to implement 
interventions to achieve improvements in both uptake and coverage. This can only be 
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achieved if there is a very good local understanding of the reasons why parents do not 
accept this immunisation for their children.  
 
Parents’ interactions with health professionals appear to be crucially important in terms 
of addressing parental concerns and also in motivating hesitant parents towards 
immunisation. At a time of increasing personalisation in healthcare (when ‘informed 
patients’ are to be considered to be the norm) and in recognition of a shift in power 
relationships between patients and health care providers which encourages patients to 
become equal partners in decisions about their health (Dixon-Woods, 2005; Leask et 
al, 2012), it seems reasonable to assume that new ways of communicating and 
interacting with parents might be needed to help guide them towards making quality 
decisions. However, in order to develop these new ways of interacting, and to be able 
to recognise and respond to different perspectives, it is first essential to understand the 
particular characteristics of the populations that you need to reach.  
 
The conclusion that can be drawn from this critique of the literature is that there are 
significant gaps in the current understanding of parental decision-making particularly in 
relation to those parents who persistently decline immunisations such as MMR and in 
respect of the experiences and decision-making that occurs for parents of school age 
children as sub-sets of the general parent population. In addition, the limitations of 
current knowledge also include a lack of information in respect of the impact of 
contextual issues of relevance to Somerset, such as, the rural nature of the county.  
 
This thesis aims to address some of these gaps by focussing on exploring the factors 
influencing the decision-making of two groups of parents of school-age children who 
were invited to have MMR as part of the 2009 MMR Catch-up Campaign and who 
remained unimmunised after this offer, within Somerset, a rural county in the South 
West of England, through a series of quantitative and qualitative studies. Having 
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provided the context and further justification for the current research, the rationale for 
the study design and methodology used to achieve these aims, along with important 
ethical considerations of relevance to the research, is explained and critiqued in the 
next chapter.
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CHAPTER 4 RATIONALE FOR THE METHODOLOGY AND THE 
APPLICATION OF RESEARCH METHODS WITHIN THIS THESIS 
4.1 Introduction 
Previous chapters have highlighted the importance of understanding the factors that 
may contribute to the uptake of MMR. Any information which makes possible the 
identification of factors which encourage acceptance of MMR immunisation, particularly 
amongst those groups who have previously declined or failed to attend, could enable 
the development of more effective, equitable and cost-effective local (and potentially 
wider) services, which is both ethically desirable and increasingly necessary at a time 
of financial constraint. 
This thesis aims to improve the current understanding of characteristics contributing to 
the uptake of MMR, and the influence of these on parental decision-making in 
Somerset, by addressing the following research questions: 
What were the social, demographic and geographic characteristics of parents / children 
who had accepted and declined MMR in Somerset in 2009? 
Are parents who persist in declining MMR a single homogenous population sub-group? 
Does the ‘Wakefield study’ remain a primary factor influencing parents’ of school age 
children to decline MMR in Somerset, or are there additional factors at play?  
How have parents’ previous experiences, attitudes and behaviours in respect of MMR 
and wider immunisation services influenced their longer term decision-making? Have 
their attitudes and behaviours regarding immunisation changed over time, or as new 
experiences occur? Are there any consistent differences in the experiences of parents 
who decide to decline MMR vaccination? 
Why do some parents persist in declining MMR, despite having information and 
experiences which counteract the basis on which their initial decision was made? 
What factors influence parents who have persistently declined to change their mind 
and accept MMR for their school-age children? 
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The present research aims to address these questions by exploring baseline 
epidemiological data, conducting a survey of parents and undertaking semi-structured 
interviews with a sub-set of these parents. This chapter provides the rationale for the 
study design, and outlines important ethical and methodological factors that were 
considered when conducting this research.  
 
4.2 Rationale for using a ‘mixed methods’ approach 
The review of the literature in Chapter 3 identified a number of methodologies that 
have previously been used to investigate immunisation uptake. These included survey, 
case studies, cohort studies, qualitative interviews and questionnaires, ethnographic 
and epidemiological studies. (Streefland et al, 1999; Streefland, 2001; Prislin et al, 
1998; Briss et al, 2000; Sturm et al, 2005; Weinkunat et al, 1998; Henderson et al, 
2004: Wood-Harper, 2005). The present study employed a mixed methods design in 
order to address the research questions outlined above.  
 
The overall objective of the present study was to investigate a number of social, 
demographic and geographic characteristics of parents and children associated with 
MMR uptake, to compare these characteristics within and between defined subsets of 
the Somerset population, and to explore the basis on which parents in Somerset make 
decisions in relation to MMR immunisation. It is also of interest to compare the findings 
from this study with those of the previous studies described (Friederichs, 2006; 
Bedford et al, 2009). The review, in Chapter 3, provided an indication of potential 
approaches which might be useful in providing evidence to answer some of the 
research questions. However, there was no evidence of studies previously undertaken 
that had achieved all of these objectives. In order to obtain sufficient evidence, both in 
breadth and depth, to effectively answer the research questions posed and to make full 
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use of the strengths of each research methodology, the design adopted was therefore 
a cross sectional study consisting of  three sequential phases as outlined below: 
 
Phase 1: A preliminary epidemiological baseline review of MMR immunisation data for 
Somerset. This initial phase underpinned the remainder of the research and was used: 
to determine any differences in demographic and geographic characteristics between 
children whose parents accepted and those who declined the offer of MMR 
as a sampling frame to identify a subset of children whose parents had continued to 
decline the offer of the MMR vaccine in March 2009 
 
This epidemiological baseline review involved quantitative analysis of routine 
immunisation data held on the local McKesson CarePlus Child Health Information 
System (CHIS), extracted using Business Objects into a standard excel database.  
 
Phase 2: A cross-sectional census distributed as a postal survey to the parents of all 
the children identified in the subset in (b) above. This study integrated both deductive 
and inductive methods and involved collection of quantitative (categoric) data via 
multiple choice / tick box questions and also the collection of free text (codable) data, 
which was later collated and analysed as one of the qualitative data sources within the 
present research. The information obtained was intended to validate the evidence on 
factors associated with declining immunisation as identified in the literature review 
(Chapter 3) within the context of Somerset, and to support the development of an initial 
framework for the thematic analysis of the semi-structured interviews 
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Phase 2 was also used as a sampling frame for Phase 3, with parents opting to 
consent to be invited to participate in semi-structured interviews by completing the 
contact details section at the end of the survey.  
 
Phase 3: Semi-structured qualitative interviews conducted with a sub-set of parents 
who had completed and returned the census survey and had provided consent and 
contact details to enable the researcher to make contact with them. The purpose of this 
component of the research was to explore and compare themes arising from these 
narratives and to use these to explore how parents make decisions about MMR 
immunisation and whether this can information can be used to influence parents’ 
decision-making in future.  
 
The three phases were designed to be linked via the use of a unique identifier for each 
child within the study populations (linked within the original database to the child’s NHS 
number). This was to enable information for each child / parent to be added to, and / or 
referred back to (to check validity of responses within each subsequent study) and to 
build a more complete dataset for comparison between groups within the population of 
parents being studied. 
 
The quantitative elements of the study provided access to information on geographic 
location, immunisation status and demographics for the population of children in 
Somerset within the two age groups included in Phase 1, and also to the complete 
dataset of children within the unimmunised subset of this population later investigated 
in Phase 2. The respondents to the Phase 2 survey then provided a sampling frame 
for, and an initial framework for the analysis of, the final Phase 3 study. The qualitative, 
Phase 3, elements then performed a role in ‘validating’ the quantitative research and 
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also in providing a different ‘perspective on the same social phenomena’ (Pope & 
Mays, 2006a) through the identification of patterns and themes within the data which 
could be used to derive possible explanations for the factors identified in the earlier 
phases of the research. 
 
The insights gained from the qualitative interviews also provided challenge to the 
researcher’s own assumptions and resulted in a periodic return to reconsider previous 
interpretations of the data during the course of the study and therefore to a fuller 
understanding of the findings of the initial quantitative studies.  
 
It is therefore argued that using a ‘mixed methods’ approach offered a more 
informative means of establishing the range of factors that may influence parental 
uptake of childhood immunisations such as MMR and of providing possible 
explanations for how these factors may interact to influence parental decision-making. 
The findings from each phase, undertaken using different methods, were then 
compared and convergence is sought in the final discussion of this thesis. 
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4.3 Phase 1 Study Design: Cross-sectional review of routine immunisation 
data for Somerset in 2009 
4.3.1 Study aims and rationale for the use of a cross sectional survey 
method 
 
The aims of this study were: 
To investigate the distribution of a number of variables relating to factors associated 
with MMR uptake in Somerset 
To compare these factors within and between defined subsets of the Somerset 
population 
 
The Phase 1 study aimed to provide answers to the following research question: 
What are the social, demographic and geographic characteristics of parents / children 
who had accepted and declined MMR in Somerset in 2009?  
 
The rationale for the use of a cross-sectional design for Phase 1 and Phase 2 is as 
follows. The main designs in quantitative health based research are cross-sectional, 
prospective longitudinal and experimental (Sutton & French, 2004). In a cross-sectional 
study, data are collected on the whole study population, or a representative subset of a 
population, at a single point in time, to examine the relationship between disease (or 
other health related state) and other variables of interest, allowing conclusions about 
phenomena to be drawn across a wide population (Shuttleworth, 2010). Cross-
sectional studies therefore provide a ‘snapshot’ of the frequency of a disease or other 
health related characteristics in a population at a given point in time (Hennekens & 
Buring, 1987). This methodology can be used to assess the burden of disease or the 
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health needs of a population, for example, and is therefore particularly useful in 
informing the planning and allocation of health resources (Shuttleworth, 2010). 
 
In experimental designs, including randomised control trials and case-control studies, 
researchers randomly assign individuals to one or more independent variables and 
then measure the effect of the independent variable on one or more dependent 
variables (measured outcomes). This ensures that every participant has an equal 
chance of being selected to each of the experimental conditions and improves the 
likelihood that there is not a third variable causing any associations, and therefore 
enables the strongest causal inferences to be made (Tickner, 2008). 
 
Cross-sectional studies differ from case-control studies in that they aim to provide data 
on the entire population under study, whereas case-control studies typically include 
only individuals with a specific characteristic. Cross-sectional studies may also be 
described as censuses and they often rely on the use of data originally collected for 
other purposes. Longitudinal studies differ from both of these designs as they involve 
making a series of observations more than once on members of the study population 
over a period of time. (Tickner, 2008). 
 
Henneken & Buring (1987) have outlined a number of strengths and weaknesses of 
cross-sectional studies. They acknowledge that this type of research is relatively easy 
to conduct as there are no long periods of follow-up, data on variables is only collected 
once, and you are able to measure prevalence for all the factors under investigation or 
study multiple outcomes and exposures. This is important because prevalence of 
disease or other health related characteristics are used in public health for assessing 
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the burden of disease on a specified population and in planning and allocating health 
resources. These studies are therefore good for producing descriptive analyses and for 
generating hypotheses. It can, however, be difficult to determine whether the outcome 
followed exposure in time, or the exposure resulted from the outcome in these studies. 
As a result these designs are not suitable for studying rare diseases with a short 
duration, they cannot be used to measure incidence, and any associations identified 
can be difficult to interpret.  
 
In summary, advantages of this methodology include the fact that the use of routinely 
collected data allows large cross-sectional studies to be made at relatively little 
expense. In reality it is often impossible to survey the entire population of interest and 
cross-sectional studies therefore have a major advantage over other forms of 
epidemiological study. A further advantage relates to the fact that most case-control 
studies collect specifically designed data on all participants, including data fields 
designed to allow the hypothesis of interest to be tested. However, in issues where 
strong personal feelings may be involved, specific questions may be a source of bias. 
For example, past MMR decision-making may be inaccurately reported by a parent 
wishing to reduce their personal feelings of guilt. Such bias may be less in routinely 
collected statistics, or effectively eliminated if the observations are made by third 
parties, for example by reviewing routine immunisation records by area. 
 
A disadvantage, however, is that the available routine data sources may not be 
designed to answer the specific question being asked. In addition, routinely collected 
data does not normally describe which variable is the cause and which the effect, in a 
particular situation. Cross-sectional studies using data originally collected for other 
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purposes are therefore often unable to include data on confounding factors, other 
variables that affect the relationship between the putative cause and effect.  
 
In the present research a cross-sectional design was employed for both of the 
quantitative Phase 1 and Phase 2 components. The factors outlined above were 
considered when assessing the use of these methods within this thesis and the studies 
were designed to try to minimise the disadvantages and weaknesses associated with 
the method, for example, by using routine data that could be identified at individual 
level as well as community level, and by then linking all data subsequently obtained 
back to this original data to both supplement and validate the dataset. 
 
4.3.2 Study design  
The purpose of an epidemiological review is to study the patterns, causes and effects 
of health, and disease conditions, in defined populations (Porta, 2014). Key features of 
this type of study design are that all findings must relate to a defined population; it must 
be oriented to groups rather than individuals; and the conclusions of the study are 
based on comparisons (BMJ, 2010). This phase therefore involved the comparison of 
routine data held on the Somerset McKesson CarePlus Child Health Information 
System for a defined population of children resident in Somerset in 2009 as detailed 
below.   
 
4.3.2.1 Population and Sample 
41,767 children aged between six and 15 years were identified on the Somerset Child 
Health Information System (CHIS) as at 31 March 2009. These children formed the 
study population for the baseline epidemiological review of data in relation to MMR 
uptake. Analysis (comparison of proportions) was undertaken on data relating to the 
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whole of this study population to provide information on factors associated with both 
accepting and declining MMR and to compare any differences between children in the 
accepted and declined groups.  
The study population was divided in to two age groups as follows: 
Age group 1 (Primary School Age) - children aged six to 10 years of age on 
31/01/2009 (birth dates 30/01/1998 – 31/01/2003) 
Age Group 2 (Secondary School Age) - children aged 11 to 15 years of age on 
31/01/2009 (birth dates 31/01/1998 – 31/01/1994) 
The rationale for choosing these two age cohorts was as follows: 
Children aged six years and over should have completed their full primary course of 
two MMR immunisations, and would have received repeated invitations for their 
parents to consent for them to receive MMR as part of the routine offer within the UK 
Immunisation Schedule.  
 
Children aged 16 years and over are capable of making the decision to accept or 
decline immunisation independent of parental decision-making, and may have done so 
in the period after the 2009 catch-up campaign 
 
Children aged six to 10 years would have been born between 1999 and 2003 and their 
parents would have been those most exposed to negative media and public interest 
following the publication of Andrew Wakefield’s research (Wakefield et al, 1999) at the 
time of their first offer of MMR vaccine for their child 
 
Children aged 11 to 15 years were born before the publication of the Wakefield paper 
and at a time when acceptance of MMR by parents was considered to be relatively 
high and improving. 
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4.3.2.2 Inclusion and Exclusion Criteria  
All children in Somerset aged six to 15 years (birth dates 31/01/2003 to 30/01/1994) 
and recorded on the Somerset CHIS were included in the Phase 1 study.  
 
4.3.2.3 Data collection 
Data in relation to the study population and immunisation uptake was extracted from 
the Somerset McKesson CarePlus Child Health Information System using Business 
Objects and imported into a standard excel database for analysis.  
4.3.2.4 Data analysis 
MMR status for each child was identified and the children within these two age groups 
were then labelled either ‘immunised’ or ‘unimmunised’. The demographic 
characteristics (age, gender, deprivation quintile, MOSAIC group, MSOA, Children’s 
Centre Area, and registered GP Practice) of all unimmunised and immunised children 
in the two age cohorts were ascertained and any associations between these variables 
and MMR uptake were investigated using comparisons of proportions. The 
demographic characteristics of the children in the study population who had had MMR 
were compared with those whose parents had not consented for them to have MMR 
(as at 31/03/2009) in order to identify whether there were any associations between 
demographic characteristics and uptake.  
 
This phase of the study was undertaken by the researcher during July 2011 and the 
sub-set of ‘unimmunised’ children identified in this Phase 1 study then formed the 
study population for the Phase 2 Parent Census Survey.  
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Findings from the review of the literature (Chapter 3) and this Phase 1 study were used 
as the basis for developing the content of the Phase 2 ‘MMR Survey’ questionnaire 
that was distributed as a census to parents of children in this unimmunised population 
subgroup.  
Figure 2 – Summary of Phase 1 study design 
PHASE 1 – BASELINE REVIEW
Whole Population
(41,804 children born 01/01/1999 – 01/01/2004 in Somerset)
Primary School Age
(Children born 31/12/1999-01/01/20014
Secondary School Age
(Children born 31/12/1995 – 01/01/1999)
Immunised
(n = 20055)
Unimmunised
(n = 2252)
Unimmunised
(n = 1568)
Immunised
(n = 17920)
Unimmunised Sub-Group
(n = 3820)
 
 
4.4 Phase 2 Study – Parent Census Survey (‘MMR Survey 2012’) 
4.4.1 Phase 2 Study aims  
The aims of this study were to: 
Establish the demographic profile of a defined subgroup of parents and children 
(persistent decliners) within the Somerset population and to compare this against those 
described in previously published studies 
Provide a sampling frame for Phase 3 of the research study 
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Phase 1 relied on information available through routine secondary data sources (the 
Somerset CHIS) and included information in relation to the child that had been eligible 
for MMR vaccine at the time of the catch-up campaign. Phase 2 aimed to supplement 
this original dataset by gathering additional data in respect of social and demographic 
information about the parents of these children and their decision-making in respect of 
MMR. 
The rationale for the use of a cross-sectional design has been provided in section 
4.2.1.  This rationale applies equally to the design of this Phase 2 study.  
 
4.4.2 Study design 
This consisted of a questionnaire, with space for parents to add free text comments 
and for consent to be given for follow-up for final phase of the research by adding 
personal contact details on the final page, which was sent as a census to the sub-set 
of parents of children who continued to remained unimmunised as at 31/03/2009 as 
identified via the Phase 1 study. Details of the questionnaire design are provided in 
4.3.3 
 
4.4.2.1 Population and sample  
A breakdown of the children whose details were held on the Somerset CHIS is 
provided in Table 1. 
  
4.4.2.2 Inclusion and Exclusion criteria (see also Table 1) 
a) Child-related exclusion factors: 
‘Medical’ – this refers to children with identified medical reasons for not being given 
MMR. In these cases the decision not to immunise is usually taken by someone other 
than the parent, e.g. the supervising consultant or another experienced clinician.  
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‘Refused’ – are children for whom parents have actively refused consent for all 
immunisations (not just MMR). These parents will have also requested not to be 
contacted by the Patient and Practitioner Services. 
‘Withdrawn’ – this category of children have commenced the primary immunisation 
programme but have been actively withdrawn prior to completing it. This may have 
occurred, for example, because of adverse reactions or unrelated medical or other 
reasons. Again, in these cases the decision may not be made by the parent. 
Children whose parents had accepted MMR before 31/03/2009 
Children who had moved out of the area were excluded, for practical reasons. 
Immunisation Status Age group of child Number of children 
Unimmunised Primary school age 2252 
Unimmunised Secondary school age 1540 
Immunised Primary school age 20055 
Immunised Secondary school age 17920 
Not allocated Removed due to no NHS 
number or missing data 
37 
Total number of 
children 
 41804 
Table 1: Breakdown of study population sub-groups 
 
b) Child related inclusion factors 
Children within both of the age cohorts whose parents had continued to withhold 
consent for MMR (persistently declined), a total of approximately 3800 children were 
included. 
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c) Parent-related exclusion factors: 
Parents who have explicitly requested not to be contacted by the Patient and 
Practitioner Services 
Parents who are not the main carer of the child i.e. who live at a separate address 
Parents of children in the five categories detailed in (a) above 
 
d) Parent related inclusion factors 
All parents of children in (b) above 
All persons who have parental responsibility for these children and who live at the 
same address, for example, a ‘legal guardians’ were included 
 
4.4.2.3 Recruitment & consent 
The initial survey package was sent to participants from NHS Somerset Public Health. 
The package contained a letter signed by the researcher (an experienced Consultant 
in Public Health) introducing the study and inviting the parent(s) to participate. The 
letter was accompanied by the questionnaire and associated participant information 
leaflets to ensure participants were fully informed about the purpose of the study and 
how their data would be used. Participants then self-selected, by completing and 
returning the form to the Public Health Directorate, where the forms had originated, for 
collation.  
 
The information letter requested that parents (or guardians) completed the form and 
returned it in the enclosed envelope provided. Data was collated in an anonymised 
form unless the participants themselves provided contact details indicated permission 
for the researcher to contact them to make arrangements for inclusion in Phase 3. 
Where consent was given, the results from the questionnaire were linked to the 
information obtained via the subsequent interview. 
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4.4.2.4 Data collection 
4.4.2.4.1 Questionnaire design 
The questionnaire was designed to collect data on a number of variables, including: 
Age and gender of person completing form  
Relationship to child 
Child’s date of birth / age 
Child’s gender 
Number of siblings 
Birth order 
Parent’s employment status 
Marital status 
Ethnicity 
Knowledge of immunisation 
Source(s) of information on immunisation and MMR accessed 
Accepted or declined MMR in the period after the 2009 catch-up campaign 
Reasons given for continuing to decline 
 
The questionnaires were coded using a unique number and a barcode allocated by 
FORMIC. FORMIC is a computerised survey package which combines survey design, 
capture and data management. It enables the collection of data from scanned survey 
forms into a SQL database using a unique identifier for each form. This enables 
collation of relevant anonymised data in a form which ensures confidentiality and 
protects the respondent’s anonymity (www.formic.com, accessed 13/5/2015). 
 
The unique number was linked to the child’s NHS number within the Patient and 
Practitioner Services Department, to enable data to be reconciled, responses 
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monitored and reminders to be sent to non-responders. It also enabled the child’s 
study cohort to be identified for analysis purposes; for self-reported immunisation 
behaviour to be verified e.g. confirmation of uptake, or not; and any associations 
between parental or child related social, geographical and demographic factors and 
uptake to be identified. The NHS number was not known to the researcher. 
 
The questionnaire was developed and refined following discussions with a number of 
departments and organisations in Somerset who advocate for vulnerable populations. 
This included: the NHS Somerset and Somerset County Council Patient & Public 
Participation Departments; the local Patient Advocacy and Liaison Service; Somerset 
Race Equality Council (SREC); and local organisations supporting new migrant, Gypsy 
and Traveller populations, and those persons with literacy problems. Access to 
alternative resources to support participants, (such as alternative media or languages, 
or an option to complete verbally over the phone) was offered, where necessary, to try 
to maximise uptake by minority groups. Advice was sought from the organisations 
listed above regarding the most appropriate resources to use to support these 
individuals.  
 
The questionnaire was piloted with a subset of parent representatives of children in 
these age groups, to assess ease of completion and appropriate level of language 
used, prior to being sent to the wider cohort. The pilot phase confirmed that 
questionnaires should take no longer than 15 minutes to complete. The questionnaires 
were administered by post, with a strategy of one follow-up reminder sent to non-
responders two weeks after the initial questionnaire. The Invite Letter for Phase 2 can 
be found at Appendix 6, the Parent Census Survey Questionnaire is included as 
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Appendix 7 and the Patient Information Leaflet (Q&As) for Phase 2 are included as 
Appendix 8.  
The survey was sent to 3820 participants in March 2012 and was followed up with a 
reminder postcard to non-responders two weeks later in mid-April 2012. 
 
4.4.2.5 Data analysis 
The data obtained via the questionnaires was scanned into a password protected SQL 
data-base using FORMIC software. The data held in the SQL database was extracted 
and imported into excel for analysis of the categoric data fields. The categoric data 
obtained from the survey was analysed using comparison of proportions to explore 
whether any relationships between personal, geographic, socio-economic, parent- or 
child-related factors, and uptake could be identified. This analysis also explored 
whether there were any differences within and between the age cohorts studied and 
whether any relationships, where identified, were different from the relationships 
identified in previous studies, such as those undertaken by Bedford et al (2009), or 
Friederichs et al (2006). 
 
FORMIC software does not, however, automatically collate free text data. All survey 
forms which included free text were collated after scanning and the free text data was 
manually entered in to the excel database, using the unique identifier to align the data 
with the correct child, for later coding and thematic analysis as part of the Phase 3 
study.  
 
The coding of the free text data obtained via the questionnaire was used to inform the 
development of an initial framework for the thematic analysis of the data obtained 
during the interviews in the final phase (Phase 3) of the study. 
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The final section of the questionnaire enabled respondents to indicate whether they 
would be willing to participate in further research. This then also formed the sampling 
frame for the Phase 3 study.   
 
Figure 3 – Phase 2 Study Design to end of Phase 2 
PHASE 2  – PARENT CENSUS SURVEY
Whole Population
(Questionnaire design informed by review of evidence (Chapter 3))
Respondents
(n = 726)
Categoric data 
analysed
Codable qualitative 
data collected
Willingness to participate in further research
(n = 243)
10th person 
sampling
 
4.5 Phase 3 Study – Qualitative interviews with a sub-set of Parents 
recruited via the Parent Census Survey  
4.5.1 Study Aims and rationale for the use of qualitative interviews and 
applied thematic analysis   
The aim of this third and final phase of the study was to gather a richly descriptive 
source of qualitative data to answer the following research questions: 
 
Does the ‘Wakefield study’ remain a primary factor influencing parents’ of school-age 
children to decline in Somerset, or there other factors at play? 
How have parent’s early experiences, attitudes and behaviours in respect of MMR and 
wider immunisation services influenced their longer term decision-making? Have their 
attitudes and behaviours changed over time or as new experiences occur? Are there 
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any consistent differences in the experiences of parents who decide to decline MMR 
vaccination? 
Why do some parents persist in declining MMR, despite having information and 
experiences which appear to counteract the basis on which their initial decision was 
made? 
What factors influence parents who have persistently declined to change their mind 
and accept MMR for their children? 
 
Qualitative methods were identified as the research approach which offered the most 
potential for the researcher to build on the previous two phases and explore, in greater 
depth, these parents’ perspectives on MMR and their experiences of both 
immunisation services and the process of making decisions in respect of accepting 
MMR for their child where this had occurred (Bowling, 2002). These methods also 
offered the potential for the development of theoretical frameworks and hypotheses to 
explain, through the identification and comparison of themes within the data, how and 
why these decisions were made and the factors influencing these decisions in order to 
identify more effective strategies for delivering immunisation services, and for 
communicating with parents about MMR and immunisation, in future (Drummond, 
1996).  
 
There are numerous approaches to undertaking qualitative data collection and analysis 
across a wide range of theoretical and epistemological perspectives (Bowling, 2002). 
However, the most common methods include interviews, focus groups, field 
observations and open-ended survey questions (Guest et al, 2012). The data collected 
then needs to be analysed in a way that is both systematic and which results in 
‘credible answers to the research questions and objectives embedded within a study’ 
(Guest et al, 2012). 
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There are two fundamental approaches to analysing qualitative data – deductive and 
inductive (Bernard, 2005). Deductive approaches utilise a structure, or pre-determined 
framework to analyse data. In this type of approach, the researcher imposes their own 
theory or structure on the data and then uses this to analyse the data in the transcripts 
(Thomas, 2006).  Thomas (2006) suggests that this approach is useful where the 
researchers are already aware of probable participant responses. Advantages of a 
deductive approach are that it is relatively quick and easy to complete (Guest et al, 
2012). Disadvantages are that this approach can be inflexible. In addition there is the 
potential for the introduction of bias because the lack of flexibility can limit any theme 
or theory development Guest et al, 2012). 
 
Within an inductive approach, however, researchers analyse data with little or no pre-
determined structure or theory. Instead the data itself is used to derive the structure for 
the analysis (Strauss & Corbin, 1998). This approach is considered to be the most 
comprehensive means of analysing the data, but as a result it is very time-consuming 
(Miles & Huberman, 1994). This approach is most suitable for use where little or no 
information is known about the phenomena being studied. Inductive analysis is the 
most common approach used to analyse qualitative data (Guest et al, 2012)  
 
Inductive approaches include ‘grounded theory’, interpretative phenomenological 
analysis, and thematic analysis, amongst many others (Braun & Clarke, 2013). These 
theme-based approaches were each explored as potential options for the design of 
Phase 3 and a comparative summary of the features, epistemology, strengths, 
weaknesses and limitations of each approach can be found in Appendix 9.  
 
In the present research, the researcher was already familiar with the relevant literature 
on MMR and childhood immunisations. Furthermore, the design of the studies was 
such that each phase was intended to inform the subsequent phase in order to develop 
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an overall understanding of factors influencing parental acceptance of MMR for this 
group of children. As a result, the researcher would necessarily have knowledge of 
potential themes already identified from these earlier phases which then needed 
further exploration via the interviews and therefore could not approach this data 
collection with an entirely open mind. The core principles associated with the 
‘grounded theory’ method were therefore not able to be adhered to in a study where 
the intention is, as here, to employ, even in part, a framework approach to support data 
analysis. 
 
Adopting a phenomenological approach offered the potential to explore the experience 
of MMR decliners and their decision-making in rich detail. However, the first two 
phases of the present research were intended to provide initial information on this 
subject, which would then necessarily be known to the researcher undertaking the 
interviews in Phase 3. The researcher could not therefore go into this phase without 
any preconceived beliefs and opinions and could not apply the ‘bracketing’ that is 
central to this approach (Easterby, 1991; Fellows & Lui, 2008), and nor would they 
want to because these early phases were designed with the explicit purpose of 
informing the areas for further investigation within the interviews. The final phase 
interviews had an explanatory as well as exploratory objective, not to ask ‘what is it like 
to experience this situation?’, but a more accurately to ask ‘what factors impacted on, 
or influenced the experience?’ and therefore required the inclusion of social, cultural 
contexts surrounding the experience. 
Common to both of the approaches considered, so far, is the technique of identifying 
and categorising themes within the data. Holoway and Todres describe this ‘thematic 
analysis’ as a ‘foundational method, with the “thematizing of meanings” being one of a 
few shared generic skills across qualitative analysis’ (2003, p347). Boyatzis (1998) and 
Ryan & Bernard (2000) also characterise thematic analysis as ‘a tool to use across 
different methods’ or as a ‘process within analytic traditions (such as grounded theory), 
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rather than a specific approach in its own right’. Braun & Clarke (2006), however, 
argue that thematic analysis should be considered a flexible and useful research tool, 
which can in itself provide ‘ a rich an detailed, yet complex account of data’ (p.5). This 
therefore offered another potential option for approaching the analysis of the present 
research. 
 
Within thematic analysis, the researcher is acknowledged as playing an active role, in 
that it is they who identifies the patterns and themes and selects which of these is of 
interest and reports them (Taylor & Usher, 2001). Inductive thematic analysis shares 
many features with grounded theory and phenomenology, but is not restricted to 
building theory (as in ‘grounded theory’) or on focussing on subjective human 
experience in the way that phenomenology is, and can therefore also include the 
exploration of broader social and cultural phenomena (Guest et al, 2012).  
In both their paper ‘Using thematic analysis in psychology’ (2006) and in Guest’s 
(2012) publication, a hybrid process is described which combines both inductive and 
deductive techniques to interpret raw data. In this approach, named ‘applied thematic 
analysis’, data driven codes are integrated with theory driven codes within a staged 
process of data coding and identification of themes. In this process, analysis of the raw 
data obtained from interview transcripts progresses through coding and recoding 
towards the identification of overarching themes as described by the participants in the 
study (an inductive process) but the approach has a pragmatic focus on using 
whatever tools might be appropriate to complete the analysis ‘in a transparent, efficient 
and ethical manner’ (Guest et al, 2012, p.189) and the techniques used may include 
deductive methods such as quantification, word searches and framework approaches 
amongst others.  
 
Pope et al (2006) suggest that thematic analysis can be the simplest and is probably 
the most frequently used technique in healthcare research. Thematic analysis involves 
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grouping the data into themes and then identifying any relationships between these 
themes (Tickner, 2008). In their 2004 study, Frith and Gleeson describe how these 
themes can then be used to develop classifications, or models, or diagrams to try to 
express the connections between the themes. Thematic analysis can also include 
themes that are already known to the researcher, for example, from literature reviews 
or from previous research studies, as well as those that emerge inductively during the 
current research process (Pope et al, 2006). The addition of a Framework Approach, 
as developed by the National Centre for Social Research in the UK, enables this prior 
knowledge to be utilised most effectively (Ibrahim, 2012). The basis for the framework 
remains the accounts of the people being studied, and it is therefore inductive in 
nature. The development of the framework is, however, a deductive process, arising 
directly from the aims, objectives and research questions that form the basis of the 
present study. This approach is more strongly informed by prior knowledge and prior 
reasoning than traditional thematic analysis procedures, but is aligned with the method 
described as ‘Applied Thematic Analysis’ (Guest et al, 2012). 
 
Having compared the three potential methods, the key element that appeared to be of 
most relevance, within this comparison, was the potential for applied thematic research 
to be used ‘to build theoretical models or to find solutions to real world problems’, since 
this explanatory process is a desired outcome of the present research. 
 
With acknowledgement of the potential limitations associated with the approach, that is 
that it may ‘miss some of the more nuanced data’ (Guest et al, 2012, p.17), and in light 
of the resources available to complete the research, ‘Applied thematic analysis’ of 
semi-structured interviews and open-ended survey questions was therefore adopted as 
the method for the design of this Phase 3 study within the present research.  
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4.5.2 Study Design  
The Phase 3 design consisted of undertaking semi-structured interviews with a self-
selected group of parents who had responded to the Phase 2 Parent Census survey. 
The interview topic guide provided a general direction for the discussions with parents, 
but was not restrictive, and this enabled a detailed exploration of the parents 
understanding of immunisation, disease prevalence and risk; of the ways in which 
parents engaged with immunisation services; what influenced parental decision-
making; and, from this, how parents made decisions in respect of MMR for their 
children and their experience of doing this in Somerset.  
 
The Interview topic guide for Phase 3 is detailed in Appendix 10.  
 
 
4.5.2.1 Population and sample 
The study population was derived from parents who ticked the ‘willing to be interviewed 
box’ on the questionnaires sent to the sample of parents of unimmunised children in 
both age groups. This ensured a sample with a common characteristic (earlier 
participation) and with knowledge valuable to the research process i.e. experience of 
making a decision to decline in respect of MMR immunisation for their child.  
 
The number of interviews conducted was intended to be determined in part by the 
number of parents who responded and provided details to permit further contact; and 
also with reference to the work of DePaulo (2000)  in respect of sample size required 
to avoid missing important information. 243 respondents agreed to be contacted were 
subsequently followed up (see 4.2.2.2 below)  
 
4.5.2.2 Inclusion and Exclusion Criteria 
The participants self-selected by completing the additional contact details section of 
the questionnaire. There were no exclusions.  
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It was recognised that this method of recruitment (self-selection) might produce a sub-
set that may not be fully representative of the wider group of parents who declined 
MMR, and the limitations associated with a study of this type are fully acknowledged. 
However, the mixed methods design ensured the availability and linkage of the 
demographic and other quantitative data from Phase 1, which meant that any such 
skewed or unrepresentative population sample could be identified. The study was 
continued, with the caveat that should any such defined group be found during the 
analysis, the study would be reported as one which specifically related to that particular 
demographic sub-group of the ‘unimmunised’ population. A full examination of the 
strengths and limitations of the study (including the methodology used) is provided in 
Chapter 8. 
 
4.5.2.3 Recruitment and Consent 
4.5.2.3.1 Semi-structured interviews 
Determination of the sampling framework for the interviews was dependent on the 
number of respondents who ticked the permission box on the postal census. Had the 
response been poor, it was intended that all of those responding would be interviewed 
and other techniques, for example, ‘snowballing’ considered to increase the data 
source.  
 
It is acknowledged that there is not necessarily a requirement for a qualitative sample 
to be statistically representative of a study sample as would be expected for a 
quantitative sample. In fact, authors such as Richie and Lewis (2003) indicate that 
purposive, or non-probability sampling is the approach most frequently used in 
qualitative research to seek out participants with particular characteristics and to 
ensure that a full range of views, including less common ones, are considered within 
the study. This study population was however already recognised as being skewed 
following the initial Phase 1 analysis and the number of interviews to be undertaken 
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within this study was therefore determined with reference to the work of DePaulo 
(2000) and that of Griffin and Hauser (1993) who propose a different approach in these 
circumstances. These authors suggest that sample size is as relevant for qualitative as 
quantitative research, and needs to be considered to avoid ‘discovery failure’; that is, 
missing an important but minority perception or attribute because the sample size is 
too small. DePaulo’s approach is that in order to discover an attribute with an incidence 
as low as 10 per cent of the population, and to reduce the risk of missing that subgroup 
to less than five per cent, a sample of N=30 should be aimed for, assuming each 
participant has an equal chance of selection. Griffen and Hauser (1993), using 
mathematical extrapolations, similarly hypothesised that 20 – 30 in depth interviews 
would be needed to identify 90 – 95% of factors in their studies. 
 
This ideal situation had to be balanced against available budget and capacity to 
undertake the study. 243 individuals (30% of all those who responded to the survey) 
indicated that they would be willing to participate in the Phase 3 study. Interviewing all 
of these respondents was beyond the capacity of the researcher and two approaches 
were therefore taken to maximise the potential number of participants engaged.  
 
Each interview was anticipated to last approximately one hour with additional time and 
resource required to transcribe and encode the interviews and other qualitative data. A 
decision was therefore made to attempt to complete 24 in depth interviews, within the 
range suggested by Griffin and Hauser above, and to then supplement this data by 
running focus groups with the remaining 219 respondents. The use of focus groups 
was added in order to provide a further source of data to that obtained via the 
interviews; to maximise the number of participants engaged; and to try to generate a 
richer and deeper body of data than could be obtained through semi-structured 
interviews alone. Further information on the Focus Groups is provided in section 
4.5.2.2.2. 
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The process for identifying the 24 individuals to be interviewed was based on a 
systematic (Nth name selection) sampling method. After the sample size required had 
been calculated, every Nth (in this case every 10th) person was selected from the list of 
respondents, starting at a random point in the list. The aim of this sampling process 
was to obtain a ‘representative’ and valid sample of the population subset being 
studied.  
 
The ‘population’ for this element of the research included all those parents who had 
returned the survey and indicated that they would be willing to participate in the Phase 
3 study. Initial analysis of the Phase 1 Epidemiological study and the Phase 2 survey 
data had identified that this population sub-set was more representative of the whole 
‘unimmunised’ population than those who had responded to the survey generally. It 
was therefore considered that this method would be simple to apply and could achieve 
good coverage. Disadvantages were that this approach is more prone to bias because 
not all the participants have an equal chance of being selected, and as a result it could 
lead to over or under-representation of groups within the population. These potential 
limitations are acknowledged.  
 
In respect of the one to one interviews, the researcher made contact with the 
participants by telephone and / or email (dependent on the details provided when the 
questionnaires were returned) to confirm the respondents consent to participate in the 
study. If given, the researcher then arranged dates, times and venues for interviews to 
take place, at the convenience of the participants. Further written consent to participate 
in Phase 3, and for the storage and use of data collected during the research process, 
was obtained at the time of the interview, before the interview commenced. 
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4.5.2.3.2 Focus Groups 
Focus groups are a form of group interview which, according to Kitzinger (2006), make 
the most of communication between research participants to generate data. The idea 
behind this method is that people are helped, through the group process, to explore 
and clarify their ideas in a way that would be difficult to achieve in a one-to-one 
interview (Kitzinger, 2006). This method has also been successfully used in previous 
studies exploring parents’ views on childhood immunisations (Evans et al, 2001; Hilton 
et al, 2006; Leask et al, 2006).  
 
To establish the focus groups, direct contact was made with 80 of the 243 respondents 
to assess their willingness to attend a focus group (rather than a 1:1 interview) and to 
ascertain potentially appropriate times, locations and dates for the groups to take 
place. The responses were reviewed and were found to be consistent and 10 focus 
group sessions were then planned at various locations and times across Somerset 
based on this information.  
 
Letters were then sent to all of the 219 respondents who had not been identified for 
interview, inviting them to take part in a focus group near to their home. The invites 
were sent two weeks before the dates of the groups, and this was then followed up 
with both telephone contact and text reminders the day before and then on the day of 
the focus groups to which they had been allocated. Participants were also given details 
of all 10 groups and were offered alternative options if they were unable to attend their 
nearest one. Despite this only one participant arrived to take part in a group and this 
person was instead interviewed as an individual. Reasons for the failure of these focus 
groups are unclear since these have been used successfully in other studies, however, 
the comments of one of the parents who was interviewed may provide some insight: 
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‘I mean it doesn’t surprise me that the public meeting wasn’t popular. I mean - If I 
turned up to public meeting I wouldn’t have had the chance I’ve got, you know you 
can’t offload like I have now in a public meeting ‘cause that’s a nightmare for 
everybody else I think’. (Interview16: F, 52, S, N). 
 
4.5.2.4 Data collection  
The method employed in Phase 3 was in-depth, semi-structured interviews. This 
method was chosen as it offered the greatest potential for encouraging parents’ to 
recall information freely and to be able to gather a range of perspectives and insights 
into factors affecting parental uptake of MMR uptake from them.  
 
4.5.2.4.1 The Interview Topic Guide and Structure  
The interview topic guide typically defines the areas to be covered in the interview and 
is based on the research study’s aims and objectives (Britten, 2006). Having an 
interview topic guide, with carefully planned, open-ended questions and probes, can 
increase the researcher’s confidence and also them to concentrate more easily on 
what is being said by the interviewee (Charmaz, 2007). A flexible interview topic guide 
was used within Phase 3 of the present research. This was used as both a guide and 
to determine the nature and direction of questioning depending on the responses that 
the interviewees gave (See Appendix 10). 
 
Each interview consisted of three phases as described by Keats (2000). These phases 
involved the opening, the development of themes and the conclusion. In the opening 
section, Britten (2006) advised using questions that can be answered easily, before 
proceeding to more difficult or sensitive topics. In the present research, each interview 
opened with clarification of the demographic information contained within the 
secondary data source and the survey response, before moving on to questions about 
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knowledge of MMR and the diseases they protect against and then on to questions 
about parental decision-making and influences on this.  
 
At the conclusion of the interviews, interviewees were asked if there was anything else 
they would like to add. This was to ensure that all topics were covered (Keats, 2000). 
The tape recorder was kept running until the end of the interview, however, on a 
number of occasions the interviewees started talking again about either issues raised 
within the interview or new material, after the tape recorder had been turned off. If 
possible the researcher asked the interviewee if the tape recorder could be turned 
back on. Where not possible, or where the interviewee declined, notes were taken, 
either immediately, or as soon as possible after the interviewer had left the interviewee. 
This situation occurred most frequently when the interviewer was on the doorstep 
about to leave and the interviewee recommenced the discussion.  Notes were then 
written up in the car before leaving the location.  
 
During the interviews, care was taken to avoid bias and ambiguity when phrasing the 
questions and to use language that was polite, neutral and not value-laden or leading, 
and that were appropriate for the interviewee (Keats, 2000; Smith, 1995). Double-
barrelled questions, that is questions that ask interviewees to respond to two issues 
within a single question without specifying which part of the question the interviewee 
should answer, were avoided (Keats, 2000). Verbal (‘Uh huh’, ‘Mmm’, ‘Can you tell me 
more about that?’) and non-verbal (nod of the head, silent pauses) type probes were 
used to encourage the interviewees and to clarify meaning where needed (Smith, 
1995).  
 
The researcher was relatively experienced in conducting interviews, having undertaken 
training in the past; however, feedback on interviewing technique was still sought 
through piloting and also through discussion of the initial interviews with her supervisor. 
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Questioning style and the use of probes were noted to improve during Phase 3 as the 
researcher became more experienced in conducting the interviews. 
 
Several methods were used to record the interviews, these included taking notes 
(during and after the interview) and audio-taping the interview. Permission was 
obtained before the start of the interview. Notes were made during the interview to 
highlight points of interest and issues requiring further clarification. Notes were also 
made immediately after each interview to record information, such as, location and the 
researcher’s own feelings about the interview. These notes were used to provide 
context to assist with the later data analysis and to remind the researcher of the nature 
and of the interview and interviewee (Tickner, 2008).This process is also an important 
part of developing ‘reflexivity’ that is the awareness of ‘self’ within the process of data 
collection and analysis in qualitative research (Payne, 2004). This is considered further 
in 4.4.4.1. 
 
All of the interviews were undertaken and transcribed by the researcher. Semi-
structured interviews produce rich data, but they are also time-consuming both to 
conduct and to transcribe (Pope & Mays, 2006a; Britten, 2006).In this study, each hour 
of recorded interview took approximately seven hours to transcribe (longer where the 
quality of the recording was not good or where there were multiple voices to 
transcribe). All 24 semi-structured interviews were transcribed by the researcher in 
verbatim form to provide a full record of what was said. Payne (2004) argues that it is 
important to transcribe both the speech of the interviewer and the interviewee, but that 
it is not necessary to include ‘paralinguistic or extra-linguistic elements’. Pope et al 
(2006), however, suggest that elements such as sighs, laughs and pauses can provide 
a valuable contribution during the process of analysis. These elements were therefore 
also included in the transcription of the interviews. 
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4.5.2.5 Data analysis  
An applied approach to thematic analysis was utilised to analyse data collected during 
Phase 3 of the present research. The use of open questions and the opportunity to add 
free text narrative comments within the questionnaire design enabled an additional 
source of qualitative data to be obtained from individuals who responded to the Phase 
2 Study survey, even where these respondents did not give consent to be included in 
the Phase 3 Study and to be interviewed. This data was able to be linked back to the 
child’s records, and therefore to the quantitative data obtained during both Phase 1 
and 2 studies, to provide further depth and explanation for the associations identified 
within these initial phases, to provide an outline framework for the coding of themes in 
the Phase 3 study, and to ensure that responses to the survey and to interviews were 
not ‘double counted’ in the final analysis.  
 
Data from the interviews was transcribed from the tape recordings into written form. It 
was then systematically analysed by coding, categorising, comparing, refuting and 
interpreting words and passages in the text (including word frequency analysis), 
context, internal consistency (were there any shifts in opinion during the interview), 
frequency and intensity of comments (counting content analysis), trends and themes. 
The method used followed the six stage process described in a number of publications 
including Braun & Clarke (2006); Thomas (2006); Burnard et al (2008); Guest et al 
(2012); and Gale et al (2013). Gale et al (2013) also describe how an analytical 
framework can be used within the same process, which is of particular relevance, and 
is included in the design of, the present research. 
 
The approach used within this study was deductive in that it initially made use of the 
framework of codes established through the initial analysis of the qualitative data from 
the Phase 2 survey, but also interpretive in that an iterative inductive approach was 
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then used to develop these codes and themes further as more information emerged 
from the data. The NVivo 10 software tool was used to code the data and to conduct 
multiple concept / coded category searches in order to assist in identifying any trends 
and themes. From this, theories about the process & experience of immunisation 
decision making were generated and these are presented in Chapter 6.  
 
4.5.3 Reflexivity and maintaining rigour in qualitative research 
The involvement of the researcher in all aspects of the data collection and analysis 
helped to ensure consistency throughout the present research. The nature of the 
research process was such that it was conducted by a single researcher. This is not 
uncommon in qualitative research studies, but does have the potential to increase bias 
(Britten, 1998). The validity of these studies can be improved by the cross-checking of 
coding strategies and the interpretation of data by other independent researchers 
(Barbour, 2001). In the present research, coding consistency was tested by initially 
using two coders (the researcher and a public health colleague) to independently input 
the codable (free text) comments from Section 5 of the survey. Nodes and coding 
stripes were then compared and a final node framework agreed before continuing with 
coding the remainder of the survey data and the interview transcripts.  The 
researcher’s academic supervisor also independently coded the first of the interview 
transcripts and also commented on the subsequent analysis and reviewed drafts of the 
results and discussion chapters of the study. These processes were useful in that the 
discussions that took place concerning the emerging coding framework and the 
resolution of any disagreements in respect of allocated codes and classifications 
provided additional insights to enable the coding frames to be further refined. 
External validity, that is, the ‘generalisability’ of the findings, can be improved by 
presenting the final analysis back to interviewees to see whether or not the analysis 
was consistent with their perceptions and experiences (Kumar & Gantley, 1999). In the 
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present research, the findings were discussed with two of the interviewees in order to 
gain, albeit in limited form, further feedback and verification. The findings were also 
discussed at two workshop sessions outside of the area covered by the research (the 
South West Scientific Conference and the Bristol Immunisation Group Health 
Integration partners Team (BIG HIT). 
 
 4.6 Summary of the Research Design 
In the preceding sections the rationale for my chosen research approach and 
subsequent research design have been outlined. The study demanded the explorative 
opportunities offered by the use of both quantitative (deductive) and qualitative 
(inductive) approaches. More specifically, the wish to explore specific phenomena 
related to MMR immunisation; the potential influences on parental decision-making at 
both a collective and individual level; and therefore on the design and delivery of 
immunisation services, was best suited to this ‘mixed methods’ approach.  
 
The design progressed through a preliminary cross-sectional study at whole population 
level, to specific population sub-group, and then to individual level enabled a 
substantive level of analysis, which ultimately led to the research findings summarised 
in Chapter 8. The overall research design from sampling through to data collection to 
data analysis is illustrated diagrammatically in Figure 4. 
 
4.7 Ethical considerations in conducting the current research 
The ethical issues associated with the respective phases of this study are described 
within this section.  
 
Phase 1 was conducted using routinely available data which did not require consent 
prior to review. No specific ethical issues were associated with this study. 
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The main ethical issues for Phase 2 related to maintaining the anonymity of the two 
groups of children and their parents, and ensuring confidentiality in respect of the 
responses received via the postal questionnaires. This was achieved by the use of a 
unique identifier and a barcode allocated by FORMIC, as previously described. 
Information on how the confidentiality of data and personal information would be 
maintained was included in the Invite Letter and Patient Information Leaflet for Phase 2 
(see Appendix 6 and 8). 
 
In respect of Phase 3, additional ethical considerations included potential risks, 
informed consent, the researcher’s role, funding and sponsorship, sensitive topics / 
confidentiality and anonymity, data handling and approval by relevant research ethics 
committees. The management of these ethical issues in the context of this study will 
now be explained.   
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PHASE 1 – BASELINE REVIEW
Whole Population
(41,804 children born 01/01/1999 – 01/01/2004 in Somerset)
Primary School Age
(Children born 31/12/1999-01/01/20014
Secondary School Age
(Children born 31/12/1995 – 01/01/1999)
Immunised
(n = 20055)
Unimmunised
(n = 2252)
Unimmunised
(n = 1568)
Immunised
(n = 17920)
Unimmunised Sub-Group
(n = 3820)
PHASE 2  – PARENT CENSUS SURVEY
Whole Population
(Questionnaire design informed by review of evidence (Chapter 3))
Respondents
(n = 743)
Categoric data 
analysed
Codable qualitative 
data collected
Willingness to participate in further research
(n = 243)
10th person 
sampling
PHASE 3  – QUALITATIVE INTERVIEWS
(N = 28) + focus groups (X 10)
Framework for analysis of qualitative data
Applied thematic analysis of all codable data
 
Figure 4: Diagram of Full Research Design 
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4.7.1 Potential Risks 
The following potential risks were identified: 
There was considered to be a potential psychological / emotional risk to participants, 
that is, there was a potential that a minority may have become distressed as a result of 
exploring their previous decisions in respect of their children’s immunisations, 
particularly if they had had poor experiences, or if they regretted a decision to have, or 
not to have had these.  
 
During the interview process there was potential that participants might change their 
mind regarding previous health choices, which may have included a desire to accept 
previously declined health interventions (e.g. immunisations).  
 
There was a risk that participants may be financially disadvantaged if the interviews 
were planned to take place at a venue other than the participants home 
 
There was a potential risk to the researcher if the interviews are conducted in a place 
that was unfamiliar to them and over which they had little control, such as the 
participants home address 
 
Procedures to safeguard against, or to mitigate, these risks were applied as follows: 
All participants were supplied with contact details for the Patient Advocacy and Liaison 
Service (PALS) who agreed to independently facilitate any access to information or 
future health services on behalf of the study participants, this included access to 
counselling or other medical services should these be necessary if distress was 
suffered as a result of participating in the study. It was recognised that this support 
should be independent of the NHS, where possible, given the nature of the study, and 
the availability of alternative provision was explored, and was available throughout the 
study period, but was not needed. 
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Participants were assured that access to health care provision would not be affected 
by any information provided by them during the study and it was agreed that access to 
health services where these were requested would also be facilitated via the PALS 
Service. This included advice on how to obtain immunisation should this be requested. 
 
Any expenses incurred by participants were reimbursed in line with NHS Somerset’s 
existing procedures and tariffs for reimbursing patient representatives 
 
The researcher made arrangements and conducted any visits in line with the NHS 
Somerset’s Lone Worker Policy. It was also agreed that if, on arrival, the researcher 
was not happy to conduct the interview at the location arranged, the interview would be 
deferred and alternative arrangements would be made.  
 
4.7.2 Informed Consent 
This study was undertaken in line with best practice guidance produced by the National 
Research Ethics Service in respect of information & consent for participants; 
confidentiality and use of personal data; and data storage (COREC 2006; National 
Patient Safety Agency, 2007). Participation was entirely voluntary and participants 
were free to withdraw consent at any point in the process without any consequence to 
future access to health care. 
 
Advice in respect of provision of information and support to participants who may not 
adequately understand verbal or written information in English was sought from the 
following persons / organisations: 
Somerset Racial Equality Council (SREC) 
NHS Somerset Patient Advice and Liaison Service (PALS) 
The Learning Shop 
Somerset County Council Gypsy & Traveller Liaison Officer 
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NHS Somerset Public Involvement and Social Marketing leads 
 
None of the participants selected for interview required translation services or any 
other support in order to take part in Phase 3 of this study. However, translation 
services were used to enable a small number of parents to complete the Phase 2 
Parent Census Survey and to translate four surveys that were returned by parents with 
comments written in languages other than English. 
 
4.7.3 The Researcher’s role 
The principal researcher was an experienced Consultant in Public Health who had 
worked in with families in the past as a Health Visitor, and more recently as 
Immunisation Coordinator for Somerset. It was recognised that the role of 
Immunisation Coordinator was significant and that this could potentially result in 
allegations of subjective bias within the research process. In order to guard against 
this, a sample of the transcripts and the free text comments were also reviewed and 
coded by a second person (the NHS Somerset Head of Health Informatics) and the 
data analysis was also discussed with the researcher’s academic supervisor in order to 
check that the performance of the interviews was appropriate, and that any coding 
carried out or analysis undertaken appeared valid and consistent.  
 
In addition, to further avoid conflict of interest, an offer was made to participants for 
interviews to be facilitated by experienced staff from either the Patient Advocacy and 
Liaison Service (PALS), or the Patient and Public Participation Service, who have no 
links with the immunisation service, should they prefer this. None of the participants 
requested this option. 
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4.7.4 Funding and sponsorship 
The outcomes of the study were used to inform the development of the Somerset 
Immunisation Strategy and Action Plan 2010 – 2013. The postal census was designed 
to provide information in respect of the local Somerset population, through patient 
involvement which had not previously been undertaken.  As such the researcher 
received support from NHS Somerset as follows: 
 
The use of a specific postal address and franking service was negotiated which 
significantly reduced costs, and an existing Service Level Agreement with Somerset 
Racial Equality Council enabled formal support to be provided to the researcher to 
inform the survey design, and for testing to ensure that this was suitable for use with 
minority populations, including those with difficulties with literacy, as well as those with 
physical or language barriers. These services were funded by NHS Somerset. 
 
Labels for the envelopes, and lists detailing the individual identifier and the Child / 
Parents personal information (names and addresses), were prepared by the Child 
Health Department. The process of reconciling the surveys and the envelopes was 
overseen by the CHRD Manager and this ensured that no patient identifiable data left 
the Department. Stationery and other consumables were provided by NHS Somerset. 
 
The postal questionnaires were physically administered (survey forms printed, 
envelopes filled, franked and posted) by volunteers from the NHS Somerset Public 
Health Directorate. Follow up reminder postcards were also processed in the same 
way.  
 
The returned questionnaires were physically scanned into FORMIC as they arrived 
back in the Public Health Department by a very experienced public health 
administrator. This administrator also collated the forms into piles relating to: 
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Not known at the address (these were then rechecked by the researcher against the 
CHIS database prior to exclusion from the sample) 
 
Completed and scanned  
 
Completed and scanned – free text comments (these forms were then reviewed in 
full by the researcher who manually transcribed the text into the database for later 
coding) 
 
 
 
Project data, including the completed, returned parent questionnaires, was then 
received and stored in an anonymised form by the researcher within secure IT systems 
which met NHS Information Governance standards. These IT systems were managed 
and backed-up by NHS Somerset. 
 
All parent queries relating to the questionnaire were directed to a single phone number. 
This phone was answered by the administrator during office hours and by 
answerphone out of hours. The administrator obtained details of each of the individuals 
who called the helpline and their query, and inputted this information in to an excel 
spread sheet. This spread sheet was forwarded to the researcher at the end of each 
day and the researcher returned the calls personally that evening. 143 calls were 
received to this helpline during the conduct of Phase 2 of this study and all were 
responded to by the researcher.  
 
Finally, support was provided by NHS Somerset to facilitate the running of the focus 
groups. Whilst it was planned that the researcher would lead these groups, members 
of the Public Health Team volunteered to support the process as second facilitators / 
scribes on the day. The administrator also made the physical arrangements for the 
running of the groups (room bookings, crèche facilities, payment of expenses to 
participants, provision of refreshments) at the direction of the researcher.  
 
This administrative support significantly reduced the time taken to obtain data back 
from the Phase 2 study in a format that the researcher could then transfer into Excel 
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for analysis and considerably improved the feasibility of an individual researcher 
conducting a multi-phased study such as this. 
 
4.7.5 Sensitive topics / Confidentiality and Anonymity / Data Handling 
Participants were assured that any information would be handled in confidence and 
would not be used or passed to other persons without the participants consent. 
However, they were advised that should issues related to Child Protection become 
apparent the researcher would have a responsibility to report these according to local 
Child Protection Procedures. If any other support was required following discussion of 
sensitive or embarrassing issues contact was offered with PALS who were able to 
facilitate appropriate support for the participant. Where this was not acceptable to the 
participant, the researcher had the option to make direct contact with any appropriate 
persons or organisations, internal and external to the NHS, as required (depending on 
the issues raised). 
 
All interview transcripts were anonymised and identified only by a reference number. 
No personal information was included in, or with, the transcripts. At the end of the 
study period the transcripts were scanned and stored in a secure electronic database 
within the Public Health Directorate of NHS Somerset. It was planned that the original 
transcripts would be destroyed and the scanned electronic copies retained and 
archived. However, the NHS underwent a major re-organisation in April 2013. As a 
result NHS Somerset was abolished and the Public Health Department was 
fragmented. The researcher became employed as Screening and Immunisation Lead 
for Public Health England (PHE) covering the South West of England, whilst other 
members of the NHS Somerset Public Health Department transferred to Somerset 
County Council, in line with the agreed arrangements within the 2010 Health and 
Social Care Act.  
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Access to previous software licenses, including FORMIC, was not maintained by any 
of these organisations and the scanned copies therefore had to be destroyed when the 
software was decommissioned. The hard copies of all forms and the remaining 
electronic databases relating to this study were transferred to the PHE Screening and 
Immunisation Team South West, where they remain in secure storage. Any future 
access to this data will require written application to the PHE Caldicott guardian 
(currently the Medical Director) and appropriate ethical approval. 
 
4.7.6 Ethical approval 
Ethical approval was sought from and granted by the Ethics Committee of the 
Department of Nursing at the University of Stirling and the Avon NHS Research Ethics 
Committee. Approval was also sought from the NHS Somerset Research and 
Development Consortium. Full approval to undertake the study was received in 
January 2012 and the study formally commenced in March 2012.  
 
Annual reports on progress have been submitted to Stirling University detailing any 
changes and progress.  Progress reports were also required by the NHS Somerset 
Research and Development Consortium and have been submitted on a bi-annual 
basis. 
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CHAPTER 5 PRESENTATION OF THE RESULTS OF THE ANALYSIS OF 
PHASE 1 AND PHASE 2 CATEGORIC DATA 
5.1 Introduction 
Baseline epidemiological investigations relating to MMR uptake had been commenced 
as part of the NHS Somerset Public Health Department’s Health Protection Team 
Work Plan in 2008/09. However, whilst this initial examination of the published 
immunisation data had confirmed a variation in the uptake of MMR and other childhood 
immunisations across Somerset, it had failed to identify any specific geographic or GP 
practice related correlations which could be used to inform the review and redesign of 
local services. The present study was designed to build upon these earlier reviews by 
exploring, in Phase 1, additional local immunisation data available via GP practice and 
CHIS systems, supplemented by data obtained via the Phase 2 Parent Census 
Survey. The results of the analysis of this data are presented in this chapter. 
 
Section 5.2 details the results of the analysis of the Phase 1 data. The Somerset CHIS 
dataset was used to identify the initial Phase 1 population and also the sub-group of 
‘unimmunised’ children corresponding to the two age groups under investigation in 
Phase 2. Parents of all children within this sub-group were sent the parent census 
survey and the survey was used to provide a sampling framework for the Phase 3 
semi-structured interviews.  
 
Given the relatively low response rates to the parent census survey (20% for primary 
school age children and 16% for secondary school age children), the demographic and 
geographic characteristics of the unimmunised children whose parents had responded 
to the survey, in each age group, were then compared with the characteristics of the 
unimmunised children in the original dataset to confirm whether the respondents were 
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representative of the wider group of unimmunised children. The result of this process 
of analysis is presented in Section 5.3. 
 
The characteristics of the children whose parents agreed to be followed up and those 
who were interviewed were each then compared with both the original population of 
unimmunised children and with the responders to the survey, to identify whether these 
groups were representative of either or of both of these previous groups. The purpose 
of these latter processes of analysis was to provide an assessment of the relative 
representativeness of the individuals participating in the survey and the interviews, and 
therefore the potential limitations of any recommendations for changes in practice 
arising from this thesis. The results of these analyses are presented in Sections 5.4 
and 5.5. The results of the analysis of the Parent Census Survey itself are presented in 
Section 5.6, and the results are then summarised in Section 5.7 
This chapter aims to address the following research question: 
What were the social, demographic and geographic characteristics of parents / children 
who had accepted and declined MMR in Somerset after 2009? 
 
5.2 Results of the analysis of the Phase 1 data 
The purpose of this section is to present the findings from the review of the 
immunisation data relating to the whole population of 41767 children aged six to 15 
years in Somerset (as held on the Somerset CHIS database in March 2009) and from 
this to compare the characteristics of those who had accepted and those who had 
declined MMR in two defined age groups to see if there were any differences between 
these population sub-groups. The two age groups investigated were: 
Children aged six – 10 years (primary school age) 
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Children aged 11 – 15 years (secondary school age) 
 
The rationale for exploring these age groups has already been described in Chapter 4.  
The MMR status for each of these children was ascertained and the children within 
each of these two age groups were then labelled either ‘immunised’ or ‘unimmunised’. 
See Figure 5 below. 
Figure 5: Study populations for Phases 1 and 2 
 
Phase 1 
Whole population 
(41,767* children born 01/01/1999 -01/01/2004 in Somerset) 
 
 
 
               Primary school age                                Secondary school age  
(Children born 31/12/1999 – 01/01/2004)    (Children born 31/12/1995 – 01/01/1999)  
 
 
 
Immunised    Unimmunised      Unimmunised              Immunised 
    (n = 20055)           (n = 2252)   (n =1540)                  (n =17920) 
 
 
 
Unimmunised population sub-group for Phase 2 (n=3792) 
 
(*Note 37children were not able to be allocated due to no NHS number or other missing data) 
 
The demographic characteristics (sex, MSOA, deprivation (IMD) quintile, MOSAIC 
group, Child Centre Area, and registered GP Practice) of the immunised and 
unimmunised children were ascertained. For analysis, children were assigned to 
MSOAs, IMD quintiles, Mosaic Groups and Children’s Centre Areas based on their 
postcode. These characteristics were then compared to investigate whether there were 
any differences within and between the two age groups. The results of these 
comparisons are detailed below: 
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5.2.1 Gender 
Unimmunised children comprised 10% of the children in the primary school age group 
and 8% of children in the secondary school age group.  Using chi-square with Yates’ 
correction, gender was found not to be significant for primary school age (p = 0.17) or 
the secondary school age groups (p = 0.59). This is summarised in Table 2 below: 
 
 
 
 
 
Secondary School Age 
   
  Males Females 
Total 
population 
Unimmunised 811 729 1540 
Immunised 9302 8618 17920 
Total 10113 9347 19460 
Proportion Unimmunised 8.0% 7.8% 7.9% 
21c 0.29 
  p value 0.59 
   
Table 2: Proportions of Immunised and Unimmunised children by gender and age group 
 
 
5.2.2 MSOA 
Super Output Areas (SOAs) are geographical areas used for the collection and 
publishing of small area statistics. There are two layers of SOAs; Lower Super Output 
Areas (LSOAs) and Middle Super Output Areas (MSOAs). Whilst both are used for 
local area planning, MSOA level data enables the release of data which might be 
disclosive if published at smaller postcode area level. MSOAs have a minimum size of 
5000 residents and 3000 households with an average population size of 7500 
(Neighbourhood Statistics, 2014). Figures 6 and 7, and scatter diagram (Figure 8) 
Primary School Age 
   
  Males Females 
Total 
population 
Unimmunised 1186 1066 2252 
Immunised 10250 9805 20055 
Total 11436 10871 22307 
Proportion Unimmunised 10.4% 9.8% 10.1% 
21c                                                                                               1.90 
p value                                                      0.17
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below illustrate the geographical distribution of children in each subgroup, based on 
MSOA.   
 
 
Figure 6: Percentage of unimmunised children of primary school age living in each Middle Super 
Output Area 
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Figure 7: Percentage of unimmunised children of secondary school age living in each Middle Super      
Output Area 
 
These maps demonstrate that there is geographical variation across the county in 
relation to MMR uptake and also variation between the two groups. 22 MSOAs have 
more than 11% of their primary school age population identified as being 
unimmunised, but there are very few MSOAs with a high proportion (>11%) of 
unimmunised secondary school age children, and a greater number of MSOAs with 
low proportions (<5%) of unimmunised children in this age group. The children who 
have not completed MMR in the secondary school age group appear to be 
concentrated in specific geographical areas, and particularly in Glastonbury (the outlier 
in the scatter graph (Figure 8) below) and Frome (next highest point), whereas there 
appears to be a more general, dispersed picture for the younger primary school age 
group.  
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Figure 8: Scatterplot of unimmunised children by MSOA for each age group 
 
 
Glastonbury and Frome traditionally have higher proportions of their populations who 
ascribe to alternative lifestyles and holistic health approaches (NHS Somerset, 2012) – 
Frome also has a large anthroposophic (Steiner) school, which is a characteristic that 
has also been found to be linked with low immunisation uptake rates in previous 
studies (Alm et al, 1999). Primary school age children are, however, the age group 
most likely to have been influenced by the controversy over the now discredited 
Wakefield paper (Wakefield et al, 1998) which gained media attention in 1999 and on 
into the early 2000s. This difference in geographical distribution may be relevant. 
 
5.2.3 Indices of Multiple Deprivation (IMD) 
Figure 9, below shows little difference in adherence to the MMR schedule across 
deprivation quintiles for the secondary school age children. There is minimal difference 
between the proportion of unimmunised children in the highest and lowest (least 
deprived and most deprived) quintiles at 9.5% and 8.5% respectively for primary 
0%
5%
10%
15%
20%
25%
0% 5% 10% 15% 20% 25% 30%
P
ro
p
o
rt
io
n
 o
f 
u
n
im
m
u
n
is
e
d
 s
e
co
n
d
ar
y 
sc
h
o
o
l a
ge
 
ch
ild
re
n
 
Proportion of unimmunised primary school age children 
133 
 
school age children and also little difference between the proportion of unimmunised 
children between the two age groups in these quintiles. However, for primary school 
age children, it is children in quintile 3 (neither low nor high levels of deprivation) that 
have the lowest uptake of MMR. 
 
This is not in line with findings from previous studies, where MMR uptake has generally 
been found to be associated with the most deprived and least deprived groups 
(Bedford et al, 2009) with poorer uptake in both of these quintiles. However, this finding 
may be due to limitations in the use of IMD in rural areas where factors such as car 
ownership (which is essential and not a luxury in these areas due to lack of public 
transport) or presence of a very small number of very wealthy individuals in an 
otherwise deprived area can act to distort the integrity of the quintiles. It is unclear 
whether this did impact and was therefore of relevance in relation to this study.  
 
Figure 9: Comparison of immunised and unimmunised children by deprivation quintile (Index 
of Multiple Deprivation) and by age group 
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5.2.4 MOSAIC Group 
MOSAIC UK is Experian’s system for classification of UK households. It is a 
commercially available geo-demographic segmentation system, which estimates the 
most probable characteristics of people based on pooled profiles of all the people living 
in a small area near a particular address. The current version MOSAIC 2009, classifies 
the UK population into 15 main socio-economic groups and within 67 different 
population types (Experian, 2014). Definitions of each MOSAIC group are detailed in 
Appendix 11. 
   
When reviewing the  MOSAIC data some groups were found to contain only a small 
number of children, there were also a small number of households categorised as 
groups L and M (elderly people) and this is most likely due to there being a mix of 
housing in that postcode area. Groups C, G, L, M, and N were therefore combined with 
Group U, to give a final group called ‘Other’ for the purpose of analysis.  The highest 
proportions of unimmunised children within this combined MOSAIC group are actually 
from the ‘Unknown’ classification. It possible that these are residents of newly built 
housing estates that were too new to have been allocated a MOSAIC group at the time 
of the survey.  
 
The proportion of unimmunised children in the remaining MOSAIC groups were then 
reviewed and the highest proportions of unimmunised populations were found to be in 
MOSAIC groups A and I for both age groups and also in group D for those of primary 
school age. Groups A and I represent ‘isolated rural communities’ and ‘lower income 
workers in urban terraces’ respectively. This does appear to reflect the findings of 
previous studies whereby immunisation uptake has generally been found to be 
associated with problems with access issues and / or social deprivation (Freidrichs, 
2006).  
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Group D consisted of ‘successful professionals in semi-rural areas’. Given that this 
group consisted of younger children whose parents were likely to have been most 
influenced by the Wakefield controversy, this is also in line with previous findings. The 
‘Other’ group has the highest proportion of secondary school age and the second 
highest proportion of primary school age children.  
 
5.2.5 Children’s Centre Area 
Somerset has 41 Children’s Centres, which are physical buildings from which a range 
of services are delivered for young children and their families and, as such, it was 
considered that these Centres might have a potential influence on parental decision-
making.  The county is divided into areas based around each of these centres, and 
children’s services including schools are frequently also co-located or located nearby.  
The proportions of children in each group were mapped (as for MSOA previously).  
There was only one Children’s Centre Area where less than 5% of primary school age 
children were found to be unimmunised. However, 10 areas were identified that had 
less than 5% of unimmunised children in the secondary school age group. Scatterplots 
were then used to identify the proportion of unimmunised children in each of these age 
groups by Children’s Centre Area. This showed a similar pattern to the MSOA data and 
the outlier again was Glastonbury Children’s Centre. See Figure 10 below: 
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Figure 10: Scatterplot of unimmunised children by Children’s Centre and age group 
 
5.2.6 GP practice 
The proportion unimmunised children registered with each surgery also differed, with 
two surgeries having no children in either of the age groups investigated. Figure 11 
and scatter plot (Figure 12) below illustrate the proportions of unimmunised children by 
GP practice for each of the two age groups: 
 
 
Figure 11: Proportion of unimmunised children by GP practice and by age group 
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Figure 12: Scatter plot of unimmunised children by GP practice and by age group 
 
 
This analysis suggests a relationship between registered surgery and parents’ 
decisions whether to have MMR for their child, or not. The data values by GP practice 
were ranked and analysed using a non-parametric test of monotonic association which 
confirmed that GP practice was highly significantly associated with decision to decline 
MMR (p value = 0.00002). 
 
GP practice may be related to people living in a geographical area (MSOA); however, 
this may not be the reason for this association. Although an exploration of the attitudes 
and beliefs of HCPs were not specifically included in the scope of this study, there was 
evidence in Chapter 3 to suggest that health care staff can have a significant influence 
on parents’ decisions to accept immunisation (both as a result of what they do and 
what they say), as can organisational systems and practices (Penn & Kiddy, 2011; 
Smallbegovic et al, 2003).  
 
There are several pieces of evidence within this dataset which suggest this may also 
potentially be a relevant factor here. The outlier in the scatter graph has the highest 
proportion of unimmunised secondary age children and a relatively low proportion of 
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unimmunised primary school age children. Further investigation with this practice 
confirmed that there had been a change in nursing staff between these two time 
periods. In addition, there are geographical areas which have more than one GP 
practice. There are two practices in Glastonbury, for example, and whilst for children of 
secondary school age they are ranked 2/77 and 5/77 respectively (therefore similar), 
for children of primary school age they are ranked 1/77 and 13/77. There is also 
evidence of significant differences even between practices that share premises, with 
one ranking 4/77 (primary school age) and 5/77 (secondary school age) respectively 
and the other ranking 77/77 for both age groups. 
 
These findings could reflect these GPs having demographically different registered 
populations, but equally this might also reflect different influences of staff, policies and 
practices within these surgeries at different points in time. These findings therefore 
require further investigation.  
 
5.3 Comparison of the data from the Phase 1 unimmunised population 
and the Phase 2 Parent Census Survey Respondents 
There were 726 responses to the parent census survey of which 19 children were 
subsequently found to have been immunised with MMR as per the national schedule 
and were reassigned to their respective ‘immunised’ age groups. A further seven 
respondents appeared to have completed the questionnaire for a different child from 
the one detailed on the letter, and a decision was made to categorise these as non-
responders. 700 responses were analysed, 453 from parents of primary school age 
children and 247 from parents of secondary school age children, representing a 20% 
and 16% response rate respectively. Demographic data for the children whose parents 
had responded to the survey was compared with data obtained for the unimmunised 
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children in the original Phase1 dataset to identify if the responders differed from these 
groups.  
 
5.3.1 Gender 
The proportion of survey responses for male children in both age groups was higher 
than the proportion of responses for female children. This was not however found to be 
statistically significant and is illustrated in Table 3 below: 
  
Table 3: Proportions of survey responders and non-responders by age group and gender  
Primary school 
age children Responders  Non responders  Total  
Males 253 933 1186 
Females 200 866 1066 
Total 453 1799 2252 
Proportion Male 56% 52% 53% 
x2 2.15 
  p value 0.14 
  Secondary 
school age 
children Responders  Non responders  Total  
Males 133 678 811 
Females 114 615 729 
Total 247 1293 1540 
Proportion Male 54% 52% 53% 
x2 0.11 
  p value 0.74 
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5.3.2 MSOA 
Response rates varied from 46% to no responders per MSOA for the primary school 
age group, and from 50% to no responders for the secondary school age group. 
Response rates were then plotted on maps to show the geographical distribution of the 
responders (See Figures 13 and 14): 
 
Figure 13: Percentage of responding parents of primary school age children by Middle 
Super Output Area 
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Figure 14: Percentage of responding parents of secondary school age children by Middle 
Super Output Area 
 
These maps appear to show a smaller proportion of responders from the Mendip 
(Glastonbury / Frome) area amongst the responding parents of primary school age 
children, and a more diverse geographic distribution of responses from parents of 
secondary school age children than seen in for the wider unimmunised Phase 1 
population. Analysis of the data found no apparent relationship between the MSOA of 
residence and the response rates from either of the two age groups. This may indicate 
a difference between the type of people who responded to the survey and the 
unimmunised populations as a whole (since the Phase 1 analysis had found an 
association between MSOA and declining MMR) however, the numbers involved are 
too small to confirm this. 
 
5.3.3 IMD 
There was a greater proportion of survey responses from parents in Quintile 5 (least 
deprived) than from Quintile 1 (most deprived).  This was observed across both age 
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groups. For responders in the primary school age group, IMD was found to be highly 
significant (p<0.001). P value for linear trend was also calculated and found to be 
highly significant (p<0.001) with response rising across the quintile from most to least 
deprived. The same pattern was found for the secondary school age group, however, 
for this group IMD was not statistically significant (p=0.25). P value for linear trend 
(responses increase as deprivation level decreases) was again calculated and this was 
found to be significant (p=0.03). This is again different from the findings for the analysis 
of the data from the whole Phase 1 unimmunised group and suggests again that the 
responders may not be representative of this wider group. 
 
5.3.4 MOSAIC Group 
Response rates varied between MOSAIC groups, but as in the Phase 1 dataset, in 
some cases the number of children in each group was very small, and some of the 
groups were therefore amalgamated.  For primary school age children the response 
rate varied between 6% (Mosaic Group O Families in low-rise social housing with high 
levels of benefit need) and 29% (Mosaic Group E Middle income families living in 
moderate suburban semis).  This corresponds with the IMD data shown above.  For 
secondary school age children the response rate varied between no responders in 
Mosaic Group N (Young people renting flats in high density social housing) and 26% in 
Mosaic group F (Couples with young children in comfortable modern housing).   
Groups D (Successful professionals living in suburban or semi-rural homes), E (middle 
income families in moderate suburban semis) and F (couples with young children in 
comfortable modern housing) however, formed a higher proportion of the parents who 
responded to the survey. These population types are likely to be more literate and 
articulate and there is evidence that this type of individual is more likely to respond to 
survey methodology. This may therefore also have acted to skew the response. 
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5.3.5 Children’s Centre Area 
As with the MOSAIC groups, response rates varied between Children’s Centre areas.  
This reflected, in some cases, the low numbers of the population in the age groups 
investigated, with 1 area (Halcon) having less than 5% of unimmunised children in the 
primary school age group, and 10 areas having less than 5% of unimmunised children 
in their respective secondary school age groups.  The three outliers were identified and 
on this occasion these were Williton and Nether Stowey, both in Sedgmoor, and 
Creech in Taunton. This may reflect small numbers, or may again indicate sub-
populations of responders, but does not appear to correspond with the response by 
MSOA as previously described.  
 
 
5.3.6 GP Surgery 
Initial analysis of responses by GP practice suggested an association between GP 
practice and MMR uptake. However, using a ranking process and non-parametric test 
as before, this association was not found to be significant for the responder groups (p 
value = 0.09), and this is therefore different than for the analysis of the previous 
dataset where the association was found to be highly significant (p value = 0.00002).  
There were five GP practices where no responses were received from parents of 
primary school age children and 13 where no responses were received from parents of 
secondary school age children. North Petherton Surgery was the outlier with a high 
response for both age groups, whereas Preston Grove had a very high response rate 
for primary school age and no response for secondary school age children. There is no 
apparent explanation for these variations. 
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5.4 Comparison of the survey responders and parents who agreed to 
follow-up 
Of those who responded to the survey, 172 (38%) parents of primary school age 
children from and 96 (39%) parents of secondary school age children provided contact 
details and agreed to take part in a follow-up interview.  The analysis of the data for 
this group of parents is presented in the following section. 
 
The “agreed to follow up” group were then compared with their respective Phase 1 
unimmunised age groups and ₓ2 tests were performed on the distributions across 
gender, IMD and MOSIAC groups. No significant differences were identified across 
any of these variables. Comparison of the MSOAs and GPs was not able to be 
undertaken for the ‘agree to follow-up’ group because of the small numbers involved. 
 
5.4.1 IMD  
In terms of IMD, the data did however suggest that the “agreed to follow up” group 
were less deprived than the wider Phase 1 unimmunised populations and it is possible 
that the ₓ2 test was not significant because there were not enough children in each of 
the groups to identify this. Previous studies have indicated that those who have 
refused to accept MMR for their children were more likely to be in the less deprived 
categories and in addition there is evidence that those in less deprived categories are 
also more likely to respond to surveys. The quintiles within the dataset were therefore 
combined to increase the number of individuals in each group. The proportion in 
Quintile 1+ Quintile 2 were then compared for the “agreed to follow up” and Phase 1 
groups and the ₓ2 tests performed did identify a significant difference, (p value = 0.03) 
with those in the ‘agreed to follow up’ group being significantly less deprived that the 
original unimmunised population (see Figure 15).  
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Figure 15: Proportion of parents agreeing to further follow-up 
 
 
5.4.2 MOSAIC Group 
The groups were amalgamated as described as before.  Response rates varied 
between the groups but were not significantly different from the average response rate. 
The pattern within and between the primary and secondary age groups was similar to 
that previously identified. However, of those agreeing to follow-up in both groups, a 
higher proportion were found to be in Group O (families in low rise social housing with 
high levels of benefit need) than either the unimmunised population as a whole, or the 
responders to the survey.  
 
 
 
5.4.3 Children’s Centre Areas 
The proportion of those agreeing to follow-up varied between Children’s Centre areas.  
This reflects in some cases the low numbers of the population in the respective age 
groups, and subsequently low numbers of responders.  However there were parents 
from most areas who were willing to be followed up with the following exceptions.  
There were no survey responses from parents of primary school age children in 
Halcon, and none from parents of secondary school age children in Sydenham and 
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Lyngford. As a result no interviews or further follow-up was able to be undertaken with 
parents in these areas. These areas have amongst the most deprived populations in 
Somerset and are therefore a group that is much less likely to respond to a survey 
approach. There were also no responses from parents of secondary school age 
children from the Chilcompton and Yeovil Children’s Centre Areas who agreed to 
follow-up. Again these are noted to be areas of relatively high deprivation. 
 
5.5 Comparison of parents who took part in interviews with those who 
responded and those who agreed to follow-up 
 
There were 268 parents who provided contact details on their survey return and 
agreed to take part in a follow-up interview, 172 parents of primary school age children 
and 96 parents of secondary school age children.  20 interviews were carried out.   
The breakdown of those invited for interview is shown below: 
 
Of the seven who were not interviewed, two did not provide a contact telephone 
number, one gave an incorrect telephone number, three were not able to take part in 
an interview, and one no longer wished to participate. The numbers involved were too 
small to undertake any meaningful comparisons between this group and the other 
groups. 
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Table 4: Outcomes for parents invited for interview 
Age group Invited Attended a 
one to one 
interview 
Removed due to 
administration 
error* 
Focus Group (which 
became a one to one 
interview) 
Not 
interviewed 
Primary 
school age 
19 15 1* 0 3 
Secondary 
school age 
9 4 0 1 4 
Total  28 19 1* 1 7 
*This participant should have been in the Immunised Group, but this was only realised after the 
participants for follow-up had been selected. 
 
 
The persons invited for interview were selected from the entire responding population 
who agreed to follow up by a process of Nth (10th) person sampling. As a result, the 
numbers invited from each cohort are roughly proportionate to numbers agreeing to 
follow-up. An alternative approach would have been to have adopted a 
disproportionate strategy that would have meant inviting roughly equal numbers from 
both cohorts. The strategy adopted is more representative of the total ‘agree to follow-
up’ sample, and was chosen because although there was an interest in understanding 
the influences on parents of children who were of secondary school age in 2009, 
primary school age children were the group with the highest levels of non-compliance 
with the national immunisation programme and therefore the group which would 
require greatest attention in any future catch-up activity to improve uptake.  The 
interview sample is therefore recognised as being weighted towards parents of children 
who were of primary school age in 2009 (and therefore of secondary school age or 
approaching secondary school entry at the time of the interviews with the parents in 
2012). 
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The numbers of parents interviewed was too small for meaningful analysis in relation to 
MSOA, MOSAIC Group, GP practice or Children’s Centre Area. Analysis was therefore 
limited to a comparison of gender and IMD of the interviewees, survey responders and 
the wider unimmunised population.  
 
5.5.1 Gender 
Parents of male and female children were equally distributed in the Phase 1 primary 
school age group. There were also similar numbers of parents of male and female 
children in the responding group and the interviewed group for this age group.  
In the secondary school age group, whilst the numbers of immunised and 
unimmunised children in the total population were not significantly different, more 
parents of female children responded to the survey and were then identified for 
interview. This difference was not, however, found to be significant (p=.0.31).  
 
5.5.2 IMD 
IMD was identified for the parents who were interviewed. This was plotted and the 
pattern was found to be different from that of the parents who responded to the survey 
and from those who agreed to follow-up. For both of these groups a significant 
relationship was found between IMD and response. 
 
The IMD for parents who were interviewed was more variable across and more similar 
to that of the Phase 1 unimmunised population as a whole. P value and P value for 
linear trend were both calculated and were not found to be significant for either age 
group (p = 0.33 and p value for linear trend = 0.08 for the primary age group and p = 
0.10 and p value for linear trend = 0.62 for the secondary school age group). These 
parents therefore appear to be more representative of the wider unimmunised 
population in this respect than either of the responding and agreed to follow-up groups.  
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5.6 Results of the analysis of the Phase 2 Parental Census Survey  
The analysis undertaken in the previous sections compared the demographic 
characteristics of the child (gender, age, GP, geographic location and therefore 
MOSAIC Group, IMD and Children’s Centre Area) obtained from routine data sources 
available within the Somerset CHIS. Additional information in respect of the 
demographic characteristics of the parents was subsequently collected using the 
Phase 2 Parent Census Survey. Whilst some of this information is the same as that 
held on the CHIS (e.g. geographic location / MSOA), other information, such as 
parents’ age, occupation, marital status, and smoking status could only be gathered by 
asking the parents’ for this information directly. This additional information provides 
valuable additional insights to answer the research question: 
 
‘What were the social, demographic and geographic characteristics of parents / 
children who had declined MMR in Somerset after 2009?’ 
 
The results of the analysis of this additional, ‘parent derived’, data is presented in this 
section. 
   
5.6.1 Demographic characteristics of parents who responded to the Phase 2 
survey 
5.6.1.1 Gender 
Women formed the largest group of respondents with 88% of respondents in the 
primary school age group and 85% in the secondary school age group; all of whom 
defined their relationship with the child as being ‘mother’. Fathers completed 11% of 
responses for primary school age and 12% for children of secondary school age. In the 
secondary school age group 3% of parents either failed to indicate their gender or 
preferred not to provide this information.  
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5.6.1.2 Parental age  
 
Previous studies have identified parental age as one of the most significant 
characteristics of parents who declined MMR (Friedrichs et al, 2006; Bedford et al, 
2009), specifically mothers who were aged over 34 years. Parents were therefore 
asked to give their age as part of the demographic data collected in this survey. In the 
primary school age group 90 % of respondents were aged over 34 years and in the 
secondary age group this rose to 97%. However, this is not surprising given the ages 
of the children (seven – 16 years). The parents’ ages were therefore recalculated to 
identify age at the time the first MMR immunisation was due by taking (parent age – 
child age) + one year. The rationale for this was that, as these children would have 
been due their first MMR at 18 months, parents would have been considering whether 
to accept it after the child was a year old. The average age of these parents at the time 
MMR was being considered is detailed in Table 5 below: 
 
Age group Average age: All parents 
Males Females 
Primary school age 33.7 35.8 33.4 
Secondary school age  33.3 35.7 32.9 
Table 5: Average age of parents who responded to the Phase 2 Survey (recalculated)  
 
Mother aged over 34 was not found to be a significant characteristic for either the 
primary school age group or the secondary school age group. 
 
 
5.6.1.3 Highest level of education completed 
Education level, that is parents (and specifically mothers) who were more highly 
educated, has been found to be a significant characteristic of parents who declined 
MMR in previous studies (Reading, Surridge & Adamson, 2004; Cassiday et al, 2006; 
Hawker et al, 2007).  
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Of parents responding to this survey, 45% of those with primary school age children 
and 48% of those with secondary school age children reported their highest level of 
education to be University / polytechnic degree level (see Figure 16 below). 
 
Figure 16: Proportion of survey responders by highest level of education completed and by 
age group 
 
 
Data reported from the 2011 Census indicates that 29.7% of people aged 16-34 
reported a degree level or above as their highest qualification However, for the age 
group 25-34,  40% of people reported having a degree level or above qualification, and 
under the age of 50 women were more likely to report having a degree or above 
qualification compared with men (Office for National Statistics, 
www.ons.gov.uk/ons/rel/census/2011.ce, accessed 28/09/2015). The survey 
respondents were predominantly women aged 50 years or under, and this therefore 
needs to be considered when reviewing this data, however, the parents who 
responded to the survey do therefore appear to be a more highly educated group than 
the general population.  
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5.6.1.4 Socio-economic status 
The economic status, occupation and National Statistics-Socio Economic Classification 
(NS-SEC) of the parents responding to the survey were all reviewed.  The majority of 
respondents, 82% of the primary school age group and 77% of the secondary school 
age group, reported being employed and working as a paid employee, or were self-
employed or freelance. Of these, 37% and 38% of the primary and secondary age 
groups respectively identified their occupation as ‘modern professional’, with 23 and 
17% reporting occupation as ‘clerical and intermediate’ and seven and 10% as ‘senior 
managers or administrators’. 17% of the parents of the primary school age group and 
20% of the secondary school age group reported not being in paid employment, 
although only 4% of the parents of primary school age children and only 2% of the 
secondary school age group considered themselves to be unemployed. There was 
very little variation between the two age groups.  
 
NS-SEC classification is derived from occupation and employment status information 
and is a nationally and internationally recognised measure of socio-economic status 
which is used as a predictor of health, educational and many other outcomes (Office of 
National Statistics, 2015). Occupation is ideally coded to the Standard Occupational 
Classification (SOC2000) which has 353 unit groups. Coding to this level is very time-
consuming and therefore a simpler version of NS-SEC has been developed involving 
five classifications. This NS-SEC5 version has been shown to be in agreement with the 
interviewer coded 353 version in 75% of cases and was therefore used here. 
 
Applying this classification, it was confirmed that 56% of parents responding to the 
survey in both age groups could be classified as ‘higher managerial, administrative and 
professional’ – the highest (least deprived) socio-economic category (See Figure 17). 
In comparison, the percentage of the population in NS-SEC category 1 in England was 
10.4% in 2011.  
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Figure 17: Proportion of responding parents by NS-SEC category and by age group 
 
The South West average was 10.2% and for Somerset 9.3% (ranging from 7.4% in 
West Somerset to 9.8% in South Somerset and Taunton Deane). The population of 
survey responders is therefore not representative of the either the whole unimmunised 
or the wider Somerset populations and this must be considered when drawing 
conclusions from the analysis of the remaining data from this survey. 
 
5.6.1.5 Parents’ marital status  
Being a single parent has previously been identified as a characteristic of parents who 
declined MMR (Friedrichs et al, 2006; Bedford et al, 2009). This was not however an 
observed characteristic of the parents who declined MMR in this study, where 69% of 
the parents in the primary school age group and 65% in the secondary school age 
group were found to be married. In comparison, the national archive Census data 
indicates that the proportion of the UK population who were part of a one family 
married couple household was 44% and the proportion of the UK population 
who were part of a one family lone parent household was 11% in 2011, Data for 
Somerset is in line with this national data, although there are variations by ward. 
(http://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration
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/populationestimates/bulletins/2011censusquickstatisticsforenglandandwales/20
13-01-30 ). See Figure 18 below.  
 
 
Figure 18: Proportion of responding parents by marital status and by age group 
 
 
5.6.1.6 Smoking status 
  
Figure 19: Proportion of parents by smoking status and by age group 
  
 
Smoking in pregnancy has previously been found to be a characteristic associated with 
parents who decline immunisations (Bedford et al, 2009). Smoking status of the survey 
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be a characteristic of the majority of these parents, it was observed that 27% of 
parents of the primary school age children and 23% of parents of the secondary school 
age children reported that they had been regular smokers in the past (and may 
therefore have been smokers at the time of making the original decisions in respect of 
MMR). Smoking is also more frequently associated with gender (men) and lower socio-
economic status, however, rates of smoking in pregnancy are noted to be higher in 
Somerset than the England and Wales average (Somerset County Council, 2014). 
Whilst no associations can be drawn from this data without knowledge of the 
proportions of parents who smoke in the wider population, the proportion of parents 
who reported that they are, or were, regular smokers is an unusual observation in a 
population sub-group comprised of predominantly women of high socio-economic 
status and may, potentially, be related to higher rates of smoking in pregnancy in this 
area.  
 
5.6.1.7 Ethnic Group 
Somerset is not an ethnically diverse county. 94.6% of the population are ‘white British’ 
which is far higher than the England and Wales average (80.5%). The ‘white British’ 
population is generally concentrated in and around the principle county towns. 2% of 
Somerset’s residents are from Black Minority Ethnic (BME) groups, which is well below 
the national average of 14|%. There has been a large increase in the number of Polish 
residents since the accession of the A8 Eastern Europeans to the EU in 2004 and 
Polish is the most common ‘non-UK’ ethnicity in Somerset forming 1% of the Somerset 
population. 
 
The parents who responded to the survey were, however, more ethnically diverse than 
the Somerset population generally, with only 86% of parents of primary school age 
responding being ‘white British’ and 80% of the parents of the secondary school age 
group being ‘white British’ (see Figure 20).  
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Figure 20: Proportion of Parents responding to the survey by ethnic group and by age group 
 
 
 
 
5.6.2 Investigation of characteristics associated with accepting and 
declining MMR  
 
The Phase 2 survey also asked parents a number of questions relating to 
characteristics that had been found to be related to decisions to accept or decline 
immunisations in previous studies. These included family size, birth order of the child, 
whether the child had been admitted to hospital before the age of five, and whether 
other children in the family had been given MMR (Reading, Surridge & Adamson, 
2004; Cassiday et al, 2006; Hawker et al, 2007). Parents were also asked about their 
knowledge of immunisation and MMR and about the sources of information that they 
accessed, and which they most trusted. These responses are now reviewed and 
observations in respect of the data described. It should be noted that there is limited 
potential to draw firm conclusions from some parts of the data, particularly in sections 
5.6.2.1 and 5.6.2.2, without access to comparative data to describe the wider 
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population in Somerset. However, since these characteristics were previously found to 
be of relevance the descriptions of these observations are included for completeness. 
  
5.6.2.1 Family size 
 
Figure 21: Family size by age group 
 
 
Both Friedrichs et al (2006) and Bedford et al (2009) identified large family size as a 
characteristic associated with decline of MMR. In the present study the number of 
children in the families of parents who responded was similar across both age groups 
and large family size was not an identified characteristic, with 87.6% of those in the 
primary school age group and 84.1% in the secondary school age group having 3 
children or fewer (see Figure 21).  
 
5.6.2.2 Birth order 
There does appear to be a linear relationship between birth order and decline of MMR 
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in the primary school age group and 45.9% in the secondary school age group) – see 
Figure 22.  
 
 
Figure 22: Birth order of the child for which the parent is answering the survey 
 
 
However, where the parent indicated that they had more than one child it appeared 
that they did not follow the same decision path for all of their children. 50% of the 
parents responding in the primary school age group and 58% of the parents of 
secondary school age children reported that all or some of their other children had had 
MMR (See Figure 23). This appears to confirm the suggestion that the parents’ 
decision to accept or decline MMR for a child may be a very individual process, related 
to the specific characteristics and circumstances of that child rather than a generic 
decision-making process in relation to the vaccine itself, and this requires further 
investigation.  
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Figure 23: Proportion of parents of unimmunised children accepting MMR for their other 
children by age group 
 
 
 
5.6 2.3 MMR status of the child at the time of the survey in 2012 – reasons given 
for accepting or continuing to decline the offer 
 
Parents were asked whether the child that they were responding about in the survey 
had now had MMR. 27% of the parents of primary school age children and 36% of the 
parents of secondary school age children reported that their child had now had MMR, 
which suggests that these parents had changed their mind and accepted the offer at 
some point after the 2009 catch-up campaign.  
 
The parents who had accepted MMR for their children were then asked to provide 
reasons for now accepting MMR. These reasons are detailed in Figure 24. The most 
frequent reasons were, firstly, the child being older, second, that they had new 
information and, thirdly, ‘being worried about measles’.  The pattern of responses was 
similar across both age groups. 
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Parents who reported that their children had still not had MMR were asked to indicate 
the reasons for continuing to decline the offer of MMR. Whilst a range of options were 
provided, the most frequent reason given was ‘other’, followed by ‘risk of side effects 
outweighs the benefits’ and ‘know of children with problems following vaccination’ for 
both age groups. Where parents ticked ‘other’ they were asked to add reason in free 
text. Examination of these responses identified that 35 of the 217 responses for 
primary school age children (16%) gave ‘had MMR in 2009’. In these cases the parents 
had assumed one dose was a full course, but the CHIS continued to flag as 
unimmunised as the complete course requires two doses of MMR. 139 of the 217 
children (64%) had had single vaccines and the parents considered them fully 
protected, and 7 (3%) parents reported that their child had had MMR abroad. Of the 
parents of primary school children who had indicated that they continued to decline 
MMR for ‘other’ reasons 83% had therefore declined because they had actually 
already accepted some form of vaccination for their children. 
 
Figure 24: Reasons given by parents for accepting MMR after 2009 by age group 
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This pattern was similar in the secondary school age group, with 43 of the 95 parents 
(45.2%) indicating that their child had had MMR1, nine (9.5%) reporting the child had 
had single vaccines, and 10 (10.5%) that they had had MMR abroad. In this age group 
65.2% of those declining for ‘other’ reasons had done so because they had already 
accepted some form of vaccination (see Figure 25).  
 
 
Figure 25: Reasons given by parents for continuing to decline MMR by age group 
 
5.6.2.4 Parents’ knowledge of immunisation and MMR 
Parents’ limited knowledge of immunisation and MMR has been suggested as a 
potential reason for declining MMR. In this survey, 93% of parents of primary school 
children and 86% of parents of secondary school children believed that they were fully 
informed or had some knowledge on which to base their decision to accept or decline 
the offer of MMR for their child and as such suggests that they believed that they were 
making an ‘informed choice’.  
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Parents obtained their information about immunisation from a range of sources which 
followed a similar pattern for both age groups. The most frequently reported sources 
for both groups were GP and the internet, followed by the media and Health Visitors. 
 
However, when asked which sources of information were trusted by them to be most 
accurate, parents of children in both age groups reported the most trusted source to be 
the GP (See Figure 26). 
 
 
Figure 26: Most trusted sources of information about immunisation / MMR by age group 
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quintile, Mosaic Group and Child Centre Area.  If not, they were categorised as 
‘Unknown’.   
 
There were 335 children with a school address (Boarding school), of which eight were 
in the immunised groups (and therefore not sent a questionnaire) and 327 were in the 
unimmunised groups. Unimmunised children formed 8.6% of the total population of 
children with no MMR or Partial MMR, but only 26 parents of these children returned a 
questionnaire, with only two of the responding parents of primary school age children 
and seven parents of secondary school age children providing a home address and 
postcode. The high number of parents who were not able to be contacted because of 
this situation may also have acted to distort the survey respondent population sub-
group in addition to reducing the response rate. 
 
The relatively high number of children in this category and low response rate from this 
group may reflect the fact that many of these children and young people are 
international students (or children whose parents are in the Armed Services) and 
therefore are unlikely to have been able to have been easily contacted by the schools 
to complete the survey. The number who did not have a complete history of MMR 
immunisation may also reflect either true low uptake, or poor collection of immunisation 
history by the schools on admission, or poor transfer of information from the schools to 
the CHIS. This group is significant because there is greater potential for outbreaks of 
infection where there are susceptible populations living in institutional settings, such as 
a boarding school. In addition, there is potential for wider spread beyond the school 
into the wider community because of the combination of Day and Boarding pupils 
attending these settings. Further detailed investigation of this group of children is 
therefore required.    
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5.7 Summary of findings from the analysis of the Phase 1 and Phase 2 
data 
5.7.1 Demographic and geographic characteristics of immunised and 
unimmunised parents / children 
The analysis of the Phase 1 and Phase 2 demographic and geographic data identified 
that there was a relationship between parental decisions to decline MMR and MSOA, 
MOSAIC Group and GP practice and therefore differences in the socio-demographic 
and geographic characteristics of parents / children who had accepted and declined 
MMR.  
 
The different patterns observed for each of the two age groups in relation to geography 
/ MSOA, suggests that parents of the unimmunised secondary school age children 
may be more aligned with traditional persistent decliners of immunisation, whilst those 
of primary school age are temporally associated with the Wakefield controversy and 
this may explain the more diverse spread across the geographical populations.  
 
Whilst there are some similarities between the age groups in terms of MOSAIC groups, 
there were a considerably higher proportion of Group D types (successful 
professionals in semi-rural areas) in the primary school age group. This is also in line 
with previous findings that refusal of MMR post-Wakefield was most associated with 
more highly educated / professional population groups (Friedrichs et al, 2006; Bedford 
et al, 2009). 
  
The most significant characteristic that was associated with parental decline of MMR in 
Phase 1 was the GP practice that the child was registered with (p value = 0.00002) and 
there is evidence to suggest that this may not be entirely related to area of residence.  
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In terms of the parents who responded to the survey, these differed from the wider 
unimmunised (Phase 1) population in a number of ways. The MSOA pattern was 
considerably different for secondary school aged children, being far more dispersed 
across Somerset, and with relatively low responses from parents in Mendip 
(Glastonbury, Street and Frome). In relation to Children’s Centre Areas and registered 
GP practice, there were some interesting outliers in the wider Phase 1 unimmunised 
group, but no apparent corresponding association for those who responded to the 
survey.  
 
However, whilst tests of statistical significance were not performed, the IMD data 
indicate that there were a greater number of parents in Quintile 5, least deprived, in the 
responding group than in the wider unimmunised group, and there were very few 
survey responses from those in the least deprived groups. This finding is not surprising 
given that these groups are likely to be more literate and articulate and are therefore 
far more likely to respond to surveys, but it did suggest that the survey responders may 
not be fully representative of the unimmunised groups and should therefore be 
considered as a sub-group of the wider unimmunised population. 
 
Finally, parents who were interviewed appeared to be far more representative of the 
wider unimmunised population as a whole than the ‘Agreed to follow-up’ or the ‘Survey 
Responder’ group. MOSAIC data also indicated that the ‘Agreed to follow-up’ group 
had a far higher proportion of Group O (families in low rise social housing with high 
levels of benefit need) for both age groups. Given that there were no parents from 
some of the most economically deprived communities in Somerset (Halcon, Sydenham 
and Lyngford) in the ‘Agreed to follow-up group’ and very few in the survey responder 
group, this potentially suggests dependence on benefits for another reason, which may 
be related to disability or ill-health. These are factors which have in other studies also 
been linked to lower adherence to immunisation schedules (Friedrichs et al, 2006).  
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5.7.2 Summary of findings from the analysis of the Phase 2 Parental Census 
Survey 
The results of the Parent Census Survey should be viewed with caution for two 
reasons. Firstly, the response rate for both age groups was low and, secondly, there is 
evidence to suggest that the survey sample is skewed (with respondents having higher 
socio-economic status and educational attainment) and may not therefore be 
representative of the wider population of unimmunised children in Somerset. In 
addition, tests for statistical significance have not been performed on all of the data 
and the findings therefore need to be viewed with these caveats in mind.  
 
The characteristics of parents / children who declined MMR were found to be similar to 
those reported in previous studies in respect of: 
Higher parental educational attainment level 
Higher socio-economic status 
Higher levels / history of maternal smoking (and therefore potentially higher levels of 
smoking in pregnancy) 
Birth order (with first children being more likely to be unimmunised) 
History of the child having been admitted to hospital before age five years 
 
The characteristics of this study population differed from those previously reported in 
respect of: 
Parental age (these mothers were not older / aged over 34 years) 
Marital status (the majority of parents in both age groups were married with very few 
single parents) 
Family size (most families were not large, the majority in both groups having three or 
fewer children) 
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Parents’ self-reported knowledge of immunisation / MMR was either ‘fully informed’ or 
‘some knowledge’ and there was evidence of parents’ accessing multiple sources to 
gain a more balanced range of information. Parents’ most frequently accessed source 
continued to be health professionals and health professionals (particularly GPs) were 
the source that was most trusted.  
 
A final finding was that almost a quarter of parents in both age groups reported that 
their child had now had a full course of MMR. In addition, where parents’ had reported 
that their child had not had MMR since 2009, the reason frequently cited was that they 
had had a vaccine (either MMR or single antigen vaccines) prior to 2009. Although 
many of these children continued to have incomplete vaccination this mean that far 
more children have received a measles-containing vaccine and population protection 
levels are therefore considerably higher than is officially recorded. This finding also 
implies that many parents who are labelled as ‘persistent decliners’ are not anti-
vaccination per se and this requires further investigation. 
 
5.7.3 Conclusion 
In summary, the results of the analysis of the Phase 1 and Phase 2 categoric data 
suggest that there are differences in the social, demographic and geographic 
characteristics of children / parents who accept and those who decline the offer of 
MMR in Somerset. In addition, there also appear to be differences in the 
characteristics of the parents / children within and between the two age groups studied. 
The population of parents / children who decline MMR therefore appears not to be a 
single homogenous group and these differing characteristics have the potential to 
result in different influences on, and mechanisms for, parental decision-making.  
 
The results of this analysis, and the characteristics identified, were used to inform the 
development of the semi-structured questionnaire topic guide and the initial coding 
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framework which underpinned the analysis of the Phase 3 qualitative data. The results 
of the analysis of this final process of analysis are presented in the next chapter.  
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CHAPTER 6 PRESENTATION OF THE RESULTS OF THE ANALYSIS OF 
THE PHASE 2 PARENT CENSUS SURVEY AND PHASE 3 SEMI-
STRUCTURED INTERVIEWS 
 
6.1 Introduction 
This chapter presents the results of the thematic analysis of the qualitative data 
gathered during Phases 2 and 3 of the present study. Nine themes emerged from this 
analysis, which appeared to underpin the thinking of the parents when making 
decisions about MMR for their unimmunised children. These themes were as follows: 
 
Risk of disease vs vaccination 
Vaccine overload 
Media 
Single vaccines 
Other medical comorbidities 
More support needed from professionals 
Medical models and health 
Natural health / holistic approaches 
Parents’ choice 
 
Further exploration of these themes, and of the commonalities, differences and 
relationships forming linkages between them, resulted in the identification of three 
parent sub-groups within the unimmunised population studied: 
 
Parents with a natural / holistic approach to health 
Parents of children who had existing medical comorbidities 
Parents who had obtained single vaccines 
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These parents were able to articulate detailed rationales for the decisions they made. 
However, they differed from each other in the way that these rationales linked to both 
their personal experiences and to their social, political and cultural perspectives. The 
parent sub-groups were also found to be linked to different outcomes in relation to the 
likelihood of accepting MMR and the potential triggers which would encourage them to 
do so. 
  
The information presented in this chapter is structured as follows: Section 6.2 provides 
an overview of the development of the nine themes; these themes are then explored in 
detail in section 6.3. Section 6.4 provides detail on the identification of the three parent 
sub-groups and the development of a parent sub-group framework. Section 6.5 
considers the generalisability of these findings in relation to the sampling strategy and 
in respect of participant feedback.  
 
The implications of the findings and the development of a theoretical proposition for 
delivering a pluralist approach to parent engagement within immunisation services to 
accommodate these differing needs in practice will be explored in Chapter 7.  
 
6.1.1 Demographics of the interview subjects 
Throughout this chapter quotes from participants are used as a primary source of 
evidence to support the author’s interpretation of the raw data and to provide specific 
examples of relevance to illustrate the theme being explored. The characteristics of the 
20 interview subjects can be found in Appendix 12. In addition a label has been applied 
to provide the reader with an outline of key demographic details of the participants for 
each quote used. The following examples provide detail of how these labels should be 
interpreted:   
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(Interview 1, M, 46, P, Y) = Interview Participant no. 1, male, aged 46, child in primary 
school age group, has had MMR now.  
 
(Interview 2, F, 37, S, N (S)) = Interview Participant no. 2, female, aged 37, child in 
secondary school age group, had not had MMR (had single vaccines).  
 
6.2 Development of the themes 
Exploration of the existing evidence in Chapter 3 and the quantitative data in Chapter 5 
provided a number of characteristics of and issues of potential significance to parents 
of children who had not accepted the offer of MMR. This information resulted in 
potential answers to the research questions exploring the ‘what’ (what are the 
characteristics of parents / children) but not to the remaining research questions that 
were attempting to answer ‘why’ these were of relevance and ‘how’ this then impacted 
on the decision-making of these parents. Review of the qualitative data in this chapter 
aims to provide evidence to fill some of these knowledge gaps through the 
identification and description of major themes within the data, the assessment of the 
relative importance of these themes, and their linkages to one another. This section 
describes the process of how the nine themes were identified and developed.  
 
The free text comments derived from Section 5 of the Phase 2 Parent Census Survey 
were read very carefully and then meaningful units of text relevant to the research topic 
were coded. The text was read and reread and the codes were reviewed and refined. 
This process confirmed that the codes were robust and could be used to provide an 
initial ‘scaffold’ upon which the coding framework was developed.  
 
The analysis then progressed to a more iterative and descriptive process. The codes 
were refined again and units of text dealing with the same issue were grouped in 
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analytic categories and given provisional definitions. A substantive analysis of the 
entire content of each of the interview transcripts was then completed using these 
categories or ‘codes’, to determine the level of literal or theoretical replication across 
the transcripts and data sources. The data were systematically reviewed to ensure that 
a name, definition, and exhaustive set of data to support each category were identified. 
 
This process of relooking at and refining the codes was repeated several times in order 
to look at the overall pattern of discourse and observations to see if the analysis 
provided evidence to support the my initial perceptions of the importance of these 
codes. Coding categories were added to, modified, reviewed, grouped and then 
regrouped into parent and child nodes, reordered and refined as all data sources were 
reread, and coding checked and revisited.  
 
This inductive thematic analysis resulted in 55 categories, which were grouped in to 
nine key themes (see Appendix 13 for a full list of categories and themes). The 
coherence and replicability of the themes was established by a second person (the 
Somerset PCT Head of Health Intelligence) independently coding the Section 5 survey 
comments, a process which resulted in a high level of agreement and inter-rater 
reliability.  
 
Throughout the analysis Nvivo10 software was also used to record personal notes and 
memos. Previous authors have described this as theorising about ideas from codes 
and their relationships in order to allow the analysis to build from the conceptual level 
towards an integrated understanding of the data and the development of propositions 
(Miles and Huberman, 1994; Docherty, 2010).  
 
Within applied thematic analysis, as described by Guest et al (2012),  the emphasis is 
on empirical investigation of the way in which meaningful elements or codes are 
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combined to generate thematic or explanatory models. A number of deductive 
techniques were used to enhance this process, to aid the development of themes, and 
to generate more detail for each of these. This included the use of word searches, key 
words in context, coded content, word frequency, frequency of coding references, 
sources and nodes clustered by word similarity, coding by item, and investigation of 
the nodes by number of items coded. This information was used to help to explore 
what I considered the meaning of the data to be, what specific instances of these 
meanings existed within the text, and whether there were any patterns of relationships 
amongst these instances of meanings within the text being investigated. In addition, 
the information obtained from the use of these techniques enabled each of the themes 
to be reviewed in detail and an assessment of the relative importance of each theme to 
be completed. Examples of the outputs from these analytical processes are provided in 
Appendix 14.  
 
The following sections detail the findings, perceptions and selected quotes in relation 
to this process of analysis. However, it is important to state that the numbers within the 
study were small and the participants were also self-selecting and this may limit the 
strength of some of the findings.   
 
6.3 Results of the analysis - the themes in detail 
This section provides detailed results of the analysis of the qualitative data by theme. 
To aid readability, the categories of each theme are presented followed by the number 
of references relating to each category in brackets. 
 
6.3.1 Risk of disease vs risks of vaccination 
The most significant theme that arose in this study related to risk, specifically the 
parents’ assessment of the relative risk of accepting or declining MMR, and how this 
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assessment differed from those of public health professionals and policy makers. The 
theme was directly referenced by all of the 20 interviewees and by 105 survey 
respondents (448 references in total). In addition, the theme generated four memos 
(autism vs death; perceived risks and guilt; how vaccines work; and health professional 
as parents and risk).   
 
6.3.1.1 Autism  
Risk naturally included references to the potential link that had been made with autism 
(108), which is to be expected given the media attention at the time many of these 
children were originally being offered MMR. However, whilst most parents confirmed 
that they were aware of the Wakefield study (Wakefield et al, 1998) and had seen 
media coverage at the time, no single, universal parent reaction was identified and this 
risk was not cited as the key influencing factor, even among those parents who had 
completely declined vaccination. In fact, several of the references clearly reiterated that 
the parent did not believe that there was any link with autism. What the parents did 
suggest was that media interest had raised an element of doubt for them and it was 
this that had acted as a catalyst for them to investigate risks associated with 
immunisation in general: 
 
‘I did an awful lot of research…I wasn’t focussed particularly on this study but it 
prompted me to think ’So now I’m gonna look into it’, and actually it was the other 
things that worried me more’ (Interview 14, F, 36, P, Y) 
 
Whilst it is not cited as a key influencing factor in ultimately deciding to accept or 
decline MMR, there is evidence that autism does appear to be intimately bound up with 
parents’ value judgements on what constitutes a worthwhile life for their child, and may 
therefore have had an impact on assessment of risk in ways that many conditions 
might not have done: 
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‘well, there’s different ranges of autism…I saw that as more of a lifelong risk for him 
and, you know, mumps…you can become sterile, measles you can be blind, you can 
become deaf…but that…you can overcome those to a certain extent. With autism, 
whatever part of the scale you are on, that’s quite devastating’  
(Interview 19, M, 49, P, N). 
 
The stigma associated with social and mental disorders (as referenced in Chapter 3) 
was also found to be significant: 
 
‘Well you shouldn’t do, but you feel sorry for somebody…you have more sympathy for 
people who are blind and deaf rather than those who have behavioural and attention 
problems, you know?’ (Interview 1, F, 38, P, N) 
 
Serious illnesses therefore appear preferable to autism because people with autism 
are considered by these parents to ‘have no quality of life’ (Interview 14, F, 36, P, Y) 
and because autism is considered by them to be ‘far worse than death (Interview 1, F, 
38, P, N (S)). These observations were not, however, made in abstract. Many of the 
parents made reference to personal experience of autism and / or to parents’ accounts 
of children changing after they had received MMR:  
 
‘And I think probably had we not known somebody personally [who had autism], maybe 
our decision might have been different. But because we knew somebody personally, 
that it could have been an effect of MMR; we went the other way really…’ (Interview 2, 
F, 45, S, Y) 
 
Many of the participants interviewed subscribed to the notion described in Chapter 3, 
that autism may be linked to particular vulnerabilities, whether genetic or associated 
with the child’s immune system response or history. Its development was not 
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considered inevitable, but a predisposition which could be influenced positively or 
negatively by biological and environmental factors that the child was exposed to: 
 
‘No, and I actually don’t have any issues with the MMR causing autism. Because I 
don’t believe that the MMR vaccine causes autism. It might be the last stress for that 
child – that tripped them into that picture, but it wasn’t, you know, the cause of it.’  
(Interview 3, F, 42, P, N) 
 
There was considerable evidence therefore that parents reflected on potential factors 
associated with their own child’s vulnerability, or family history, and then factored this 
in to the decision-making process: 
 
 ‘And [child]…he’s always been one that’ll run a very fine line and, you know, could that 
have just swayed him the other way and pushed him the other way to make him 
autistic, Aspergers or whatever, something like that, who knows? So I think that was 
the decision really.’  
(Interview 8, F, 44, P, N) 
 
Many of the parents interviewed for this study acknowledged that they had had pre-
existing doubts about their own child’s development, to a sufficient degree that this was 
what had initially prompted them not to have the MMR. They also provided credible 
explanations for these doubts, most commonly family history. However, their 
responses also suggested that, had they accepted the vaccine, any appearance of the 
disorder would, nevertheless, have been fully attributed to MMR and the contribution of 
these underlying concerns would have been retrospectively minimised. There was no 
consideration that this may have been exactly the same for parents in a similar 
situation who had accepted MMR, and whose retrospective accounts had so 
influenced their own perceptions of causation.  
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The evidence reviewed here suggests that the possibility of risks associated with 
autism whilst reported as not being the only, or most important, factor influencing these 
parents’, did still have a considerable impact on how they behaved in terms of their 
decision-making. There is, however, evidence that previous decisions made on this 
basis can be altered over time by the reframing of the respective risks. For example: 
 
‘There was all this stuff about measles and people saying about how parents were 
putting children at risk by not having the MMR…I thought, well ok I’m still not sure it’s 
ok, and I knew I’d feel bad if it goes wrong, but I’ll get it done because they’re now 
saying its bad not to have it more than about the autism stuff... so I’ll do as they say…’ 
(Interview 10, F, 49, P, Y) 
 
6.3.1.2 Knowledge of the diseases, the immune system and how vaccines work 
A significant body of the professional and policy-based evidence reviewed in Chapter 3 
concluded that vaccine refusal is, in large part, the result of poor levels of public 
understanding of how vaccines and the immune system work (Elliman et al, 2001). 
This lack of understanding, they argue, subsequently fosters a more irrational and 
emotionally driven approach to the assessment of risk, which is further compounded by 
the lack of knowledge of the complications these childhood diseases may cause 
because parents now rarely experience them. The main issue for professionals and 
policy makers therefore becomes the rebalancing of these knowledge ‘deficits’ to 
enable more effective estimations of risk and benefit to occur. (Bedford and Elliman, 
1998). 
 
Survey respondents and interview subjects did provide evidence (26 references) to 
support these conclusions, or at least the assumptions that some parents do consider 
that having more information about the diseases would have been of value: 
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I was aware that there were side effects with vaccinations. I didn’t look, so I was, sort 
of feeling I ought to look into it more…in terms of the risks of the diseases, you know 
I’d had all these illnesses when I was a child so I don’t think I was quite so aware of 
how dangerous they could be. I didn’t understand quite how dangerous measles could 
be.’ (Interview 16, F, 52, S, N) 
 
Parents also highlighted the importance of being supported to be able to digest and 
explore this information as being equally as important in making their decisions: 
 
‘Maybe I could have talked about it and, you know, been more informed myself rather 
than just having the information sent to me, had time to do a bit of other….looking into 
it which is what I subsequently did, and then came to the conclusion that actually, you 
know, I was perhaps jeopardising her by not doing it’. (Interview 2, F, 45, S, Y) 
 
These parents were however in the minority. Most parents in this study emphasised 
that they believed that they had sufficient knowledge both of the diseases and of how 
the immune system works when they made their decisions. However, many also 
acknowledged that their knowledge of the immune system rarely exceeded an 
understanding of basic principles. For example: 
 
 ‘I know obviously they are injected with a mild dose of whatever it is and it builds up 
their immune system and therefore hopefully they don’t get it at all, or they may have a 
very mild version that they can deal with themselves.’(Interview 7, F, 41, P, Y) 
 
The human immune system involves highly complex, multifactorial chemical and 
biological processes. Whilst the basic principles can be readily articulated, as above, 
understanding of the very complex interactions associated with the various elements of 
the system requires a highly technical level of knowledge. Whilst the majority of 
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parents for whom this was a concern reported that they were educated to degree or 
technical / professional level, this did not mean that they were educated to this level in 
science. In fact, for most their knowledge of science rarely extended beyond school or 
GCSE level. This therefore frequently renders much of the information on immunology 
inaccessible or incomprehensible for most members of the public.   
 
In comparison, groups and individuals who oppose the use of immunisation in general, 
and / or MMR specifically, often use arguments which are underpinned by simplified 
scientific arguments which align with the basic principles and educational level that 
appear to be well understood by parents. These authors frequently use elements of 
both scientific methodology and language to ground their arguments, turning 
professional information and advice back on itself. For example, if the vaccine ‘kicks 
the immune system into gear’, it does not seem unreasonable to argue that too much 
might kick it into overdrive, or might allow a disease to run wild, or for it to have 
unexpected results. Similarly, the science and evidence base surrounding public health 
suffers from the fact that interventions necessarily relate to populations, rather than 
individuals. This then results in data which can be interpreted in many different ways 
and may not always appear to relate to the highly personalised, individual situations 
that parents find themselves in.  
 
Parents are aware of this, but the fact that they have a level of knowledge that enables 
them to engage, but not necessarily to challenge the detail of these opposing 
arguments, results in widespread concern about the validity of any available 
information source: 
 
‘But you know if you look at the research it seems to me that you know you can make, 
well you can make statistics look however you want them to look I suppose depending 
on how you present it.’ (Interview 5, M, 47, S, N)  
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Many parents reported extensive, multi-source research when seeking information on 
immunisation and its potential side-effects. However, their knowledge of the diseases 
themselves appeared to be gained almost entirely from experiential sources. Parents 
talked with their families, their neighbours and other members of their communities and 
drew on these experiences to make sense of these issues.  How parents then 
considered the various issues associated with the vaccination of their children was, to 
a large extent, shaped by these social interactions, combined with any direct personal 
experience. This process appeared to strongly influence the parent’s current decision-
making process: 
 
‘I mean I talked about it with my Mum, um, and of course in my Mum’s generation they 
weren’t vaccinated for any of those, you know, if she got measles …they just took a 
chance and I thought, well that’s what I’ll do too’. (Interview 9, F, 39, P, N) 
 
Immunisation against many of the most prevalent childhood diseases only became 
possible in the latter half of the 20th century, and prior to this, deaths and serious 
illness as a result of these infections were not uncommon. Being commonplace, 
however, means that many people also recall only suffering mild disease and had 
subsequently recovered without any long term consequences: 
 
‘I know when my parents were younger there was none of this and children got 
measles you know, and I know horrendous things can happen from it, but it’s, I don’t 
know, it’s one of those flip things isn’t it – you know horrendous things can happen 
from it but you know children do come through it safely, and if you go back to the 50’s 
then it was a matter of routine. I mean I can remember my mother saying that if 
someone in her street had measles everybody was in the house to get it to get it over 
with’ (Interview 4, F, 44, P, N) 
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Grandparents, and older family members or carers, had their own experiences of 
parenting at a time when there was generally greater acceptance of scientific 
explanations and also greater deference towards health professionals and childcare 
experts. It might therefore be expected that they would align themselves more with the 
authority of the state, and be more willing to accept the positive value of MMR. But this 
does not seem to be the case.  
 
Whilst older family members will have experienced the first successes that followed the 
advent of mass immunisation programmes in the UK, such as the eradication of 
smallpox and the elimination of polio, they will have also experienced first-hand 
previous medical controversies and adverse medical events (e.g. thalidomide and 
pertussis). Conversely, the threat of disease, in an age where medicine now offers 
considerable improvements in treatment and care, alters the recall of the experience of 
communicable disease, and renders the perception of any consequences mild in 
comparison. In addition, autism and Asperger’s Syndrome were not widely used as 
diagnostic terms until the 1980’s and 90’s. This means that grandparents will not have 
been familiar with the term when they were parenting themselves and will regard it as a 
new disorder rather than an old one which is now more easily identified, and the 
apparent rapid increase in diagnosed cases of a supposedly new disease has potential 
to create fear and concern, especially if linked to previous medical controversies to 
which parents and grandparents can relate. 
. 
Grandparents and older carers were reported by the participants to have had 
significant influence on parents’ decisions to decline, even where there was little day-
to-day contact with the child. Examples of these influences included actively voicing 
their concerns to parents, sending information and articles, and, most significantly 
offering material payments to fund alternative immunisations or treatments. The latter 
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was often reported to be the final deciding factor for parents in this study who opted for 
single vaccines. 
 
Finally, first-hand or shared knowledge of the potentially serious complications of 
infectious diseases does not necessarily appear to create the same fear, or to result in 
parents accepting or following the authorised schedule because ironically, there is a 
belief that, because medical science has progressed since they were children, it will 
now be able to resolve any problems arising from these infections: 
 
 ‘And I think because medical science has moved on that much and there’s so, you 
know, there’s so many things that can be cured, we almost expect it just to be sorted’. 
(Interview 4, F, 44, P, N) 
 
6.3.1.3 Adverse events after immunisation 
Whilst mention of the issue of autism was common to many parents, a much smaller 
number of the interviewees (seven) and survey respondents (26) reported that they 
had made their decisions based on more general experience of adverse events 
occurring after immunisation. For some these were not recent events, but involved 
recall of historical events that had occurred many years before or to wider family 
members:   
 
I can remember (my niece) having her jab and afterwards she was quite ill…and, um, I 
can remember being actually quite frightened because she had this really sort of 
glazed look in her eyes…and I thought “Oh my gosh, this is it”…and I mean, you know, 
she has got better and she was absolutely fine but, you know, I thought, “Crikey, if this 
is what it does to you…” (Interview 6, F, 50, S, Y)  
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Experiences such as these were used as evidence to support the notion, that whilst 
immunisation was considered generally safe, it had to be acknowledged that there 
could be serious negative consequences and things could sometimes go wrong. There 
was a strong feeling that health professionals, at pains to promote vaccination, 
sometimes underplayed these risks and when they occurred, the unexpected nature of 
the event added to the suspicion that something was being hidden: 
 
‘I mean it could have been coincidence, you know, that’s what they said happened to 
them. But on the other had I know plenty of people who’ve you know had problems, I 
mean most people don’t. You don’t always see any outward signs of, you know, 
vaccine damage, I guess.’ (Interview 5, M, 47, S, N(S)) 
 
Concerns relating to family history were frequently translated beyond the individual, to 
general familial vulnerabilities, and likewise to potential vulnerabilities to all, or other 
vaccinations. Such a fear, based on some form of personal experience, however 
distant, is perfectly natural, even if illogical, and does impact on levels of confidence in 
the somewhat impersonal, population-based presentation of risk that currently 
predominates within health protection risk communications.  
 
This confidence is further shaken where individuals also recall experience of the 
fallibility of health professionals or the systems within they work: 
 
‘Cause I mean I remember them saying back then, the live vaccine they reckon that’s 
what caused most of the polio, was a child taking the live vaccine. Yeah, and the guy 
he developed it, he well, apparently it was the same, he made a mistake’ (Interview 5, 
M, 47, S, N(S))  
   
184 
 
‘[Child] had a very strong reaction to the polio vaccination. The doctor’s response was 
that this had not happened because no-one had ever reported it before – so he wasn’t 
going to report it.’ (Survey Response Ref 6, F, 37, S, N) 
 
These concerns further reinforce the findings of the previous section – that parents 
appear to evaluate the perceived dangers of MMR, not in general terms, but in relation 
to their individual assessment of the child’s particular vulnerability to any adverse 
effects of the vaccine. However, the evidence examined in this study suggests that this 
view is also influenced by family history and the parent’s own experience of being 
vaccinated, and that these factors are highly relevant in a parent’s assessment of the 
possible risks associated with accepting MMR and other vaccines.  
 
6.3.1.4 Health professional and professionally trained parents and assessment of 
risk 
There is an assumption in much of the existing literature that an individual’s social and 
professional roles can be to some extent compartmentalised (with all health 
professionals, for example, being expected to be willing and able to be acceptors of 
and accurate disseminators of national immunisation advice) (Leach & Fairhead, 2007; 
Leask et al, 2012). Indeed, the recommendations from many studies habitually return 
to the issue of addressing professional concerns by simply suggesting that the 
educational knowledge base of these individuals needs to be improved (Smailbegovic 
et al, 2003; Wood-Harper, 2005; Leask et al, 2006). 
 
However, what became clear in this study was that professionals social roles as 
parents, grandparents, uncles and aunts are highly significant. They are part of the 
communities that are debating these controversies and concerns, they are subject to 
the same social and political interactions as other parents, they have vested interests 
and they harbour similar doubts. They have access to a wider range and complexity of 
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information sources and they are expected (as part of both their professional and lay 
roles) to accept, understand and disseminate this information to others, but they also 
often experience considerable conflict within and between these multiple social roles 
and do not always act in the way that is expected of a health professional. 
 
Four of the 20 interview subjects identified themselves as health professionals, and 
most were in highly influential positions. None of these participants were prepared to 
accept MMR and two had refused all immunisations for their children. The reasons 
given either mirrored those of their contemporaries, in relation to risk, or were a further 
extension of those rationales that had used elements of scientific evidence and 
professional experience to build apparently evidence based, but factually incomplete or 
incorrect, arguments. For example: 
 
‘I was concerned about the whole idea of vaccination programmes when I read about 
it, and I’ve got a nursing background as well, and I looked at the immune system and 
how it worked and how it developed, and I breastfed them as well. So I had my own 
immunity when they were babies…So I certainly wasn’t at all concerned when they 
were babies. I was also aware of herd immunity and so the likelihood of them actually 
getting any of the diseases was quite slim.’ (Interview 10, F, 49, P, Y (delayed)) 
 
These views appear to be endorsed and reinforced by other colleagues in the 
workplace both in terms of confirmation, or by the lack of challenge by other 
colleagues:  
 
‘Being from a medical background anyway, I spoke to colleagues who also had 
children of the same age who also said “well unless we can have it done separately 
we’re not going to risk it.”’(Interview 14, F, 36, P, Y) 
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Interviewee 14 also recalled a discussion with her GP, and wondered whether he 
‘would have responded to her in the same way had he not known she was a nurse?’  
Similarly, Interviewee 10 mentioned that her Midwife and GP also ‘knew her 
professionally, to a degree’, and suspected that they did not ‘put as much pressure on 
her to change her mind’ as they might otherwise have done. 
 
Healthcare workers when responding to the concerns of friends are equally unlikely to 
challenge negative ideas about immunisation as robustly as other parents, especially if 
they are in the minority, for fear of damaging their personal and social relationships. 
This lack of challenge and tacit endorsement of these rationales then continues to 
perpetuate feelings of doubt amongst their wider social networks: 
 
‘A friend…she’s almost in a medical profession and she won’t let any of her children be 
immunised for anything….they’ve had no jabs, nothing. She’s so anti it and I don’t 
actually know why (laughs). I wouldn’t mind asking her why, but I won’t cos I just know 
that she’s dead against it and it’s those sorts of things makes you think, “I wonder what 
she knows?”.’ (Interview 12, M, 48, P, Y) 
 
These social factors are significant in that, in policy terms, this potentially impacts on 
considerations of the reliability and effectiveness of health care workers as a source of 
advice for other parents, especially given the potential for these individuals to be highly 
influential, not just as professional advisors, but also as knowledgeable friends and 
social acquaintances.  Whilst accurate information is vital, education and training is as 
unlikely to address the concerns of these professionals as it is to resolve those of 
parents in general. Most immunisation sessions for professionals remain primarily 
didactic, information-giving exchanges. They rarely provide opportunities for an open 
exchange of ideas or for challenge in a non-judgemental environment. If, as has been 
evidenced, parents and professionals both formulate their decisions in a similar way 
187 
 
through social talk, then everyday interactions with other health professionals, and with 
parents, all have a significant part to play in influencing the outcome of parent’s 
immunisation decisions This evidence therefore suggests that there is a need to 
reconsider the purpose of professional ‘education’ forums and to instead provide 
opportunities for more open discussion in respect of immunisation in a safe 
environment regardless of their area of work.  
 
6.3.2 Vaccine overload 
All of the groups of parents within this study made reference to the concept of ‘vaccine 
overload’, and to the fact that they felt that multiple antigen vaccines such as MMR 
were ‘too much in one go’. Specific mention of this was also made by 16 out of the 20 
parents who were interviewed. This confirms previous findings widely reported in the 
literature (Offit et al, 2002), and as discussed in Chapter 3, that the idea of the immune 
system, its development, and its ability to cope with multiple assaults, appears to be 
central to how these parents conceptualise their individual child’s health.  
 
Evidence that parents make individualised assessments of health has already been 
established in 6.3.1, as has the principle that parents use these assessments to frame 
their thinking around child rearing by building on their child’s strengths and limiting their 
vulnerabilities in order to protect them from  illness. In light of this, the key concept 
underpinning concerns about ‘vaccine overload’, confirmed again here, appears to be 
a perception that the immune system needs time to mature in order to be able to ‘deal 
with’ immunisation. As a result, babies are considered to have ‘weak or undeveloped 
immune systems, but as children get older, and therefore ‘stronger’, both they and their 
immune system are better able to cope with the stress of these interventions: 
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 ‘I think like puppies and babies, all new-borns, um, their immune systems are so 
vulnerable. Because they’re brand new and they suddenly have all this stuff thrown at 
them, dirt you know and everything that’s going…and I just thought “No, this is the last 
thing that we need to do to an immune system that is still developing, is throw some 
more stuff at it that it’s got to cope with”, if it can wait ‘til later when they’re older and it’s 
developed and settles (Interview 5, M, 47, S, N) 
 
Parents also find immunisation a counterintuitive activity. Parents are told that infants 
require protection from many common hazards to enable them to survive and thrive 
and, against this backdrop, it is perhaps not surprising that many parents harbour the 
belief that the immune system needs to be nurtured and trained to enable it to be 
slowly built over time, and that they are so concerned about the use of multiple 
vaccines which they perceive as increasing the risks associated with the vulnerability 
of the child and the possibility of adverse reactions: 
 
‘You think, they’re small and you’re shoving all this into them, you know it can’t be, 
surely it can’t be good for them’ (Interview 17, F, 45, P, N) 
 
While this issue is very well reported in the literature, parents reported that these 
concerns had never really been challenged by peers or by professionals. When asked 
about this in the interviews, they typically responded that: 
 
‘Nobody did. Nobody ever sat me down and said, “Well, why do you think your babies’ 
immune system can’t cope with it? Because we think it can and here’s why…” Nobody 
ever said that to me.’ (Interview 9, F, 39, P, N(S)) 
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6.3.3 The role of the Media  
Many of the respondents to this study were highly influenced by the media, referring to 
the ‘huge coverage’ and ‘all the furore in the press’ (Interview 7, F, 47, P, Y / Interview 
14, F, 36, P, Y). They also reported feeling ‘bombarded daily’ and being ‘scared 
witless’ by ‘very alarmist’ reports (Interviews 1, 4 and 16). A fundamental difficulty for 
parents in these situations was that, while school teaches you to analyse books and 
pictures, no one actually tells you how to make sense of the news and parents 
therefore find making sense of media debates on health issues particularly difficult: 
 
‘It’s because they take over everything…I know you shouldn’t listen or read 
everything… or believe everything you read, but it’s difficult when they’ve got a way of 
putting it over to you…and that’s what they’re trying to do isn’t it?’ (Interview 8, F, 44, 
P, N) 
 
Parents who had opted for single vaccines (142 references) appeared to have been 
the most influenced by popular media coverage, and many made frequent reference to 
TV programmes such as ‘Richard and Judy’ which gave considerable air time to parent 
pressure groups, and to supporters and owners of ‘single vaccine clinics’. Much of this 
was justified by these programmes as being necessary in order to provide information 
that was unbiased; however, journalists gain their credibility from being viewed as 
ordinary members of the community and as parents themselves, with their own 
concerns and doubts. It is difficult to be neutral and still engage parents in an unbiased 
way in these situations. As a result, many of the parents interviewed for this study 
confirmed that they did ‘get incredibly influenced by stuff like that when it’s in the 
media’ (Interview 9, F, 39, P, N(S)) and some reported that they had actually been so 
influenced that they had ‘phoned the clinic featured on the TV straight away and made 
an appointment for single vaccines’ (Survey ref 48, F, 41, P N(S)). 
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Parents who held natural health beliefs, however, had very different ideas in respect of 
the mass media and reported that it had very little influence on their decision-making, 
what was of more significance for these parents was the potential link to politics, to the 
state, and the role of the ‘Government press’ within that. Parents in this group were 
found to be far more cynical about any press reporting and about the validity of claims 
made by either side of the debate: 
 
‘Of course then he went public and basically said it was a whole pile of rubbish, which 
then made you think it’s probably one of those conspiracy theory things…Was it 
something that his hand was forced to make him do that to try and get people to have 
the MMR because his career was on the line? There was no real explanation as to why 
it happened, so…..’ (Interview 4, F, 44, P, N) 
 
Whilst the media appears to have been highly significant in the decision-making 
processes, particularly of those parents who opted for single vaccines, the media as a 
means of bridging these opposing views now appears to have limited relevance, both 
for parents who have not personally experienced the controversy and for those who did 
but remain unconvinced. In fact, to continue to fight this out in the media is considered 
to be counter-productive by most parents, who argue that open dialogue offers a much 
more acceptable way forward: 
 
And I just think that advertising if you remember that it was on the telly, was really 
harsh and to scare you…it could’ve gone a long way to laying down an awful lot of 
parents fears. And if they’d addressed that instead of saying “oh no, no, no, no, no, no” 
and, you know, brushing parents’ concerns away, and been more open about it then 
you probably would’ve found an awful lot more parents would’ve gone for all the jabs’ 
(Interview 20, F, 41, P, Y). 
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6.3.4 Single Vaccines and Parental Choice 
Access to single vaccines was found to be a common issue for the study participants. 
Seven of the 20 interviewees had opted for single vaccines and an additional two 
would have done so, but could not obtain them for their children. There were 551 
references to them in the interviews, 678 in the Section 5 survey comments and 1303 
additional free text comments within the survey responses. The debate is, however, 
essentially an extension of the arguments in relation to parental choice and the two, 
whilst slightly different were found to be inextricably linked within the analysis of the 
data.  
 
Parents who confirmed that they had opted for single vaccines (259) did not espouse 
strong alternative beliefs, but instead generally expressed more liberal political views 
with an emphasis on personal and collective responsibility: 
 
‘Yes I mean immunisation, I think it is absolutely the most brilliant thing and not only 
does it protect your child, but it also protects the population. It’s kind of a good full 
circle – if everybody gets them immunised it really does work’ (Interview 7, F, 44, P, Y)
  
Perceived vulnerability was again cited as a key factor in the assessment of risk for the 
parents of children who had single vaccines, with many parents (73) also making 
reference to pre-existing medical conditions as a rationale for their choice. These 
parents were almost universally traditional acceptors of immunisation, and continued to 
strongly advocate the benefits of immunisation in their survey and interview responses: 
 
‘I think that’s why I chose not to not vaccinate [child], even though there was the furore 
going on I chose to vaccinate them because I genuinely believe that immunisation is a 
very good thing’ (Interview 1, F, 38, P, N(S)) 
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This situation therefore posed a considerable dilemma for them because it challenged 
their secure beliefs in a service which they had previously strongly supported. They 
wanted to be compliant, but felt frustrated by the perceived inflexibility of the system, 
especially when an alternative option existed that had previously been approved for 
use within the national schedule (Interviews 1, 5, 7, 9, 16, 18 and 20). It is true that 
single vaccines were available in 1970s and 80s, but the impact on disease incidence 
was limited (see Appendix 2). Policy makers also had concerns that parents may not 
complete the full course of immunisations, or that children may be at additional risk of 
acquiring disease in the gaps that are necessary between doses of immunisations 
(Ramsay, 2002). 
 
Parents who had chosen single vaccines were all able to produce records of their 
child’s private vaccinations, and had shared these with their GP to ensure that their 
child’s medical records were complete. They had also shown considerable physical 
and financial commitment in completing the courses, often travelling hundreds of miles 
and spending hundreds of pounds per child to do so. As a result they were indignant 
about the official rationale for not providing single vaccines (as evidenced above) and 
did not agree that this warranted any restriction of their individual personal choice. In 
fact, many of these parents (commented on the complete irresponsibility, and lack of 
logic, of a system which extolled the virtues of immunisation, but whose intransigence 
and unwillingness to compromise potentially left children unprotected: 
 
‘If the government is so concerned about these diseases they should make the single 
jabs available, even if the recipient has to pay a fee or a contribution towards the cost.  
Providing no alternative verges on the negligent’ (Survey Ref 49, M, 52, P, N(S)) 
 
This created not just frustration, but significant levels of anger, feelings which have 
persisted over time, and which have had an enduring impact on relationships between 
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these parents and professionals long after their concerns about MMR subsided. In the 
absence of other medical co-morbidities, parents who had opted for single vaccines 
reported that, if they had not been able to access these, they probably would have 
accepted MMR (Interviews 1, 5, 16) – but that anger at the attitude of health 
professionals, and the complete lack of open engagement or dialogue, acted as a 
block to parental compliance: 
 
‘I dragged myself kicking and screaming to that point because I was so resentful of the 
approach that I felt the Health Service took…I felt patronised and angered, I still do, 
and that really stopped me from doing anything for a long time – SO THERE!!!!’ 
(Survey Ref 62, F, 42, P, N(S)) 
 
Concerns about pharmaceutical industries do exist for parents who opted for single 
vaccines. However, they appear to have been evoked simply by frustration at the lack 
of choice and would not necessarily impact on any future considerations in relation to 
other immunisations. However, for parents who hold natural health beliefs, the 
perception of the industry’s manipulation of the manufacture, distribution and 
regulatory frameworks which control the supply of vaccines appeared to form a 
fundamental socio-political aspect of their immunisation decision-making pathway and 
this is considered further in section 6.3.8.  
 
In terms of parent choice and decision-making, in most cases (647 / 700), the parent 
who responded to the study survey and/or was interviewed had been instrumental in 
making the decision. While some partners had become actively engaged in the 
decision-making process, for many the process was one of passive acceptance and 
tacit support of the dominant partner’s decision-making. For others, there had been a 
process of negotiating or rationalising the decision, influenced sometimes by events or 
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more frequently by research undertaken by one or other of the parents. As a result 
there was little disagreement between parents of children included in this study: 
 
‘I think we were agreed, yeah I mean, I think probably if I’d had the children 
immunised, I think he probably would’ve gone along with that as well quite honestly…I 
don’t know it’s a bit like I’ll let him to sort the car out and he leaves me to sort the kids 
out’ (Interview 10, F, 49, P Y). 
 
Birth order was also found to be of relevance, with levels of anxiety and non-
compliance being reported to be highest for parents of first children (14 of the 20 
parents interviewed). However, this was slightly more nuanced than first appeared, 
with some parents (18) justifying their MMR choices by reference to a perception that 
their male first children had ‘weaker immune systems’ or were ‘less robust’ and 
therefore as having been less able to cope with immunisations such as MMR:  
 
‘Um, the girls are OK, but they were very healthy.  They were very healthy babies, 
there was nothing in there whereas he wasn’t, he was very sickly, so I just wouldn’t 
have ... I didn’t risk it’ (Interview 14, F, 36, P, Y) 
 
6.3.5 Other medical comorbidities 
In the previous sections the interactions between social perspectives and personal 
experience has been demonstrated to be a key influence on decisions to accept or 
decline immunisations, including MMR. A significant proportion (32%) of the survey 
population and 10 of the 20 interviewees were parents of children with disabilities or 
pre-existing medical conditions.  Whist this group of parents shared many of the 
anxieties of other parents as already described, for these parents there were also 
additional considerations which brought their concerns about immunisation into even 
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sharper focus. Some of these considerations were the result of more extreme personal 
experience, but others involved a much more reflective process, and some were quite 
pragmatic given the circumstances these parents found themselves in. These 
additional considerations will be explored in this section. 
 
Parents of children with medical conditions or disabilities were often found to have 
arrived at their decisions through a very different assessment of relative risks, 
reflecting not only their previous experiences of disability, ill-health or immunisation, 
but also previous outcomes when they had accepted assessments of an event being 
considered a low risk medical probability: 
 
‘Yeah, I would still have chosen the same decision because…to me it felt like there 
was a risk…and because we’d already had something go, you know, something 
happen, I didn’t want it to be me taking that chance, whereas I probably would have 
taken that chance otherwise’ (Interview 11, F, 44, P, Y) 
 
For many (164), the act of delaying their child’s immunisation was directly associated 
with the progression of their child’s disease, for example, related to waiting for breaks 
in courses of treatment (Survey ref 26, F, 45, S, Y) or confirmation of diagnoses 
(Interview 20, F, 41, P, Y). For others (63), there was an acute awareness of the 
possibility of a developmental disability occurring as a result of prior family history, and 
therefore a rational desire to avoid falsely attributing the occurrence of such a disability 
to the vaccine: 
 
‘The reason I had the MMR later for my child was because of family circumstances. I 
have a mentally handicapped brother with a brain age of approx. 2 years, he also has 
autism. I also have an uncle with similar disabilities…We made the decision to have 
our child vaccinated when she was older, so that we knew she was completely 
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healthy…I needed to know that if anything was the matter with my child that the MMR 
was not to blame’.(Survey ref 11, M, 52, P, N(S)) 
 
Parents of this group of children also referenced the contemporaneous impact of other 
medical interventions on the child, particularly in relation to the timing of immunisations 
as being a significant influence on their decision-making: 
 
‘I mean she wasn’t poorly, but I mean she had…you know, two big operations, um, and 
this stupid great big plaster cast and everything, um, and it was a really difficult time’ 
(Interview 18, F, 38, P N(S)) 
 
These parents also reported declining MMR to be have been directly related to the fear 
of the possibility of further adverse events occurring at that time: 
 
‘I didn’t want anything else to happen if you know what I mean. I thought at the time 
they had had enough and I didn’t, you know, I was scared, I was unsure so I just didn’t 
do it’ (Interview 11, F, 44, P, Y) 
 
But this fear often had a very practical basis, and the decisions were often pragmatic, 
balancing a known uncertainty with another that is as yet unknown: 
 
‘I did not give my son the MMR jab because I have a handicapped second child, a 
daughter. She has cerebral palsy – she was damaged at birth through lack of oxygen. 
We found out later that the midwives went on a tea-break and we weren’t looked after 
properly. So when they said that MMR might be connected with autism I found it very 
hard to let my son have the MMR. I would have found it very difficult to look after two 
disabled children.’ (Interview 12, M, 48, P, Y) 
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Parents almost universally reported apparent disconnect between their own needs and 
concerns and the level of support received from health professionals involved in 
immunisation. This resulted in a perceived lack of sensitivity by parents of sick or 
disabled children. One respondent summarised the most important thing that could be 
done to improve services as: ‘to have an understanding of the position of parents who 
have children with disabilities or special needs’ adding: 
 
‘The Health Authority we lived in when my eldest son was born regarded us as 
statistics and didn’t understand why we might have reservations whilst still holding 
concerns about leaving our child unprotected’ (Survey Ref 12, F, 42, S, Y). 
 
Another recalled receiving the standard leaflets and thinking: 
 
‘they’re sending me really horrible umm leaflets saying ‘this is what could happen to 
your child’ and you just think, you know, we’ve got enough trouble keeping him alive, 
we don’t need to have this hassle as well.’ (Interview 20, F, 41, P, N(S)) 
 
While such concerns might be expected to result in parents completely declining MMR, 
the reality is that for the majority immunisation is something which they value, and 
which they actively desire for their children. As a result, almost all the children who 
were not truly medically contraindicated had either had MMR at a later age (173) or 
had opted for single vaccines (68), or had had both. In fact, many of these parents (52 
references) were quite indignant at being included in the survey with its implication that 
they might be bad or non-compliant parents: 
 
‘I was slightly annoyed at being labelled a ‘non partaker of immunisation’ when all my 
children have had their inoculations. My youngest child had nephrotic syndrome but he 
has been inoculated when a break in his drug programme had allowed it to be done 
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safely and with lessened risk. At no point would I have not considered inoculation.’ 
(Survey Ref 6, F, 41, P, Y) 
 
Within this wider group of medical conditions, children with allergies and/or other atopic 
conditions seem to require different consideration. The parents of these children 
shared some of the concerns of those whose children had various disabilities, but they 
also had other concerns which were much more aligned with parents who adopted 
natural/holistic approaches to parenting, often as a result of having to try other 
remedies and dietary approaches when traditional medical treatments offered little 
improvement in their child’s condition. These parents typically had anxieties about the 
child’s immune system being ‘already weakened’ by allergic conditions, and fear that 
this might make them more susceptible to any adverse effects: 
 
‘At the time he had all these allergies and we didn’t know what the allergy was and …I 
thought to myself “Well you know, if he’s weakened already with eczema and asthma it 
is putting everything at once into his weakened system, is that going to, um, is it going 
to work? And what could that trigger”’ (Interview 19, M, 49, P, N) 
 
This resonates with the wider public concerns about how the immune system works, 
and is further complicated by the fact that being ‘immune-suppressed’ is identified on 
parent information as a contraindication to immunisation (Department of Health, 2013) 
but parents and professionals interpret what this means for these children from 
different knowledge bases and perspectives and come to different outcomes in relation 
to risks associated with accepting or declining immunisation. This uncertainty and 
confusion is of particular relevance where conditions, such as coeliac disease, are 
referred to as having ‘autoimmune’ components: 
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‘As coeliac disease is an auto-immune disorder, although he is fit and healthy we were 
not happy with the possibility of compromising our son’s health by allowing him to have 
MMR – it states anyone with immune conditions should not have it. We appreciate that 
coeliac disease is an auto-immune disorder but it is still to do with the immune system 
and therefore we are not prepared to take the risk’ (Survey Ref 26, F, 39, P, N)  
 
Finally, parents of children with serious illness or disability often have a very different 
social and parenting experience than other parents. They often find themselves 
marginalised and stigmatised (Slade et al, 2009) and, as a result of this, their social 
networks often consist of other parents of children with similar disabilities or conditions, 
whether through special schools, hospital attendance, or attendance at specialist 
support groups. By coming together in these potentially skewed populations, parents 
can get a distorted impression of the incidence of such diseases and disabilities. They 
are also more likely to be exposed to parents who may have compelling stories about 
the cause of their problems, for example a link to MMR, and are inclined to reflect on 
the similarity of their own situation when making their immunisation decisions.  
 
These are significant issues when considering how to apply the findings from this study 
to improve the impact of immunisation programmes. Transitional periods such as 
school entry and transfer to secondary school, as well as piggy-backing checks onto 
other interventions such as those associated with the 5 – 19 Healthy Child Programme, 
offer opportunities to interact positively with these young people and their parents, and 
to complete immunisation on a ‘never too late’ basis.  In addition, there is a need for 
better recording of medical conditions and disabilities by the CHIS systems so that 
professionals can be aware of the child’s condition and adopt a more individualised 
approach in practice.  
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6.3.6. More support required from Health Professionals 
The previous section has highlighted that parents of children with medical conditions 
quite clearly feel that they require more support from health professionals, both 
generally, and specifically in relation to managing decisions in respect of immunisation. 
Parents who participated in this study, as a more general group, commented that what 
would help them to make decisions would be ‘more information from professionals’ (64 
references) and this seemed to align neatly with the knowledge ‘deficit’ models that 
underpin much of current immunisation policy (Pareek & Pattison, 2000). However, 
closer unpicking of this with the interviewees revealed that what all of them, with the 
exception of those who chose alternative lifestyles, wanted was actually more support 
from professionals in making what they considered to be very difficult decisions 
(Interviews 5, 8, 9, 11, 13, 14, 15, 16, 19, 20). There are also significant differences 
between what they want to receive and how they want to receive it, and the ‘what’ and 
the ‘how’ that health professionals currently deliver within local and national 
immunisation services.  
 
Parents reported that the information they receive from professionals is often 
inconsistent, confusing and varies between professional sources even within the same 
GP practice (Survey Ref 1, F, 51, S, N; Survey Ref 2, F, 38, P, Y; Interviews 6, 9 and 
16). Parents constantly emphasised that what is needed is for them to have 
information explained, to have an opportunity to discuss what it means, and then to 
have time to consider this before making a decision: 
 
‘It’s a question of having had the information, having the time to talk to other people 
about it and having time to let it sink in….’  (Survey Ref 2, F, 38, P, Y), 
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This further supports the finding that these parents make their decisions by ‘talking 
through’ their concerns, and that decision-making is achieved through a process of 
social interaction. However, the experience of the majority of respondents was that 
there were few opportunities for this type of interaction with health professionals and 
instead the process of receiving immunisation was felt to be almost impersonal: 
 
 ‘You know, I mean you can make an educated decision if you, if you’re sensible about 
something like this ‘cause it’s very important, but what I found is, I was just not getting 
an educated answer... a decent adult conversation from any of the health service 
really, yeah, that would’ve helped definitely’ (Interview 5, M, 47, S, N) 
 
Effective social interaction requires the establishment, on some level, of a personal 
relationship. Professional / patient relationships featured highly in parents’ responses, 
with some evidence of a correlation between previous ‘bad’ relationships’, or ‘bad 
experiences’, with professionals and decisions to decline. Some parents reflected that 
if they’d had a completely different GP, they ‘may have treated it very different at the 
time’ (Interview 6, f, 50, S, Y). They were also very frustrated when professionals failed 
to engage: 
 
‘Well…when you went and asked the health visitor, the um nurses or the, um, doctors, 
all they did was give you a leaflet’ (Interview 4, F, 45, S, N)  
Or,  
 ‘It would’ve been nice to have had some support from the local health authority to say 
well actually we understand why you can’t have it, instead of having really horrible 
snotty cards every 6 months’ (Interview 20, F, 41, P, N) 
 
Conversely, where parents had changed their mind and had subsequently accepted 
MMR, they referred to professionals being ‘very good about it’ and ‘he listened to me’ 
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(Interview 12, M, 48, P, Y) – or reported that they were able ‘to have a different 
conversation with her so that I did look at it from both angles’ (Interview 2, F, 45, S, Y). 
 
The pragmatics of delivering population-based immunisation programmes plays a 
significant part in limiting the scope of these patient/professional interactions. However, 
social talk has been found to be a very salient factor for the parents in this study. If 
they do not get it from professionals, they will seek it elsewhere – for example, from 
unregulated internet chat rooms and blogs. At first sight, this kind of interaction with 
professionals appears too resource-intensive and impractical; but it involves relatively 
few parents, and should be considered in relation to the costs in time, resources and 
reputation of outbreaks and of catch-up campaigns.  
 
Parents are no longer passive recipients of healthcare, they expect, and increasingly 
demand, personalised pathways for both health and child care. They are also being 
encouraged to be more proactive about their health: 
 
‘The fundamental point is, it’s your body…and the more you understand about the 
drugs you are taking, or what you might be able to have, the better you are able to 
work with your doctor…It is essential for the future of the health service and for the 
future health of the nation, that patients understand their conditions, their treatments, 
and work with health advisors so that they can have the best care.’ (Haslam, Chair of 
NICE, 2013) 
 
Current immunisation services seem out of touch with this change, and need to 
embrace the concept of the patient as consumer. One respondent commented that 
when you go looking for any other service, or want to buy something, you speak to 
someone in the shop, you get a chance to look at the product information, and you talk 
to your friends about what they chose and why. After all, ‘you wouldn’t buy a washing 
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machine if you did not know what it did, would you, you’d want someone to tell you and 
to know it was the best for the job!’ (Interview 9, F, 39, P, N(S)) 
 
It is clear that parents who decline are a minority; but small numbers matter, and the 
difference between meeting target uptakes and failing to do so is shown to depend on 
just a few patients per month for each GP practice in Somerset (Vaccine and 
Immunisation National Support Team, 2011). Parents do change their mind, and the 
evidence from this study is that they are more likely to do so when there are 
opportunities for the small number of parents who have doubts to explore these 
through active, meaningful, ‘adult’ conversations: 
 
‘I think maybe if you have somebody who is sort of not sure about it or doesn’t want to 
go ahead with it, say “I’ve got a number of parents like you, can I get you to come 
along and have an informal group discussion, or just have a talk, um, so that you all 
are clear why you’ve decided against it, and to see if we’ve missed anything” Um, 
possibly if I’d been offered that I would have gone along, I probably would have gone 
along and I would’ve listened’ (Interview 8, F, 44, N) 
 
6.3.7 Medical Models, Politics and Health 
A specific strand of enquiry, when interviewing parents as part of this study, was to 
establish what their opinions were in relation to the societal principles of personal 
freedom versus social responsibility, and how this affected their decisions to accept or 
decline immunisation.   
 
Parents who advocated alternative therapies strongly articulated the importance of 
individual responsibility for their personal health and for their childrearing practices, 
and the importance of maintaining personal resilience through the adoption of healthy 
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lifestyles and natural remedies. They rarely expressed any concerns about 
responsibility to the wider society, often referring to the choices made by others as 
being at the root of those particular individuals’ problems. These opinions were framed 
in the context of alternative lifestyle choices, and this group of parents expressed 
negative views concerning the role of the state in family and personal life.  
 
Having taken personal responsibility in making a decision to decline MMR, parents in 
this group felt patronised by NHS health professionals, and felt that their individuality 
had been overridden, especially when they repeatedly received invitations for their 
children: 
 
‘I was so resentful of the approach that the Health Service took in dealing with people’s 
personas…I felt patronised and angered. They never actually came and said “Why 
haven’t you? We’d be interested to know why you made this decision” and I think they 
should have been supporting my freedom to make this choice, but instead I just got all 
these reminders saying “Oh we’ve made another appointment for you” and just kept 
getting all these cards through…’ (Interview 5, M, 47, S, N) 
 
This approach just served to alienate them further from mainstream policy 
recommendations and to increase their confidence in their personal convictions: 
 
‘It was made very clear that they would prefer me to have my children immunised, yes. 
Um, but that’s what I would have expected from them because that’s what they do…it’s 
a bit like you know an evangelical minister is going to preach to people that his way of 
life is the way to live, um, so somebody who works in the NHS and does immunisations 
all the time is of course going to be concerned to discover that none of your children 
have been immunised and try to persuade you otherwise. But yeah, I mean, that’s fine 
I knew what I was doing was right.’ (Interview 3, F, 42, P, N) 
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Some parents, particularly those who had opted for, or who would have preferred the 
option of, single vaccines, seriously considered the issues of social responsibility, and 
felt anxious that they were not exercising options which enabled them to have the 
freedom to choose while protecting their fellow citizens: 
 
 ‘It’s really difficult, because you’ve got your own child and their wellbeing is 
paramount, but then, you know, if somebody else was to put your child at risk in that 
situation then you wouldn’t be very happy about it…it comes down to the dangers of 
the disease and if your child is going to be able to catch it from somebody else who 
hasn’t had it, you know, you really ought to vaccinate your own child so that they don’t 
spread the disease too…I mean…we’re all part of a bigger society aren’t we?’ 
(Interview 20, F, 41, P, N(S)) 
 
Others, often those who had just declined or delayed MMR, openly reported that they 
depended on the social conscience of others and therefore the principle of ‘herd 
immunity’ to enable them to abdicate responsibility for making any decisions. But in 
doing so, they recognised that there were significant limitations to this approach: 
‘Oh, taking a very selfish view, most other people were having their children immunised 
against it, so it seemed there would be little risk of them catching the three diseases 
that they were being vaccinated for. So I felt fairly safe in leaving it until they were 
older…then if we all did that, nobody would get their kids immunised would they?’  
(Interview 9, F, 39, P, N(S)) 
 
All these parents recognised that their decision-making was very subjective, and had 
sufficient insight into the process to recognise the conflict between their collective 
responsibility as ‘responsible citizens’ and their personal responsibility to their child. 
Invariably, the parents’ rationales ensured that consideration of their responsibility to 
their child took precedence over any sense of collective responsibility.  
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This suggests that using the concept of ‘herd immunity’ in order to appeal to the social 
conscience of MMR decliners (as suggested in Chapter 3) will have little effect, and 
that maximising the dialogue around potential benefits to the individual child, especially 
those relating to children with medical co-morbidities, would be a much more 
productive strategy. In fact, the concept of ‘herd immunity’ itself implies, by default, that 
a decision to immunise is not right for some children, and this actually reinforces the 
decision-making pathways of some groups of parents. As one parent stated: 
 
‘If the philosophy behind immunisation is that it is for the greater good, this implies that 
occasionally some children might be harmed to achieve this. As a parent, your child is 
the most important child to you. This will always lead to a conflict of interests between 
parents and medical professionals’ (Survey Ref 31, F, 40, S, N) 
 
A frequent complaint articulated by parents who did not follow the accepted national 
schedule, was that they felt coerced by an inflexible health system and pressurised by 
the heavy handed tactics of unsympathetic health care workers: 
 
I want not to be treated as if I am ill-informed or irresponsible when not taking the 
MMR. I have been lectured by a GP and a GPs receptionist looks down her nose…I 
want not to feel pressurised or bullied into making decisions …or to be made to feel 
stupid if they don’t agree with my decision’ (Survey Ref 8, F. 42, P, N) 
 
Lack of respect by health professionals for alternative points of view was almost 
invariably found to be counter-productive: 
 
‘And he said “Don’t read anything about them”. He said “They’re just terrorists”. And I 
always remembered that (laughs) and I looked at him. He said “They’re medical 
terrorists”, and I thought ok, but you know I am quite intelligent, I took it, I took 
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everything on board…but I think it was the terrorist comment, “Don’t believe a word, 
they don’t know what they’re talking about” and I’m thinking, these people have done 
their research. Their children are affected… and I think it turned me off the 
MMR…having that said by a GP’ (Interview 6, F, 50, S, N). 
 
Trust was a concept raised by many parents and intrinsically linked with concerns that 
health professionals may not always be acting in the best interests of their patients. 
These concerns were invariably evidenced by reference to financial incentives being 
paid to doctors for administering vaccines, or for reaching particular uptake targets. 
Issues of trust also, however, related to more general contexts – lack of trust in 
government, or in the institutions that decide government policy in respect of 
immunisation: 
 
‘I mean at the end of the day it’s a great business isn’t it ‘cause it’s a licence to print 
money isn’t it…it’s about you know how you have these drugs that are allowed to be 
used and then you find out that well actually the people who did the research worked 
for the bloody pharmaceutical companies, or they paid for the research, they can 
choose which, you know, the ones that give the results they want, oh we’ll let everyone 
see that but we won’t let them see the other results you know, how are you meant to 
trust these people?’ (Interview 5, M, 47, S, N)) 
 
Vaccine manufacture involves the application of global technologies and the 
mobilisation of global assets and resources and the development of new vaccines are 
therefore high on national and international policy agendas and necessarily involve 
relationships between pharmaceutical companies and local, national and international 
governments (Leach and Fairhead, 2007). Parents’ concerns about the economy of 
vaccine production are invariably linked to the power and political influence of the large 
208 
 
multi-national companies that oversee the mass production of vaccines in their 
societies: 
 
‘Yeah well, I mean I can’t see me ever trusting politicians or corporations ever, I mean 
politicians are only there because of the corporations anyway basically ‘cause they’re 
the ones that pay to get there and run for, you know all these millions that they, you 
have to spend to get them voted in I mean the whole lot of them should be locked up 
shouldn’t they really or you know, they should’ (Interview 3, F, 42, P, N) 
 
A final element of relevance to this theme was the comparative experience of parents 
who had accessed immunisation services in other countries, with that experienced in 
the UK. Key issues highlighted were the impact of societal normalising of immunisation 
on parents who had previously declined, and as part of this, the role of compulsion, 
which itself acted in many ways to normalise parental behaviour in many of these other 
countries: 
 
‘and then, you know, you go to a different country and it’s just not even an issue. I 
suppose it made a big difference ... yes, potentially.  Yeah.  Probably was.  It wasn’t in 
the forefront.  It wasn’t there staring you in the face, you know, wasn’t being talked 
about all the time …when we went to France I think it did change things because it just 
...you just had it done.  It wasn’t queried and they didn’t query it’   
(Interview 6, F, 50, S, Y) 
 
It should also be noted that parents living in the UK, but who originated from other 
countries, often reported that they continued to access immunisation services for their 
children on visits back to their native country and according to the schedules of these 
countries On occasion this had resulted in differences in the reporting and 
understanding of the child’s immunisation status where the parents considered the 
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child to be up to date according to their home schedule, but UK systems considered 
them not to have completed the programmes appropriately or at the correct times.  
This is relevant when considering the impact of small numbers, and of data accuracy, 
on local uptake rates, especially where there are large ethnic minority populations. 
 
6.3.8 Natural therapies and Holistic Approaches to Health Care 
Four out of 20 of the parents interviewed had refused all immunisations; a further two 
had rejected the majority of immunisations, including MMR, but had accepted some 
because of specific perceived risks to their children (tetanus from horses for one, and 
polio from swimming for another). All of these parents articulated very strong 
alternative health beliefs and refusal of immunisation in these cases was not limited to 
family members, but also extended to family pets.  
 
In addition, reference was made to natural health or alternative therapies by a further 
two of the interviewed parents who had declined MMR and by 15 of the survey 
respondents. None of the parents who had refused all, or the majority of, 
immunisations had changed their mind at the time of the interview, and all made it very 
clear that they had no intention of doing so in future. In fact a common feature of this 
group of parents was their confidence in the decision that they had made when 
compared with those who had delayed or opted for single vaccines.  
 
Parents who subscribed to alternative health beliefs in both the interviews and the 
survey responses described a number of consistent views in relation to immunisation. 
These include the perception that infectious diseases were already declining before the 
advent of mass immunisation, and therefore the claims made by medicine for the use 
of this intervention were a myth: 
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‘You know if you look at statistics and things about when immunisation came in in the 
50’s and 60’s, all these illnesses were already going down anyway, a lot of it, I read so 
much stuff saying it was basically sanitation, better diet and all those sort of things, 
that’s why kids weren’t getting ill, not immunisation at all’ (Interview 5, M, 47, S, N (S)). 
 
Secondly, that nutrition and maintaining a healthy lifestyle are the most important 
factors in maintaining a healthy immune system, and that breastfeeding alone would 
provide adequate protection for children if continued for long periods:  
 
 ‘Yeah, I mean (immunisation is) no substitute for colostrum and good bacteria…I was 
talking to a microbiologist, he works for a probiotics company, and about how 
devastating it is for a baby’s immune system if it is a) caesarean and b) not breastfed; 
that your whole gut makeup is completely different and how much more pathogenic it is 
from then on… so we need to get over the message about breastfeeding the longer the 
better, you know best milk and the best start in life to grow a strong immune system’ 
(Interview 6, F, 50, S, Y) 
 
Healthy lifestyles are acknowledged as a core component of mainstream public health, 
and there is actually a sound scientific evidence base for this (Bundle, 2014; Frenk, 
2015; WHO, 2015). Similarly, there is evidence to support the benefits of breastfeeding 
for very young babies. However, the physiological effects of breastfeeding in relation to 
immunity are limited (and dependent on maternal immunity status) and the benefits are 
relatively short-lived (NHS Choices, 2015) and this is itself a factor in the timing of 
primary immunisations in the UK schedule. The interpretations of scientific principles 
by practitioners of alternative medicine therefore appear not unreasonable at a 
superficial level; and although these interpretations of scientific fact are in fact 
misinterpretations, they could offer a potential starting point for engaging in dialogue 
with these individuals. 
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Vaccination is also seen by some anti-vaccine protagonists as an ‘old model’, which 
‘singles out just one part of the immune system’ (antibodies) which they argue causes 
stress and is thought to ‘put toxins in the blood so that the immune system can’t carry 
out its functions as effectively as before’ (Interview 5, M, 47, S, N(S))  In addition, it is 
believed that vaccination acts in some way to suppress diseases which ‘have to come 
out later often as worse diseases’ (Interview 3, F, 42, P, N), or conversely that not 
having these diseases naturally means that the immune system is ‘not adequately 
challenged and so, instead, turns in on itself causing new illnesses such as 
autoimmune disorders’ (Interview 9, F, 39, P, N(S)) and the rise of other ‘modern’ 
diseases, for example, eczema and asthma. The increased incidence of these 
diseases and the lack of a full medical explanation are considered proof of the causal 
relationship between these two factors, without any consideration of the possibility of 
multiple other confounding variables. Concerns about the possibility of long-term 
unknown effects of vaccination were also referenced: 
 
‘I was talking to my daughter yesterday…and she was saying “What if you know, in a 
few years’ time all these people who’ve had vaccination …they find there’s something 
wrong with the vaccine and they all just get cancer?”’ (Interview 6, F, 50, S, Y) 
 
These concerns are particularly difficult to discount since there is no way of 
guaranteeing that there will not be such unlikely, but not impossible, effects in future. 
However, whilst all these parents expressed concerns about the links between ‘modern 
illnesses’ and vaccination, interestingly there was little or no reference to any 
presumed link between MMR and autism. These parents paid little attention to 
mainstream media reports, preferring to rely on alternative sources of information and 
personal research. 
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For all the parents who referenced alternative approaches, adherences to alternative 
views on immunisation were grounded in a much wider individual lifestyle choice. 
These parents had similar views on socio-political issues – commerce, the state, 
personal choice and personal freedom, social responsibility – to a greater extent than 
any other group. In addition, they appeared to circulate in a distinct social world, often 
having social relationships exclusively with ‘like-minded people’ (as described in 6.3.7). 
Their choices were therefore reinforced as a result of these social interactions, and 
were supported by ‘natural’ therapists who provided an alternative source of 
information and who employed a personal way of engaging with their clients that those 
promoting medical models could learn from.   
 
It should be acknowledged, however, that alternative therapy is not a single entity and 
that there are some inherent dangers in stereotyping. There are many varied ideas and 
traditions within the spectrum of ‘natural health’ approaches. Some accept 
immunisation but many do not. Rarely, parents who hold these views will accept 
certain immunisations because of very specific perceived hazards (for example, 
tetanus and horses), and some will re-evaluate their choices as a result of changing 
social circumstances: 
 
‘And, you know, she’s a robust little girl now, and kind of, if someone came to me and 
said, “Right, this is the age when we need to give the injections” I’d kind of say 
OK…partly because I’m no longer practising acupuncture and I’ve got a bit more 
mainstream again now…’ (Interview 18, F, 38, P, N(S)) 
 
Finally, some of these parents also do admit that the information they are referencing 
is potentially biased; and while they are very confident in the approach they have taken 
for their children, this confidence is often partly grounded in the fact that they feel free 
to do this because the majority of parents do comply with immunisation: 
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 ‘part of my training (in acupuncture) was about the body’s natural defences and all of 
those things, but also knowing, and this is the mean bit of it really (laughs) … knowing 
that the majority of people would have it done, so there was for [child], there would be 
a lower risk anyway…’(Interview 18, F, 38, P, N(S)) 
 
6.4 Development of the Parent Group Framework  
This chapter has, so far provided an in-depth exploration of the nine themes which 
were found to underpin the thinking of the parents who responded to the Phase 2 
Parent Census Survey and those who were subsequently followed up in Phase 3. 
 
The fundamental logic of the organisation of immunisation services is the provision of a 
‘one size fits all’ approach, predicated on the premise of a homogenous population. 
Detailed exploration of these themes, however, confirmed that the study population 
was not, in fact, homogenous, and as a result parents were not reaching their 
decisions to accept or decline MMR for the same reason, or even through the same 
decision-making process.  
 
Further analysis of these themes using cross referencing within and between data 
sources and queries within NVivo10 produced a number of observations from which 
three parent sub-groups were identified within the study population. These general 
observations were as follows: 
 
Issues of ‘risk’ and ‘parent choice’ were found to be salient in all the parent groups, as 
was the concept of ‘vaccine overload’. ‘Vaccine overload’ was referred to by all parent 
groups. Parents had remarkably similar rationales and they subscribed to the same 
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misunderstandings. This has significant implications for all immunisation services, not 
just MMR.  
 
The issue of parent choice was significant for all parents, but parents in the single 
vaccine group were more likely to have been influenced by family members, and 
particularly grandparents, than parents in the other two groups. 
 
Parents in the single vaccine group accepted the general principle of immunisation, but 
had specific concerns about the risks associated with MMR vaccine. There were some 
overlaps between this parent group and the medical co-morbidity group, with some 
parents in the latter also opting for single vaccines. 
 
Parents of children with medical co-morbidities did not necessarily have any specific 
concerns about MMR, but had made personalised assessments of risk in the context of 
the current state of health of their child. These parents had a different perspective on 
the probability of low-risk outcomes occurring because of previous personal 
experiences of a ‘low risk’ event actually happening. 
 
The political and economic issues associated with MMR and immunisation were of 
relevance to both single vaccine and natural health groups; but whilst for the latter 
these were a subset of their ‘alternative’ views – which were likely to impact on all 
decisions about immunisation – for the former, the concerns were limited to MMR as a 
single issue and were unlikely to influence future immunisation decisions. Each of 
these groups considered risk from a different social/political reference point.  
 
Parents who subscribed to natural/homeopathic medicine had significant general 
concerns about the principles, practice and perceived risks associated with all 
immunisations, not just MMR. This group also had serious concerns about the power 
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of pharmaceutical companies, and the consequent emphasis on population health 
initiatives, such as immunisation, at the expense of ‘healthy’ lifestyles and individual 
responsibility.  
 
The impact of popular media coverage was most significant for the single vaccine 
group. For parents of children with medical co-morbidities, the highly personalised 
nature of their decision-making acted to some extent to divorce them from the wider 
debate; and for those in the natural health group, inherent distrust of the popular press 
as a tool of the state meant that they took little interest in the specific debate, except in 
so far as it reinforced negative perceptions of immunisation in general.    
 
Finally, both single vaccine and medical comorbidity parent groups indicated that they 
would welcome greater support from health professionals. However, the very clear 
message was that this should be in the form of a dialogue with parents, rather than in 
traditional formats such as leaflets or websites. Parents in the natural health group 
indicated that they would be interested in more data, but implied that it would be highly 
likely that they would use this information to reinforce, rather than to dispel, 
preconceived ideas.  
 
A number of key considerations, which differed for each of these parent groups and 
which potentially impacted on the outcome of the parents’ decision-making, were 
identified from examination of the decision-making pathways for each parent group. 
These included: 
 
 how parents considered vaccinations, such as MMR, in the context of what they 
believe needs to be done to keep their children well 
 the role of the parents’ social interactions and relationships, and how these 
became part of the process of accepting or declining immunisations  
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 the role of parents’ political concerns and how these relate to the way they 
experience and think about immunisation 
 how parents frame concepts in respect of immunisation, and especially MMR, 
and how this interacts with the views of health professionals   
 
Based on these considerations, the following characteristics were identified for each of 
the parent groups: 
 
Single Vaccines 
Not anti-vaccine; agree with principles and have strong beliefs in relation to collective 
responsibility and medical models of health; feel let down by a system that they believe 
in. Needs to be acknowledged; continued potential to impact negatively on 
patient/professional interactions in medium term  
Highly influenced by popular media – single issue triggered response 
No impact on decisions about other immunisations 
Link to socio-political issues relates to power relationships and choice in healthcare, 
limited wider concerns 
Want to engage in social dialogue with health professionals 
Will consider changing mind, may accept ‘boosters’, may allow older children to 
have an active role in decision-making 
 
Medical Co-morbidities 
Not anti-vaccine 
Highly personalised decision-making dependent on the parents’ assessment of the 
specific vulnerability of the child 
Assessments of relative risk based on negative prior personal experiences - balance of 
personal freedom versus social responsibility tipped in favour of individual 
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Very likely to delay all immunisations (not just MMR) until the child is ‘stronger’, unless 
specifically advised by paediatrician or other trusted medical source 
Want support from health professionals 
Some overlap with Single Vaccine group, especially where medical concerns relate to 
developmental delay, behavioural issues or atopic conditions 
Concept of protection via ‘herd immunity’ is necessary for some children in this group, 
but knowledge of this can act to reinforce parental concerns for others who are not 
technically contra-indicated  
Will consider changing mind, and often do spontaneously as child’s condition 
stabilises or when treatment allows 
 
Natural Health 
Decisions are based on wider ‘alternative’ convictions and different socio-political 
rationales 
Parents apply different explanations of ‘scientific’ evidence, and extrapolate different 
truths and logics from a basic understanding of the scientific method 
Very strongly held alternative beliefs on both health and childcare linked to lifestyle 
choices 
Willing to engage with health professionals and accept information, but likely to 
interpret this in ways that reinforce existing beliefs 
Unlikely to accept any immunisations (for children or pets) and very unlikely to 
change mind
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            Table 6: Relationship between parent sub-groups and identified themes 
 
 
                                                                                
 
 
 
 
            Table 7: Impact of decision making pathway on immunisation outcome by parent sub-group
Parent sub-
group 
Risk  Medical 
comorbidity 
Vaccine 
Overload 
Natural / 
homeopathic 
Media Medical 
models,  
Politics 
& 
Health 
Parent 
choice 
More 
support 
Single 
vaccines 
Single 
Vaccines 
X X X  X X X X X 
Natural / 
Homeopathic 
X  X X  X X   
Medical co-
morbidity 
X X X    X X X 
Parent sub-
group 
No MMR MMR - 
Delayed 
Single 
vaccines 
Changed 
decision? 
No Immunisations 
Single Vaccines  X X Yes   
Natural / 
Homeopathic 
X     No           X 
Medical co-
morbidity 
 X X Yes  
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The relationship between parent sub-groups and the nine themes are summarised in 
Table 6.  
 
The identification of these parent sub-groups then generated a further hypothesis that 
each group might not just have different characteristics but might also be associated 
with different outcomes and therefore require different approaches from immunisation 
services. The impact of the group specific decision-making pathways on immunisation 
outcome by parent sub-group is summarised in Table 7 and appeared to further 
support this hypothesis.  
 
This was further investigated and the outcomes and potential mechanisms for applying 
these findings to improve immunisation policy and practice are discussed in Chapter 7.  
  
6.5 Summary and generalisability of the findings 
The evidence presented in this chapter provides a rich source of information in respect 
of the characteristics and decision-making processes of specific groups of parents who 
had declined MMR immunisation. Whilst it is acknowledged that the sub-set of parents 
who responded to the survey may have been skewed, and the findings may not 
therefore be fully transferrable, the sub-set who were interviewed were confirmed to be 
much more representative, in demographic terms, of the whole unimmunised Phase 1 
study population.  
 
The data provides many insights into the ways that parents formulate and rationalise 
their decision-making, and it is clear that this is a dynamic process which is highly 
influenced by the parents’ social interactions and social contexts. This information is 
valuable because it offers the possibility of using these insights to inform the 
development of communication frameworks and models to improve engagement with 
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parents in respect of immunisation, which are tailored to the needs of the groups 
identified, but also have relevance and application to the wider parent population and 
to all immunisation discussions, not just those involving MMR. 
 
The key findings arising from this research and the overarching MMR Parent 
Engagement Strategy which was developed as a result are discussed in Chapter 7. 
The thesis then concludes with consideration of the potential impact of this study on 
immunisation policy and practice; with recommendations for further research; and with 
a discussion on the limitations of this research in Chapter 8 
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CHAPTER 7 DISCUSSION AND DEVELOPMENT OF THE MMR PARENT 
ENGAGEMENT STRATEGY 
7.1 Introduction 
The primary purpose of this study was to identify whether there were any 
characteristics, common to parents / children who had refused the offer of MMR, which 
could be used to help improve the understanding of how parents’ make decisions to 
accept or decline immunisation, and in particular MMR vaccine. It was hypothesised 
that by improving this understanding it might be possible to recommend changes to 
practice to improve the delivery of immunisation services and therefore the uptake of 
MMR in Somerset.  
 
Those who decline and those who promote immunisation often appear to be locked in 
an almost irreconcilable stand-off in relation to MMR. The finding that those who 
decline this offer are not a single group, but are more complex and comprised of sub-
groups, provides evidence to explain why the current ‘one size fits all’ approach by 
health professionals and policy makers to engage these parents in the immunisation 
decision-making process may not be effective and therefore different approaches, 
tailored to the needs of these groups, may be needed. A better understanding of the 
reasons why parents adopt their particular approach should be seen as an essential 
step in bridging these opposing viewpoints. This understanding then has the potential 
to be applied to improve the delivery of immunisation services and to ensure more 
effective targeting of available resources, whilst avoiding alienating those parents who 
hold different views.  
 
Rather than perpetuating the conventional professional wisdom that parent’s decisions 
in these situations are based on a lack understanding of risks, rooted in distorted social 
and emotional factors that have been communicated by a misleading media (Leach 
and Fairhead, 2007), the evidence from this study suggests that parents’ decisions 
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should perhaps be viewed as a rational framing of their understanding of competing 
uncertainties, related to their own knowledge and understanding of their child’s health. 
This then explains why this process cannot be considered in terms of a single, 
deliberate and objective calculation of risk, which professionals could readily influence 
by appropriate provision of better information, but instead should be seen as a much 
more complex and evolving process of personal engagement and evaluation of many 
differing experiential sources of evidence.  
 
What this also implies is that, if social interaction and engagement is the key factor, 
professionals can also potentially influence this process by also engaging in an on-
going social dialogue with parents on these matters. However, to do this requires a re-
thinking of attitudes towards parents who fail to comply with prescribed immunisation 
practices and a greater commitment to engage with them, and to engage in different 
ways. 
  
To be successful, any campaign therefore needs to be targeted, not only to areas of 
low coverage and at those who have not complied with national schedules, but also 
within this group at a much more refined level corresponding to the motives identified 
for specific individuals or population sub-groups, and this requires an understanding of 
the different reasons that parents have for making these decisions. The MMR Parent 
Engagement Strategy described in 7.2 has been developed as a mechanism to apply 
this knowledge and understanding to address these individual needs.  
 
7.2 Development of the MMR Parent Engagement Strategy 
The previous chapter explored in detail the nine themes that were found to underpin 
the thinking of parents’ of unimmunised children in relation to MMR decision-making. 
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Exploration of these themes, their differences and relationships, resulted in the 
identification of three parent sub-groups: 
 
Parents with a natural / holistic approach to health 
Parents of children with medical co-morbidities 
Parents who opted for single vaccines 
 
Having identified these common themes and parent sub-groups, the sub-groups were 
investigated to see whether they were associated with different outcomes in relation to 
MMR and also whether different strategies and approaches were required to achieve 
these outcomes. This hypothesis was tested by reviewing the summary data obtained 
via the Phase 2 survey and the Phase 3 interviews, by using cross-referencing and 
queries in Nvivo10. Further analysis was then undertaken using data obtained in 
relation to the 20 interview subjects. Table 8 provides details of the MMR outcomes by 
interview subject and parent sub-group.  
 
It was identified that 10 of the 20 interview subjects had changed their original decision 
and had accepted MMR for their child at some time between 2009 and 2012. A further 
four had documented evidence of a complete course of single vaccines at the 
appropriate intervals. Of the parents who were interviewed, 70% had therefore made 
decisions to ensure that their children were fully protected against measles by 
accepting some form of immunisation.  
 
10 of the parents interviewed were in the Medical co-morbidity group. Of these eight 
had subsequently accepted MMR and one had accepted single vaccines. The 
remaining child in this group had on-going medical and behavioural issues and the 
parent reported that they would be unlikely to change their mind.  
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Interview Number Vaccination Category Parent sub-group Comments 
Had MMR - Delayed Had single vaccines No MMR No immunisations 
1    x   Single Vaccines  
2 x x   Single Vaccines  
3   x  Natural Health  
4  
 
 
 X 
 
 
 Single Vaccines Would have accepted 
singles, might 
consider MMR if 
there was a measles 
outbreak 
5   x x Natural Health  
6 X    Medical  Would have accepted 
singles 
7 X    Medical  
8   X  Medical  
9 x X   Medical  Initially had singles, 
MMR booster 
10  X   Single Vaccines  
11 X    Medical  
12 X    Medical  
13   X  Natural Health / 
Medical 
History of adverse 
reactions. No 
pertussis 
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Table 8: Immunisation outcomes by Interviewee and by parent sub-group
14 x    Medical  
15 X    Medical  
16 X    Deferred acceptor Delayed MMR2 
17  X   Single Vaccines  
18   X  Natural Health Accepted oral polio 
19  x   Medical  
20 x    Medical Has considered single 
vaccines 
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There was a degree of overlap between the Single Vaccine and Medical Co-morbidity 
groups. One of the parents in the Medical group had eventually accepted MMR, 
indicating that they would have considered immunising their child earlier had single 
vaccines been available. Another had accepted MMR booster after initially opting for 
single vaccines. A third parent who had not accepted MMR reported that they would 
have accepted single vaccines had they been available.  
 
Of the six parents who had not accepted MMR or single vaccines at the time of the 
study, four belonged to the Natural Health group and had also refused other vaccines. 
The fifth had on-going medical co-morbidity, while the sixth had a complicated family 
history of adverse reactions to vaccines, and had held Natural Health beliefs in the 
past. This parent reported that they no longer held these beliefs following changes in 
social circumstances and indicated that they may now consider accepting MMR if there 
was evidence of a measles outbreak in their area. 
 
The data provided many insights into the ways that parents formulate and rationalise 
their decision-making, and it is clear that this is a dynamic process which is highly 
influenced by the parents’ social interactions. This information is valuable because it 
offers the possibility of using these insights to inform the development of frameworks 
and models to improve communication and engagement with parents in respect of 
immunisation, which is tailored to the needs of the groups identified, but also has 
relevance and application to the wider parent population and to all immunisation 
discussions, not just those involving MMR. 
 
Communication with parents in relation to immunisation is currently usually undertaken 
in very short consultations, at or around the time the vaccinations are being given. The 
focus of these discussions has generally been a simple didactic provision of 
information. Education of professionals has been approached in a similar way – 
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professionals learn what to say to parents, but not ‘how’ to say it. Parents want to 
engage with professionals, but they clearly express that this engagement needs to be 
based on open, two-way dialogue. Professionals therefore need to focus equally on 
communication skills that build trust and rapport with parents, that enable them accept 
questions and rapidly identify parents’ specific concerns, to elicit parents’ motivations 
and information needs, and enable parents to make quality decisions in respect of 
vaccination, without the encounter deteriorating into a prolonged, polarised, adversarial 
debate.  
 
As a result of reviewing the study findings and of gaining an improved understanding of 
the motives, decision-making pathways and potential outcomes for each of the three 
parent sub-groups, I have developed the following over-arching MMR Parent 
Engagement Strategy as a potential way of improving communication and engagement 
in respect of immunisation with all parents, but particularly those who decline MMR.  
The framework is based on the following premises, derived from the analysis:  
Parents who decline MMR are not a homogenous group 
Parents in the study population have highly personalised approaches to decision-
making 
There are groups within the study population which share similar perspectives in 
relation to the nine themes, and these shared perspectives result in them taking similar 
courses of action in respect of MMR  
Parents’ decision-making processes are linked to their social worlds, and are 
dynamically influenced by social interactions and relationships 
That analysis suggests ways of interacting with parents to reduce the current 
polarisation of parental and professional views 
The analysis implies strategies that could be applied in practice to develop a means of 
engagement with parents in each of the three groups   
The strategy is outlined in the following diagram (Figure 27): 
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Figure 26: MMR Parent Engagement Strategy  
Interactions at Community level: Maximise opportunities for immunisation ‘talk’ 
via social groups, youth groups, children’s centres, schools and social media. 
Consider ways to engage grandparents / wider family members, and to challenge 
beliefs in respect of immunisation (e.g. vaccine overload) – normalise 
immunisation. NB. Consider the potential impact of different schedules and 
immunisation practices for ethnic minority populations 
Universal services for all families: Use relationships built with professionals from 
pregnancy onwards to open dialogue at appropriate intervals. View 
immunisation as an integral part of the Healthy Child 0-5 and 5-19 programmes. 
Ensure that there is an opportunity for open discussion to identify any specific 
concerns and for explanation when providing standard information  
Additional services that any parent may need some of the time (e.g. concerns 
about specific vaccines): Ensure that there are individual opportunities for 
meaningful discussion and open dialogue. Provide, delegate or refer to an 
appropriate professional to achieve this. Provide opportunities to explore new 
evidence as it becomes available and to revisit decisions 
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Additional services for vulnerable families (e.g. children with disabilities or 
medical comorbidities): Awareness and sensitivity for those with medical 
contraindications. Acknowledge specific concerns and liaise with medical 
specialists leading child’s care to ensure consistent messages and to identify 
appropriate opportunities to immunise. Flag on CHIS and ensure status updated. 
notes updated 
Total Refusers (e.g Parents with ‘natural health’ beliefs): Acknowledge beliefs 
and concerns, offer information, explanation and constructive challenge where 
appropriate. Ensure open door policy and opportunities for dialogue. Consider 
wider impact on child. Consider flagging on CHIS to prevent issuing of further 
invites. Never too late allows those who change their beliefs to opt back in 
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This framework is underpinned by an overarching open door, ‘never too late’ policy to 
foster effective communication with all parents, and to use key contacts and transition 
points in the child’s life as further triggers to open this dialogue. Whilst the MMR Parent 
Engagement Strategy has been predicated on the present research in relation to MMR, 
the approach is equally applicable for all missed immunisations.  
 
Overt ‘never too late’ policies have been very successfully implemented in other 
countries. For example, this was the primary approach used by NHS Scotland during 
the period following the MMR controversy, and MMR uptake rates were maintained at 
much higher levels than those achieved in England in the same period (Health 
Protection Agency, 2013). This ‘never too late’ approach should not just be applied in 
principle, but will require a fundamental shift in primary and community care to ensure 
that opportunistic delivery of immunisations, such as MMR, become a practical reality 
rather than a theoretical consideration. What the MMR Parent Engagement Strategy 
offers over and above this is a tool to enable practitioners to develop dialogue and to 
engage with parents in a way that is more likely to be positively received by them, and 
in doing this to increase the likelihood of a positive outcome when they are ready to 
make this decision and come through the door.  
 
There has been an increasing amount of published evidence exploring both the 
characteristics and attitudes associated with uptake of MMR and also more recently a 
number of published papers which advise health professionals on vaccination 
communication (Leask et al, 2012). However, there are very few that consider the 
possibility of a spectrum of different parent sub-groups and perspectives within the 
unimmunised population, or that look at tailoring strategies to meet the needs of these 
sub-groups of parents.  
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The MMR Parent Engagement Strategy that I have developed as an outcome of this 
thesis therefore offers a new approach to communicating with parents about MMR and 
immunisation and, as a result, the opportunity to improve service delivery, parent 
satisfaction with these services, and ultimately the uptake of immunisations such as 
MMR.  
 
The conclusions, recommendations and a discussion of the limitations of this study are 
presented in, Chapter 8, the final chapter of this thesis. 
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CHAPTER 8 CONCLUSIONS, RECOMMENDATIONS AND STUDY 
LIMITATIONS 
8.1 Introduction 
This study was undertaken to explore, in depth, the quantitative data available in 
respect of MMR in Somerset at the time of the 2009 MMR Catch-up Campaign, and to 
provide new qualitative data in relation to the attitudes, beliefs and experiences of 
MMR and immunisation services of a sub-set of parents’ who, at the end of March 
2009, continued to decline the vaccination. The aim of the study was to identify the 
characteristics of parents who continued to decline MMR and any factors which 
influenced parental decision-making within this sub-set of parents; to add to the wider 
knowledge base in this area of inquiry; and to use this knowledge to improve local 
immunisation services by answering the following research questions: 
 
What were the social, demographic and geographic characteristics of parents / children 
who had accepted and declined MMR in Somerset in 2009? 
Are parents who persist in declining MMR a single homogenous group? 
Does the ‘Wakefield study’ remain a key factor influencing parents’ of school age 
children to decline MMR in Somerset, or are there additional factors at play? 
How have parents’ early experiences, attitudes and behaviours in respect of MMR and 
wider immunisation services influenced their longer term decision-making? Have their 
attitudes and behaviours changed over time, or as new experiences occur?  
Why do some parents persist in declining MMR, despite having information and 
experiences which appear to counteract the basis on which their initial decision was 
made? 
What factors influence parents who have persistently declined to change their mind 
and accept MMR for their school-age children? 
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These questions have all been addressed in the previous chapters and the outcomes 
will be summarised in this chapter. It should be noted that he study sample was found 
to be skewed and this needs to be considered when assessing the outcomes, however 
the findings did appear to add evidence to support the findings of previous studies in 
relation to the characteristics of parents and children in the unimmunised population 
(for example, in relation to parents’ education and economic status, and birth order of 
the child) (Dannentun,2005; Friedrichs, 2006).  
 
Key observations arising from the present study are as follows: 
 
Parents who decline MMR for their children are not a single homogenous group. In fact 
they consisted of a number of identifiable sub-groups, each of which had different 
motives, decision pathways and predicted outcomes in relation to potential to change 
their mind and accept MMR. From this it was possible to identify interventions and 
changes in practice to maximise opportunities to engage with these parents and as a 
result increase the possibility of achieving a positive outcome (immunisation).   
 
In terms of geographic characteristics, the parents / children in the two age groups 
studied did have different patterns of distribution across Somerset. The secondary 
school age children were found to be concentrated in areas that are recognised as 
having large populations which ascribe to more alternative lifestyles, whilst there was a 
much more generalised distribution for the primary school age group across all parts of 
the county.  
 
Whilst many parents were keen to emphasise that the ‘Wakefield’ controversy was not 
the primary factor in making their decisions, the very high number of references made 
to this suggests that this was a very significant factor. For example, the primary school 
age group were temporally associated with the ‘Wakefield’ controversy and more 
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generalised concern about MMR, whilst the older children are more likely to be more 
traditionally ‘anti immunisation’. Even the differences in geographic distribution are 
therefore also likely to be linked to parent sub-group types as identified in this study 
and were therefore, at least in part, determined by reactions to the Wakefield study.  
 
However, for most parents, the exploration of the nine themes arising from the data 
illustrate that this is not the only, or the most important factor in their continuing 
decisions, and very many had changed their decisions over time and had accepted 
MMR for their children. The reasons for doing this were multiple and were again 
intrinsically linked to the particular parent sub-group.  
 
There is good evidence that health professionals have a key role in addressing 
parental concerns in respect of immunisation. The evidence from this study confirms 
that GP practice was the most significant factor associated with uptake, and the 
interviews with parents appear to support the suggestion that interaction between 
health professional and parent is critical, with evidence of examples of effective 
interactions addressing concerns and motivating parents towards accepting vaccines, 
whilst poor communication leads not only to refusal, but can also result in long-term 
damage to these relationships and dissatisfaction with the care they have received. 
Assuming that refusal to accept MMR, and other immunisations, arises from a position 
of ignorance which can be simply addressed by persuading or by providing more 
information is likely to be counterproductive when interacting with these parents, 
because it fails to take account of the multiple, complex reasons that underpin these 
parents decisions.   
 
Parents report a reluctance to change their views because of a perception that this 
would mean having to admit that their original decision was wrong, or more importantly 
because their attempts to engage professionals had previously failed, making them so 
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angry that their views had become entrenched. Providing opportunities for dialogue to 
be reopened offers the possibility of interaction which could enable parent and 
professional views to be explored, to shape future experience of immunisations, and to 
potentially negotiate a way forward together. However, it is recognised that once 
children reach school age there are currently very few structured or routine 
opportunities for parents to make contact with health professionals and identifying and 
capitalising on these in practice may require a more creative approach.  
 
Health professionals, as parents themselves, also have a significant influence (as 
friends, as family members, and as colleagues) far beyond their professional roles, but 
in the main these individuals share wider parental concerns and, ironically, lack 
confidence in medical models. The assumption that simply educating those who have 
an overt role in administering immunisations will change attitudes, similarly overlooks 
the impact of their underlying parental concerns on their own interactions with other 
parents, and also the influence of the wider health care workforce who may have 
limited professional knowledge of immunisation but who may also be approached as 
health ‘experts’ by their roles as friends, neighbours and peers. An approach more in 
line with the personalised engagement needed with parents, may also be more 
effective in positively addressing and utilising these professional influencers, rather 
than just relying on traditional, technical education for immunisation service providers. 
 
The fact that parents in the sub-groups identified within this study appeared to make 
decisions through engagement, through communicating with and through relating to 
others, reflects the findings from other recent research (Leach and Fairhead, 2007). 
The potential to explore the factors that influence these decisions through open 
engagement, rather than always resulting in division or polarization of views, has the 
potential to offer a means of effecting change by blurring and bridging parent and 
professional perspectives. This could have positive outcomes for all involved.  
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8.2 Recommendations 
A very strong message arising from this study was the need, expressed by parents, for 
more dialogue with health professionals. Parents, in all three groups who had declined 
MMR, reported that the reasons for them reaching this decision had rarely been 
explored or challenged by health professionals. Many also felt that professionals were 
ill-equipped to do this, or had personal doubts themselves. They reported that there 
were actually few, or no, opportunities for dialogue to take place in the current 
organisation of immunisation services. If parents’ needs are to be effectively met, 
practice needs to change to facilitate these opportunities and to enable professionals 
to actively engage in open dialogue with parents on these issues. 
 
This study builds on previous evidence relating to characteristics which influence 
decisions to accept or decline immunisation, and specifically MMR. Identification of the 
parent sub-groups; an improved understanding of the factors associated with these 
groups; and of how these then inform their decision-making pathways, offers an 
opportunity for health professionals to use new more structured approaches for 
communication and engagement, which are specifically tailored to the needs of each of 
these sub-groups of parents. These approaches also align well with the current 
personalisation agenda in health care (NICE, 2014) and with contemporary ‘nudge and 
shove’ theories of public health behaviour change (Thaler and Sunstein, 2008) and 
have the potential to normalise the experience of accepting immunisation by 
developing a professional approach based on greater openness, and more 
opportunities for discussion and challenge, similar to that which has already been 
highly successful in increasing rates of breastfeeding (http://www.clahrc-
bbc.nihr.ac.uk). It is an approach that can also be readily integrated with existing 
professional frameworks, such as, the Healthy Child Programme (0-5 and 5-19), and 
the Health Visiting ‘A Call for Action: Service Model’ and can be implemented by 
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adapting the principles of ‘motivational interviewing’ which the majority of health 
professionals involved in the delivery of immunisation services will be familiar with, and 
already use in other aspects of healthcare where individuals may be resistant to 
change (for example, smoking cessation). 
 
8.2.1 The Overarching MMR Parent Engagement Strategy and group-specific 
actions 
 
The MMR Parent Engagement Strategy that has been developed within this thesis 
offers a framework for engaging with all parents, but particularly those who decline 
immunisation. It offers strategies to address the concerns of each of the three parent 
groups identified in this study, based on their different information needs, and 
requirement for different approaches and levels of engagement. 
 
From a commissioning perspective, embedding frameworks such as this in service 
specifications and commissioning intentions offers a more cost effective approach to 
improving immunisation uptake than funding large, poorly targeted and ineffective 
catch-up campaigns. It is therefore recommended that further research is undertaken 
to provide evidence of the effectiveness of the approach in practice and to inform 
future commissioning decisions (for example, by undertaking studies comparing 
standard approaches in GP practices with the framework approach, and measuring 
impact on uptake and acceptability for patients and professionals). There is also a 
wider need to build the evidence base to inform effective communication in relation to 
immunisation, given the significance of the interaction between professionals and 
parents on decisions to immunise.  
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8.2.2 Additional recommendations 
Good communication, as described above is only one element of a range of measures 
that have been identified to improve uptake of immunisation in Somerset.  Whilst this is 
considered to be the most significant of the study recommendations, and is of 
relevance to all parties who deliver immunisation services, strategies are also required 
to address other potential barriers identified as a result of undertaking this study, such 
as difficulties with access to healthcare, or specific factors associated with the 
providers of immunisation services.  
 
8.2.2.1 GP Practice specific factors 
This study identified some very specific findings in relation to immunisation uptake in 
local GP practices. Whilst the application of the framework may act to improve 
engagement with parents, regardless of the practice with which they are registered, it 
is not clear from the evidence obtained as part of this study whether there are other 
underlying issues in relation to practice-specific factors and uptake in these GP 
practices. It is therefore recommended that an additional investigation is undertaken 
with those practices that were identified as significant outliers in Phase 1 of the study.  
 
8.2.2.2 Independent schools 
There is a need for a further investigation of the immunisation history of students in 
independent boarding schools in Somerset to ascertain if low uptake is related to poor 
record keeping or represents a true incidence of under-immunisation, especially 
amongst international students. 
 
8.2.2.3 Ethnic Minority Communities 
There is a need to consider the use of alternative schedules, and access to 
immunisation services in country of origin, by parents of children from ethnic minority 
communities. Parents may not report immunisation abroad to local health systems, and 
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my not be aware of any need to do this which may result in under-recording of vaccine 
uptake. Further work is needed with health services in areas with large ethnic minority 
communities to identify mechanisms and opportunities to identify the true immunisation 
status for these children.  
 
8.2.2.4 Vaccine overload 
All parents identified ‘vaccine overload’ as a theme, and their rationales and 
misunderstandings in respect of the capacity and capability of human immune systems 
were almost universal regardless of sub-group. This has serious implications as new 
programmes enter the national schedule and combination vaccines containing multiple 
antigens become ever more common. In line with other parental concerns, the parents 
in this study reported that there was little attention given to addressing or challenging 
these misconceptions by health professionals. In fact, there was evidence that many 
health professionals themselves express similar reservations. There is therefore an 
urgent need for this to be considered early in any engagement with both professionals 
and parents as part of any social interaction relating to immunisation and in 
communication and training strategies at local, regional and national levels.  
 
8.2.2.5 Media 
There was a clear message from parents in this study for immunisation services ‘not to 
waste money’ on media campaigns, especially those related to MMR, since these 
appear to do little to reassure parents, or to change their mind. One to one social 
communication and follow up, in person or by phone, was identified as a more effective 
approach and this should be the focus of future communication should additional 
activity be required.   
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8.2.2.6 Data validation 
A key finding when undertaking the study was that the current data held by Child 
Health Departments, particularly in relation to the immunisation history of school-age 
children is not accurate. Control over data and the processes which underpin its 
accurate collection are vital if that is to be achieved. This must include processes for 
regular updating and cleansing. In order to achieve the required standards for CHRDs 
and CHIS system information requirements, it is essential that a national service 
specification is developed not just for the IT systems themselves but also for the Child 
Health Records Department that manages the whole arrangements around this. This 
specification should clearly outline the expectations for data sharing and accuracy, 
define the deliverables and outcomes, and provide mechanisms for joining up teams 
and systems nationally and locally to minimise inaccuracy and ensure continuity of 
immunisation history.  
 
However, the NHS Information Centre COVER programme, which obtains data 
electronically from CHRDs, does not currently monitor school leaver booster, or BCG 
testing or vaccination. These activities have to be recorded and reported separately on 
KC50 forms and returned directly to the NHS Information Centre. This complicates the 
return process, and introduces greater potential for inaccuracy, manual data entry 
error, and therefore poorer reporting.  
 
Any specification must therefore clearly define the cohort that the system must record 
as being children aged 0–19 years in order to have national validity. The system 
should be automatically linked to routine national datasets, with the COVER data 
collection expanded to capture uptake and coverage of all childhood immunisations 
including the existing adolescent programmes, the new Meningitis C booster, and 
childhood flu programmes.  
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8.2.3 Summary of Recommendations: 
Undertake further research to test the framework model in practice and to explore the 
impact of changing approaches to improving communication with parents in primary 
care  
 
If effective, align the ‘Never too late’ framework approach with existing public health 
nursing service frameworks and service models, and embed the framework into 
specifications for commissioning immunisation services 
 
Undertake a specific exploration of potential models for improving access to 
immunisation services for children with pre-existing medical conditions. Link with 
Paediatric clinicians and specialist children’s services. 
 
Investigate fully the immunisation status of, and access to services for, students 
attending local independent boarding schools, and those in ethnic minority 
communities 
 
Review current communications and media strategies to include approaches detailed 
in the framework, and specifically to identify ways of addressing issues related to 
vaccine overload 
 
Undertake a full data validation exercise for all immunisation programmes in Somerset 
 
8.3 Study Strengths and Limitations 
The findings of this study have provided in depth information on the issues which are 
relevant and important to a group parents in Somerset who decline MMR, and there 
are many commonalities with previous research findings. The methodology used 
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enabled the topic to be explored in both depth and breadth, with rich subjective data 
obtained from individual parents supplementing and enhancing the epidemiological 
and demographic data obtained via the survey and baseline study. This has provided a 
much greater understanding of the issues related to the Somerset area than had 
previously been available and has enabled very effective targeting of approaches to 
improve local services. Whilst it is acknowledged that there were some significant 
limitations to elements of this approach, the mixed method study design, and 
particularly the linking of data by unique identifiers attempted to mitigate against some 
of these limitations and to provide greater validity and robustness to the study 
conclusions and recommendations.  However, it is recognised that there are a number 
of limitations which do need to be considered, as follows: 
 
The response rate was relatively low at 16% for the secondary school age group and 
20% for primary school age group. The responses may not therefore be representative 
of the wider unimmunised populations. There may be a number of reasons for the low 
response rates. Outcomes of the data validation exercise and the national evaluation 
undertaken in 2013 suggest that it is possible that the original groups that were sent 
the surveys may have contained children who were actually vaccinated, and therefore 
should have been in the ‘unimmunised’ groups, or who had moved away and should 
therefore have been excluded. These surveys may have been discarded by the 
recipients rather than returned. Whilst this would not impact on the validity of the 
survey responders, whose data was cross-referenced to ensure eligibility, it would 
have potentially impacted on the numbers of children in each age group and therefore 
on the response rate.  
 
Evidence from the telephone helpline, that was set up to respond to queries from 
parents who received the surveys, suggested that there were parents in both the 
‘alternative health beliefs’ and the ‘single vaccine’ group who may also have discarded 
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the survey as they did not wish to have any further correspondence from immunisation 
services on this matter, or because they thought that the survey was yet another invite 
to attend for immunisation. These groups may therefore be underrepresented in the 
survey response and agreed to follow-up populations.   
 
The data obtained from Phase 1 and Phase 2 also suggests that there may be 
underrepresentation of parents from lower socio-economic groups, particularly in the 
survey responder group. The study methodology, that is use of surveys, is likely to 
have limited the response amongst this group, despite having put in place alternative 
means of completing the questionnaire (by phone or home visit), alternative versions 
including ‘easy read’ and different languages, and piloting the approach with a variety 
of different parent groups. There is good evidence that parents in lower socio-
economic groups fail to immunise because of very practical issues with access to 
services. These parents’ needs would be addressed in part by the implementation of 
the framework and also through application of the NICE Guidelines 21 compliance 
framework, and there is already a requirement for NHS immunisation services to 
implement this. The study intended to look at other factors that may have also 
impacted on decisions to accept or decline, which had been identified as requiring 
further investigation in these guidelines and the findings should therefore provide 
additional information to supplement the actions arising as a result of the 
implementation of the NICE Guidelines.  
 
The qualitative data for this study was obtained via a number of sources. These 
included informal telephone conversations with individuals who had accessed the 
helpline following receipt of the survey questionnaire, respondents to the survey, and 
people who agreed to take part in one-to-one interviews. Consequently, this is a self-
selecting group. Moreover, the study is grounded in a particular context (Somerset), 
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time (2009 / 2012), and cases (these respondents) and the findings may not therefore 
be fully applicable in other settings or populations.  
 
The possibility of recall bias is a recognised as a potential risk when using interviews 
with parents to explore historical events related to decision-making. However, the 
study included independent checking of immunisation status and timings as a way of 
identifying and reducing the potential impact of recall errors on the results. Similarly, 
there was cross referencing of demographic, immunisation uptake and qualitative data 
between and within the immunised and unimmunised groups to try to improve, as far 
as possible, the validity of the data.  
 
The factors identified above may have acted to skew the findings of the study, 
potentially towards those who were in principle more positive and naturally accepting of 
immunisation, but who had not accepted this immunisation or had not adhered to the 
national schedule where this was accepted, for example, those with pre-existing 
medical conditions. The study should therefore be considered as a specific 
investigation of a sub-group of the under-immunised population, rather than being fully 
representative of the whole unimmunised population, on this basis. 
 
The numbers of children required to be vaccinated in order to achieve the required 
levels of uptake and coverage for Somerset are relatively small, and may be achieved 
by focussing on specific sub-groups of children who are under-immunised. The 
recommendations within this study therefore do have valid application in practice and 
have the potential to improve both immunisation uptake and the experience of using 
immunisation services for the Somerset and wider populations in the South West of 
England in which this will be applied in future.  
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8.4 The impact of the study on current practice  
This study has already directly influenced practice in the following ways: 
The approach to the 2013 MMR Catch up Campaign was completely altered as a 
result of the findings from this study. The national plan for the campaign recognised 
that there may be an issue with the accuracy of data for this age group of children. 
However, this was to be addressed by paying GPs to send letters to patients on their 
lists that they had recorded as under-immunised. This would have had little or no 
impact on improving data accuracy at CHRD level. Within the South West an 
arrangement was therefore negotiated with the local GPs, Primary Care 
Commissioning, Local Medical Committees and the Clinical Commissioning Groups to 
instead fund the GPs to validate lists produced by the CHRD, to correct any errors 
where children had been vaccinated or were no longer registered, add missing 
children, and then return these validated lists to CHRD. This then enabled the CHRD 
to update the central CHIS records and to send letters on behalf of the GPs only to the 
parents of children on the newly validated lists. This reduced the number of letters sent 
by the NHS England Area Team by more than 8000, and saved over £20,000. More 
importantly it also reduced the time spent by GP Practices and other staff in 
responding to calls from parents who were just advising that the letters were wrong, or 
complaining about receiving a letter when their child had had MMR, reduced parental 
anxiety, and enabled more effective planning of clinic time to deliver the programme 
alongside other primary care priorities.  
 
Data validation significantly improved the uptake rates as recorded nationally for the 
NHS England Area Team. It also enabled better use of resources by more accurately 
targeting the delivery of services to those areas identified with genuinely poor uptake 
and coverage. Good practice and lessons learned from the data validation exercise 
has been shared regionally and nationally via the South West Scientific Conference 
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February 2014 and the Field Epidemiology National Conference in March 2014. The 
researcher also contributed to the development of the protocol, and with coordination 
and data provision for the National Evaluation of the 2013 MMR Catch-up Campaign, 
including development of the final report for the Department of Health’s Oversight 
Group, which was published in February 2014 
 
Evidence from the study was used as part of the BBC Inside Out investigation into the 
use of homeopathic ‘vaccines’ and the researcher’s interview was used as part of the 
subsequent broadcast in January 2012. Following the investigation, the MHRA took 
action by issuing instructions to two large suppliers of homeopathic remedies 
(Ainsworths and Helios) to prevent them from advertising their homeopathic products 
as alternative treatments to proven, conventional vaccines such as those for measles, 
meningitis or whooping cough. 
 
An independent schools project has been commenced in Somerset. The initial phase 
involves a collaborative approach with the CHRD staff linking with head teachers and 
with nursing and GP staff responsible for providing medical services to these schools 
working together to validate the records of children who attend. This includes 
developing communication protocols and processes to ensure on-going validation and 
updating each school year. This has improved the targeting of services to this group of 
children. 
 
A specific investigation of current practices with the GP surgery which was identified as 
the most significant outlier in this study identified a number of administrative issues in 
relation to the provision of immunisation services. These included insufficient and 
inflexible clinic timings, waiting lists and lack of any proactive follow-up of non-
attenders. The Practice had persistently low uptakes of all childhood immunisations, 
and there was a general perception that this was associated with the alternative 
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lifestyles of many within the local population. The Screening and Immunisation Team 
worked with the GP practice to identify the potential issues and to develop an action 
plan. This plan included introducing additional clinics, improved data recording, 
strengthening the support provided by CHRD to schedule children into these clinics 
and telephone follow-up and re-booking of non-attenders. The plan has been fully 
implemented and the first quarter data is awaited to assess whether the changes have 
improved uptake. If effective this approach will be used by the Screening and 
Immunisation Team to investigate and support other poorly performing GP practices 
 
The recommendations for further research – particularly the case-control studies of the 
MMR Parent framework approach - forms part of the submission, and will be taken 
forward as part of the research programme, for the Bristol Immunisation Group Health 
partners Integration Team (BIG HIT) project. This project is a collaborative between 
NHS and Academic partners (including University of the West of England, Bristol 
University, the Bristol Vaccine Research Unit and Social Medicine and Behavioural 
Insights experts from Public Health England) which aims to improve healthcare by 
developing research to support innovative ways of improving care through whole 
systems approaches.  
 
The aim of this study was to investigate the distribution of a number of variables 
relating to factors associated with MMR uptake in Somerset, to compare these factors 
within and between defined subsets of the Somerset population, to explore the basis 
on which parents in Somerset made decisions in relation to MMR immunisation, and to 
compare the findings from this study with those of previous studies described. The 
evidence presented in this thesis confirms that these aims have been achieved and the 
research questions have been answered.  
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In relation to the research questions posed at the outset, the demographic 
characteristics of the parents and children who accept, decline or fail to attend are 
clearly described in Chapter 5 and the evidence of the qualitative factors that 
influenced their original decision not to accept MMR is explored in Chapter 6.  
 
The key findings is that parents who decline or delay MMR are not a single 
homogenous group, and that there are instead, parent sub-groups within this 
population who have specific rationales and motivations for the decisions that they 
make. There is evidence that parents of children with medical conditions, and those 
who have opted for single vaccines in the past, for example, are more likely to change 
their mind and accept MMR at a later date than parents who have alternative health 
beliefs, however, the latter group forms a large proportion of the remaining 
unvaccinated population and this remains a challenge for immunisers.  
 
There are however some clear similarities between the characteristics of parents in this 
study and those described previously, particularly within the Millennium Study (Bedford 
et al, 2007), and this information can be used to inform the development of more 
effectively targeted and responsive immunisation programmes.  
 
The new information in relation to the identification of specific parent sub-groups offers 
possible explanations for parental decision-making, and the MMR Parent Engagement 
Strategy developed as a result of this improved understanding offers new structured 
ways of interacting and engaging with parents, and with health professionals who 
provide care and advice to members of the public, to improve the quality and 
effectiveness of immunisation services and a potential means of improving the uptake 
of programmes such as the MMR immunisation programme.  
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Appendix 1: MMR Coverage at 2 and 5 Years of Age, England, 1997/08 – 2011/12 
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Appendix 2: MMR Uptake in the South West and Somerset in 2008 
 
 
                    MMR uptake at 24 months of age by PCT in the South West in 2008 (MMR1) 
 
 
           MMR uptake at 5 years of age by PCT in the South West in 2008 (MMR2) 
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Appendix 3: Measles Notifications & Vaccine Coverage 1950 – 2000 
 
 
Annual Measles Notifications & Vaccine Coverage, England and Wales, 1950 - 2000 
 
 
 
 
 
 
 
 
 
 
 
 
Monthly Cases of Confirmed Measles, 2008 – March 2013, England 
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Appendix 4: Measles notifications and deaths in England and Wales: 1940 to 2013   
 
Published 10 January 2014 
 
Year Notifications 
Total 
Deaths 
1940 409,521 857 
1941 409,715 1,145 
1942 286,341 458 
1943 376,104 773 
1944 158,479 243 
1945 446,796 729 
1946 160,402 204 
1947 393,787 644 
1948 399,606 327 
1949 385,935 307 
1950 367,725 221 
1951 616,182 317 
1952 389,502 141 
1953 545,050 242 
1954 146,995 45 
1955 693,803 174 
1956 160,556 28 
1957 633,678 94 
1958 259,308 49 
1959 539,524 98 
1960 159,364 31 
1961 763,531 152 
1962 184,895 39 
1963 601,255 127 
1964 306,801 73 
1965 502,209 115 
1966 343,642 80 
1967 460,407 99 
1968 236,154 51 
1969 142,111 36 
1970 307,408 42 
1971 135,241 28 
1972 145,916 29 
1973 152,578 33 
1974 109,636 20 
1975 143,072 16 
1976 55,502 14 
1977 173,361 23 
1978 124,067 20 
1979 77,363 17 
1980 139,487 26 
1981 52,979 15 
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Year Notifications 
Total 
Deaths 
1982 94,195 13 
1983 103,700 16 
1984 62,079 10 
1985 97,408 11 
1986 82,054 10 
1987 42,158 6 
1988 86,001 16 
1989 26,222 3 
1990 13,302 1 
1991 9,680 1 
1992 10,268 2 
1993 9,612 4 
1994 16,375 0 
1995 7,447 1 
1996 5,614 0 
1997 3,962 3 
1998 3,728 3 
1999 2,438 3 
2000 2,378 1 
2001 2,250 1 
2002 3,232 1* 
2003 2,488 0 
2004 2,356 1 
2005 2,089 0 
2006 3,705 1 
2007 3,670 1 
2008 5,088 2 
2009 5,191 1 
2010 2,235 0 
2011 2,355 1 
2012 4,210 1 
2013** 6,102 1 
*Known not to be measles infection 
**Provisional data 
Source: Office for National Statistics
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Appendix 5: Literature Review MeSH Terms and Search Results 
 
 
 
 
 
Search Strategy Results 
MeSH terms  No. of Articles 
identified 
Articles included 
(2009) 
Additional articles 
identified  
(2013 - 14) 
‘parents’ AND ‘risk’ AND ‘immunisation’ 112 12 0 
‘parents’ AND ‘risk’ AND ‘MMR’ 97 9 5 
‘parents’ AND ‘perceptions’ AND ‘MMR’ 21 9 5 
‘parents’ AND ‘attitudes’ AND ‘MMR’ 76 19 9 
‘parents’ AND ‘decision-making’ AND ‘MMR’ 60 18 10 
‘parents’ AND ‘decisions’ AND ‘MMR’ 78 13 3 
‘factors’ AND ‘affecting’ AND ‘MMR’ AND ‘uptake’ 6 3 0 
‘factors’ AND ‘affecting’ AND ‘immunisation’ AND ‘uptake’ 20 4 2 
‘factors’ AND ‘influencing’ AND ‘immunisation’ AND ‘uptake’ 28 3 1 
‘factors’ AND ‘influencing’ AND ‘MMR’ AND ‘uptake’ 28 3 1 
‘MMR’ AND ‘Autism’ 
Limit to publication year 1990 – 2005 
Limit to publication year 2005 – 2013 
 
387 
289 
 
86 
28 
 
0 
23 
‘MMR’ AND ‘Bowel Problems’ 23 5 0 
‘MMR’ AND ‘Crohn’s Disease’ 50 9 3 
    
Total no. of articles reviewed 1275 229 53 
Total no. related to Autism or gastrointestinal problems and MMR 749 128 26 
No. of duplicates removed from remaining articles  51 0 
    
Policy documents and academic sources   35 
    
Total no. of articles included relating to specific factors associated with uptake  40 112 
‘individual’ AND ‘freedom’ AND ‘MMR’ 2 1 0 
‘collective’ AND ‘responsibility’ AND ‘MMR’ 1 1 (duplicate) 0 
‘Compulsory’ AND ‘vaccination’ 35 9 0 
‘Herd’ AND ‘immunity’ AND ‘MMR’ 57 5 5 
‘Vaccine’ AND ‘overload’ 83 8 2 
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Appendix 6 – Invite letter Phase 2  
 
 
Dear Parent / Guardian, 
 
Somerset MMR Immunisation Study 
 
In January 2009, the Chief Medical Officer announced a ‘catch-up campaign’ for children 
who had not received Measles, Mumps and Rubella (MMR) as part of their routine childhood 
immunisations. Your child (whose name appears on the envelope) was one of approximately 
13,800 children in Somerset who were invited to attend as part of this campaign. 
 
NHS Somerset wants to find out what parents know about immunisations, particularly MMR, 
and investigate any reasons why parents have accepted or declined this immunisation for 
their children. We are inviting the parents of all children in Somerset who were invited to 
have the immunisation during the ‘catch-up campaign’, and were between 6 and 15 years 
old at the time, to take part in this study. Please note that when we refer to parents this also 
includes ‘legal guardians’. 
 
We are really interested in your views and information, and would be grateful if you could 
take the time to complete the enclosed questionnaire and return it the FREEPOST envelope 
provided.  
 
The information will be used to help us plan and improve services for children and families in 
the future. 
  
I can assure you that the information you give will be treated in the strictest confidence, and 
no reference will be made to any individuals in any publications. The results of the survey 
will be compiled into a report about immunisation in Somerset, which will be posted on our 
website (www.somerset.nhs.uk). It will also be used to inform a wider research project which 
will explore this in more depth by interviewing parents. 
 
Completing this survey will not commit you to any further involvement.  
However, if you would like to take part, and would be prepared to be interviewed, all you 
need to do is include your contact details in the last section of the questionnaire. We will 
then contact you with more information and to discuss any future participation in the study 
with you. 
 
An Information Sheet with the answers to frequently asked questions is attached to this 
letter, but if you have any other queries regarding this survey please contact us on 01935 
384084 and leave your name and a daytime contact number. We will return your call. 
 
Thank you for your time in taking part in this survey. 
Yours faithfully 
 
 
Julie Yates 
Consultant in Public Health 
NHS Somerset 
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Appendix 7: Parent Census Survey Questionnaire 
 
 
 
MMR Project Survey 
JY Size 12 Colour new.pdf
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Appendix 8 – Parent Information Leaflet (Q & As Phase 2) 
 
What is this study about? 
This study is about finding out from parents what they understand about immunisations, 
particularly MMR, and how they then make decisions to accept or refuse these 
immunisations for their children.  
(For the purposes of this study we are including anyone with parental responsibility for the 
child when we talk about ‘parents’, for example if you are a ‘legal guardian’ then we include 
you). 
 
Why did you pick me? 
The questionnaire is being sent to parents of children who were invited to have the MMR 
immunisation as part of the 2009 ‘catch-up campaign’, and who were aged between 5 and 
15 years old at the time. We are interested in finding any reasons for accepting or refusing 
the MMR vaccine 
 
How did you get my address? 
We have access to the names and addresses of all people registered with a GP in 
Somerset. We contact patients and the public, from time to time, in order to help the NHS to 
improve the service that it provides. 
 
How can this be confidential when you have an identification number on the 
questionnaire? 
Each questionnaire has an identification number in order that we can see who has 
responded to the survey. We use the identification number to send out reminders to those 
who have not replied. Only a limited number of people are able to access the names and 
addresses, and as we will not store your personal information (name, address or which GP 
you are registered with) with your responses your anonymity will be maintained. 
 
Can I give this to someone else to complete? It seems much more relevant to them. 
The questionnaire should be answered by the person to whom it is addressed. Please feel 
free to discuss the questions with other members of your household or friends (and of 
course, they may fill in the questionnaire on your behalf) – but make sure all the answers 
relate to you and your child. 
 
Do I have to complete this questionnaire? 
It is not compulsory to complete the questionnaire, but it would help us if you would. If you 
really feel that you don’t want to complete it then you do not have to do anything. You will 
automatically be sent one reminder after about two weeks. If you do not respond to this 
within one month your identification number will be removed from the database and you will 
not be contacted again.  
 
Isn’t this very expensive to carry out? 
A very small part of the overall NHS budget is set aside to look at people’s experiences of 
NHS services. In order to improve and change services, and to make them more effective, 
we need to consult with patients and the public. As part of this work we often collect 
information which helps health professionals to plan services appropriately. 
 
If I agree to take part in this study what do I need to do?  
Please complete the enclosed questionnaire and post it back in the FREEPOST envelope 
provided. This is all you need to do for this part of the study. 
 
If I complete the questionnaire will I be involved in further research on this subject? 
 
No. You need not be involved in anything else. 
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However, there will be a second phase of the project which will involve asking parents to tell 
us about their own experiences of the immunisation processes and services. This will be 
done by interviewing parents and, if you chose to participate, would be arranged at a time 
and place convenient to you. 
 
If you would like to be involved in the second project, and would be prepared to be 
interviewed, you need to include your name and contact details in the section at the end of 
the questionnaire so that we can contact you with more information. 
 
Providing your personal details will not commit you being involved in this further research 
and you may withdraw your consent at any time if you change your mind.  
 
I’m having difficulty filling out this questionnaire 
If you would like help, we can complete the questionnaire over the telephone. It will take 
approximately 20 minutes. Please phone us on 01935 384084 and leave your name and 
daytime contact details.  
We will phone you back to save your phone bill and will help you complete it. 
 
Thank you for reading this information leaflet.  
 
If you need more information, contact the researcher:  
 
Julie Yates. 
NHS Somerset,  
Wynford House,  
Lufton Way,  
Yeovil,  
BA22 8HR 
 
Telephone: 01935 384084   
Email:  Julie.yates@somerset.nhs.uk 
 
If you would like to speak to an independent advisor who knows about this study you 
can contact: 
 
Professor William Lauder,  
Department of Nursing and Midwifery,  
University of Stirling,  
Stirling,  
FK9 4LA 
 
Telephone: 01786 466345  Email: William.lauder@stir.ac.uk 
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Appendix 9: Comparative summary of three theme based Approaches to Analysis 
(taken from Guest et al, 2012, p.17): 
 Phenomenology Grounded Theory Applied Thematic 
Analysis 
Defining 
features 
Focusses on subjective 
human experience 
Analysis typically thematic 
in nature 
Often used in humanist 
psychology, but approach 
has been adopted in 
humanities and social 
sciences 
Uses a systematic 
comparative technique to 
find themes and create 
codes 
Properly done, requires 
an exhaustive comparison 
of all text segments 
Theoretical models built 
on themes / codes that 
are ‘grounded’ within the 
data 
Identified key themes 
in text. Themes are 
transformed into codes 
and aggregated in a 
codebook 
Uses techniques in 
addition to theme 
identification, including 
word searches and 
data reduction 
techniques 
Can be used to build 
theoretical models to 
real-world problems 
Epistemological 
Leaning 
Interpretive 
Subjective meaning is 
interpreted and 
extrapolated from 
discourse 
Interpretive / positivist 
Interpretive in that 
quantification is not 
included 
Positivist in that it is 
systematic and assertions 
are required to be 
supported with evidence 
(text) 
Positivist / interpretive 
Positivist in that 
assertions are required 
to be supported by 
evidence (text) 
Processes are also 
systematic and 
quantification can also 
be employed 
Methods and 
processes (except 
those of a quantitative 
nature) can also be 
used in an interpretive 
analysis 
Strengths Good for smaller data 
sets 
Has latitude to explore 
data more deeply and 
extrapolate beyond the 
text 
Good for cognitively 
oriented studies 
Good for smaller data sets 
Exhaustive coverage of 
the data 
Interpretation supported 
by the data 
Can be used to study 
topics other than 
individual experience 
(e.g. social process, 
cultural norms etc) 
Well suited to large 
data sets 
Good for team 
research 
Inclusion of non-theme-
based and quantitative 
techniques adds 
analytic breadth 
Interpretation 
supported by the data 
Can be used to study 
topics other than 
individual experience 
Limitations Focuses only on human 
experience 
May interpret too far 
beyond what’s in the data 
Not necessarily 
systematic 
Does not include 
quantification 
Time consuming; 
logistically prohibitive for 
long data sets 
May miss some of the 
more nuanced data 
Key sources Giorgi (1970, 2009); 
Moustakas (1994); Smith, 
Flowers & Larkin (2009) 
Glaser & Strauss (1967); 
Corbin & Strauss (2008); 
Chamaz (2006) 
No one text 
Elements of inductive 
thematic analysis can 
be found in numerous 
books on qualitative 
data analysis 
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Appendix 10 
 
 
 
SOMERSET MMR STUDY 2012 
 
Interview Topic Guide for Phase 3  
 
Introduction 
 
Obtain consent and confirm understanding of study. 
 
Background 
 
Confirm details from postal questionnaire – ages of children; immunisation history; 
demographic data, etc (brief) 
 
Knowledge of immunisation and MMR  
 
 General (what does it do / how does it work?) 
 Think about the first time MMR was offered. What did they know then about 
risks of the diseases / of side effects related to immunisation? Relative risk of 
each?  
 Was this knowledge different when they were offered the vaccine during the 
catch-up campaign? 
 What are their beliefs in relation to collective responsibility / individual freedom 
in relation to immunisation? 
 What information did they have to help them make their decision? Did they feel 
sufficiently informed? 
 Where did they get their information on immunisation / MMR from? (friends, 
family, professionals (GPs, nurses, Health Visitors), the internet, media (TV, 
radio or newspapers) or somewhere else?).  
 If more than one which was most influential? 
 How did they use this information? 
 
How did they make the decision to vaccinate or not?  
 
 Was this an active or passive decision? (e.g. refused consent or just didn’t 
attend) 
 What previous experience did they have of immunisation services? (Access, 
appointments, confidence in professionals, attitudes of professionals or other 
key staff?) Positive / negative. 
 Had the child had previous immunisations? Previous children had MMR? If so, 
why different this time?  
 Explain how and why the decision was made and by whom:  
- initially 
        - during the catch-up campaign? 
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Appendix 11: MOSAIC Group Definitions 
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Appendix 12: Characteristics of interviewees 
Interview 
no. 
Area Child 
gender 
Child age 
group 
(age) 
Hosp 
adm / 
med 
condit 
Had 
MMR 
now  / 
single 
Rate 
knowledge 
Parent 
gender 
Parent 
Age 
(at 
birth) 
Smoked Marital 
status 
No. of 
children 
Birth 
order 
Ethnic 
group 
Educ 
level 
1 Coleford F Primary (8) No / 
No 
No / 
Yes 
Full F 38  Past Sep 2 1
st
 White/
British 
Prof / 
tech 
2 Yeovil M Secondary 
(12) 
Yes / 
No 
Yes Some F 45 No Married 1 1
st
 Polish 6
th
 
Form 
3 Bishops 
Lydeard 
F Primary 
(10) 
No / 
No 
No Full F 42 No Married 3 1
st
 White/ 
British 
Prof / 
tech 
4 Cheddar F Primary (8) No / 
No 
No Full F 44 No Married 2 2
nd
 White/ 
British 
Uni 
5 Queen 
Camel 
F Secondary 
(14) 
Yes / 
No 
No / 
Yes 
Some M 47 No Married 3 2
nd
 White/ 
British 
Uni 
6 Castle 
Cary 
F Secondary 
(14) 
No / 
Yes 
Yes Some F 50 Past Cohabit 1 1
st
 White/ 
British 
Uni 
7 Burnham M Primary 
(10) 
Yes / 
Yes 
Yes Some F 41 Past Married 2 1
st
 White/ 
British 
Prof / 
tech 
8 Cheddar M Primary 
(10) 
No / 
Yes 
No / 
will 
have 
Full F 44 No Married 2 1
st
 White/ 
British 
Uni 
9 Norton 
Fitzwarren 
F Primary (9) No / 
Yes 
No / 
Yes 
Limited F 39 Past Married 1 1
st
 White/ 
British 
Prof / 
tech 
10 Yeovil M Primary 
(10) 
No / 
No 
Yes Some F 49 Past Cohabit 3 3
rd
 White/ 
British 
Prof / 
tech 
11 Wells M Primary (7) Yes / 
Yes 
Yes Some F 44 Past Married 2 1
st
 White/ 
British 
Uni 
12 Taunton F Primary 
(10) 
No / 
Yes 
Yes Some M 48 No Married 2 1
st
 White/ 
British 
Uni 
13 Taunton F Secondary 
(13) 
No / 
Yes 
No  Full F 49 No Married 2 1
st
 White/ 
British 
GCSE 
14 Coleford M Primary 
(10) 
No / 
Yes 
No* Some F 36 No Married 3 1
st
 Indian Prof / 
tech 
15 Crewkerne F Primary 
(10) 
 
Yes / 
Yes 
Yes Full F 41 No Married 3 1
st
 White/ 
British 
Uni 
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16 Shepton 
Mallet 
F Secondary 
(14) 
No / 
No 
No / 
Yes 
Limited F 52 No Married 2 1
st
 White/ 
British 
Uni 
17 Yeovil M Primary (7) No / 
Yes 
No Full F 45 Yes Sep 4 3
rd
 White/ 
British 
GCSE 
18 Coleford M Primary (9) No / 
No 
No / 
Yes 
Some F 38 Past Married 1 1
st
 White/ 
British 
6
th
 
Form 
19 Taunton M Primary 
(10) 
No / 
Yes 
No / 
No 
Full M 49 No Married 3 3
rd
 White/ 
British 
Uni 
20 North 
Petherton 
M Primary (8) No / 
Yes 
No / 
Yes 
Some F 41 No Married 2 1
st
  White/ 
British 
Prof / 
tech 
 
*Not offered 
 
 
 
 
 
 
 
 
 
 
 
 
285 
 
. Appendix 13: Full list of categories (codes) and themes derived from the Phase 3 Thematic Analysis 
Category (Code) Sources References Created on Created 
by 
Modified on Modified 
by 
Risks of disease vs vaccinations 21 129 13/11/2012 14:31 JFY 21/11/2013 03:50 JFY 
Autism 21 108 13/11/2012 14:33 JFY 20/11/2013 23:49 JFY 
Advantages and disadvantages 10 111 20/05/2013 16:43 JY 14/11/2013 02:41 JFY 
Knowledge of the immune system and how vaccines 
work 
9 26 04/11/2013 07:14 JFY 14/11/2013 04:11 JFY 
More information on the diseases 8 20 20/05/2013 16:53 JY 14/11/2013 01:07 JFY 
Adverse events after immunisation 7 16 04/11/2013 09:05 JFY 14/11/2013 05:26 JFY 
Statistics 5 22 20/05/2013 16:43 JY 14/11/2013 03:23 JFY 
No side effects 3 5 21/05/2013 07:35 JY 04/11/2013 09:02 JFY 
How the vaccine is made 2 11 20/05/2013 17:47 JY 21/11/2013 03:50 JY 
Vaccine overload 17 69 14/11/2012 18:25 JY 14/11/2013 05:01 JFY 
Delay 15 38 13/11/2012 14:39 JY 21/11/2013 03:50 JY 
Media 16 46 13/11/2012 15:18 JFY 21/11/2013 04:08 JFY 
Irresponsible media reporting 7 25 20/05/2013 17:41 JFY 14/11/2013 05:31 JFY 
Openness and honesty 3 38 20/05/2013 16:46 JY 14/11/2013 05:16 JFY 
       Mistrust 9 95 14/11/2012 18:45 JY 14/11/2013 05:10 JFY 
       Unbiased information 5 41 20/05/2013 16:44 JY 31/10/2013 02:30 JFY 
            Trusted sources 1 1 31/10/2013 02:30 JFY 31/01/2014 01:23 JY 
       Independent research 4 20 20/05/2013 16:42 JY 21/11/2013 03:50 JFY 
Single Vaccines 15 142 13/11/2012 14:31 JY 21/11/2013 04:19 JFY 
More support from Professionals 11 91 20/05/2013 16:49 JY 14/11/2013 04:25 JFY 
Information Format 6 10 31/10/2013 01:05 JFY 07/11/2013 09:38 JFY 
       Written information 3 12 20/05/2013 16:46 JY 21/11/2013 04:15 JY 
Information confusing 5 10 13/11/2012 14:33 JY 
JFY 
14/11/2013 05:19 JY 
Problems with access 5 11 13/11/2012 14:40 JFY 20/05/2013 19:36 JFY 
Antenatal information 1 4 20/05/2013 17:28 JY 21/11/2013 04:15 JFY 
Inconsistent professional advice 15 60 20/05/2013 16:48 JY 21/11/2013 03:50 JFY 
Other Medical Co-morbidities 11 42 14/11/2012 18:28 JY 14/11/2013 05:20 JFY 
Allergy 3 11 13/11/2012 15:10 JY 20/05/2013 16:32 JFY 
‘needle phobia’ 1 2 14/11/2012 18:47 JY 20/05/213 18:12 JFY 
Previous adverse reactions to vaccines 1 21 13/11/2012 14:39 JFY 21/11/2013 04:20 JFY 
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Natural Health or Holistic Approaches 4 1 20/05/2013 18:04 JY 14/11/2012 04:05 JFY 
Non-conformist 5 6 14/11/2012 18:43 JFY 14/11/2013 04:23 JFY 
Homeopathy 5 22 13/11/2012 14:30 JY 04/11/2013 09:24 JFY 
Wider health of families 3 14 13/11/2012 14:35 JFY 06/11/2013 05:29 JFY 
Having symptoms is good 2 4 04/11/2013 08:51 JY 31/10/2013 02:43 JFY 
Breastfeeding 1 3 31/10/2013 02:41 JY 04/11/2013 09:08 JFY 
Alternative information sources 1 5 04/11/2013 08:44 JFY 21/11/2013 03:50 JFY 
Medical models, politics and health 4 16 13/11/2012 14:37 JY 14/11/2013 05:07 JFY 
Freedom vs responsibility 16 40 31/10/2013 14:37 JY 21/11/2013 04:09 JFY 
Bullying 15 46 31/10/2013 02:21 JY 21/11/2013 04:09 JFY 
Financial incentives 10 37 13/11/2012 14:27 JFY 10/11/2013 09:59 JFY 
UK vs other countries 4 23 20/05/2013 16:52 JFY 04/11/2013 09:23 JFY 
Drug companies 3 18 14/11/2012 19:03 JY 21/11/2013 04:12 JFY 
Waste of tax payers’ money 1 5 13/11/2012 14:34 JY 21/11/2013 03:50 JFY 
Parents’ choice 3 23 13/11/2012 14:29 JY 31/10/2014 01:23 JFY 
Family influences 17 46 20/05/2013 15:45 JFY 21/11/2013 04:30 JY 
Difficult decisions 17 44 31/10/2013 00:50 JFY 21/11/2013 04:32 JFY 
No choice 14 65 04/11/2013 06:55 JY 20/05/2013 19:32 JFY 
      Serology 1 3 20/05/2013 16:51 JY 21/11/2013 04:30 JFY 
Differing parental opinions 13 21 20/05/2013 18:39 JFY 14/11/2013 03:35 JFY 
Guilt 10 28 14/11/2012 18:48 JFY 13/11/2012 15:17 JFY 
      Gender 1 3 31/10/2013 00:41 JY 14/11/2013 05:22 JFY 
Birth order 5 10 13/11/2012 15:11 JFY 14/11/2013 04:22 JFY 
Child’s choice 3 4 04/11/2013 07:19 JFY 14/11/2013 18:56 JFY 
Flexibility 1 5 20/05/2013 16:50 JY 20/05/2013 18:47 JY 
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Appendix 14: Examples of Outputs from the Phase 3 Deductive Process 
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